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Chapter 1 
Advancements of medical care and rehabilitation in the past decades have contributed to 
longer life expectancies for people with cerebral palsy (CP). Adults with CP may experience 
health problems and functional limitations such as chronic pain or fatigue, a low level of 
physical fitness, difficulty in walking, dependency in self-care, and early onset of chronic 
diseases. A substantial proportion of adults with CP have low levels of physical activity 
and seem restricted in their participation, for example in paid employment. Additionally, 
their functioning, disability, and health changes across the lifespan in response to aging. 
Because of increasing physical disability with increasing age, people with CP are suggested 
to experience accelerated aging. Systematic follow-up of the core outcomes that reflect the 
most important health issues, activities and participation of adults with CP would allow us to 
design appropriate rehabilitation interventions and prevention strategies for this population.
This thesis describes the level and long-term course of functioning, disability, and health 
in adults with CP, and the core outcomes for this population based on current literature. In 
addition, it describes how a core outcome measurement set for adults with CP is developed, 
focusing on chronic disease risk.
CEREBRAL PALSY
Cerebral palsy (CP) is the most common cause of physical disability in childhood, with a 
prevalence ranging from 1.7 to 3 per 1,000 live births.1 According to its definition, CP 
describes a group of permanent movement and posture disorders that result from non-
progressive disturbances to the developing fetal or infant brain. Impairments commonly 
associated with the condition are included in the definition because of their substantial 
impact on the individual. The motor disorders of CP are often accompanied by disturbances 
of sensation, perception, cognition, communication and behavior, by epilepsy, and by 
secondary musculoskeletal problems.2 Almost half of the population has a moderate to 
severe intellectual disability.3
The existence of different typologies refers to the complexity of CP. Clinical signs and 
symptoms, topographical involvement of extremities, and the severity of the motor 
disorders may differ largely between each individual with CP. The three main types of 
clinical symptoms and signs (spasticity, dyskinesia, or ataxia) can manifest in either all 
four limbs (quadriplegia), primarily on one side of the body including one upper and lower 
extremity (hemiplegia), or primarily in the lower extremities (diplegia).4, 5 The Surveillance of 
Cerebral Palsy in Europe (SCPE) agreed on distinguishing four main types of CP: unilateral 
spastic, bilateral spastic, dyskinetic, and ataxic.6 The severity of motor disorders can be 
classified by the Gross Motor Function Classification System (GMFCS)7. In this system, 
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Introduction
distinction between five levels of gross motor functioning is based on ambulatory and 
postural abilities, the need for assistive technology, and – to a much lesser extent – quality 
of movement. Individuals with GMFCS level I generally walk without restrictions, but speed, 
balance, and coordination may be limited. At the other end of the spectrum, individuals with 
GMFCS level V are dependent on extensive assistive technology and physical assistance.7 
Approximately 60% of the population is classified as GMFCS level I-II and thus has a mild 
motor impairment.8
Lifelong condition
Due to several advances in healthcare resulting in increased survival, nowadays most 
individuals with CP have a nearly normal lifespan.9 If ambulatory, manual, mental, and visual 
impairments are not severe, life expectancy is close to that of the general population.9, 10 
Adults with CP represent a growing population and now outnumber children and youth 
with CP by approximately 3:1.11 Consequently, clinicians and researchers are changing their 
perspectives towards considering CP as a lifelong condition.
Aging with CP demands a lot from the individual’s body and its available capacity. Over 
time, neuromuscular and skeletal changes occur that can lead to secondary health issues: 
additional health problems that occur as a result of having a primary disability.12, 13 Common 
examples in CP are pain, fatigue, or depression.14 Furthermore, adults with CP often 
acquire chronic diseases like cardiovascular disease, diabetes, or chronic lung disease, at a 
younger age compared to the general population.15, 16 These additional health conditions 
(i.e. comorbidities) can develop independently of the primary disability. Aging with CP 
therefore presents itself in three different forms: (1) normal aging as it affects everyone, 
where body functions become less vital and deteriorate; (2) increasing secondary health 
issues that are influenced by the primary disability (e.g. pain resulting from spasticity); and 
(3) early onset of comorbid, chronic diseases (e.g. cardiometabolic disease).
CONSEQUENCES OF CEREBRAL PALSY
The primary movement and posture disorders, secondary health issues, and comorbid 
chronic diseases that may occur in people with CP, have lifelong consequences for their 
level of functioning. Outcomes of functioning are often described by the International 
Classification of Functioning, Disability and Health (ICF).17 This conceptual framework 
can be used to describe the consequences of a health condition, like CP, in a broader 
biopsychosocial context. The ICF distinguishes the components of body functions and 
structures, activities and participation, and elaborates on their interactions. Importantly, 
the framework also incorporates the notion that personal and environmental factors 
1
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Chapter 1 
can facilitate or hinder successful functioning (Figure 1). In the ICF, the term functioning 
refers to all body functions and structures, activities and participation, while disability is 
the parallel term for body impairments, activity limitations and participation restrictions. 
For healthcare providers, the ICF provides a basis to guide goal setting and intervention 
planning, and assists them to look beyond their own areas of practice and communicate 
across disciplines.18 On a population level, the ICF allows for understanding and studying 
functioning, disability and health, and for describing outcomes and its determinants.
Figure 1.1 The International Classification of Functioning, Disability and Health (ICF) framework.17
Body functions and health issues
Body functions refer to physiological functions of the body, such as neuromotor functions 
related to joints, muscles, and movement. Impaired neuromuscular functions are hallmark 
for CP and present symptoms such as spasticity, hypertonia, muscle weakness, or lack 
of selective motor control.19 These body impairments can lead to a variety of health 
issues. For example, spasticity and hypertonia may result in musculoskeletal problems 
(e.g. muscle contractures, joint dislocation)20 that often result in or are accompanied by 
pain and/or fatigue.14, 21-23 Both pain and fatigue are more frequently reported by people 
with CP compared to the general population.22, 24 Impairments can also occur in functions 
of ingestion (e.g. difficulties in swallowing), digestion, voice, or speech.25 Other common 
health issues in CP include epilepsy, disturbed bowel and bladder function, respiratory 
problems, and sensory problems such as seeing or hearing impairments.25, 26 These health 
issues, in conjunction with musculoskeletal problems, may also result in sleep disorders.27
Health-related physical fitness
People with CP demonstrate low levels of health-related fitness, including poor 
cardiorespiratory endurance, unfavorable body composition, and low muscular strength.28 
Studies consistently report low levels of cardiorespiratory endurance for children, 
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adolescents, and adults with CP.28-30 Overweight and obesity are common, but literature is 
inconsistent regarding differences between people with CP and the general population.28, 31 
Reduced levels of health-related fitness may contribute to the worsening of health issues and 
development of chronic diseases. Recent reports have demonstrated that adults with CP are 
at heightened risk of multimorbidity,32-34 the presence of multiple (comorbid) chronic diseases.
Activities
Activity refers to the execution of a task or action, like activities of self-care and mobility 
in which people with CP may experience limitations. Self-care encompasses general daily 
activities like washing, toileting, dressing, eating and drinking.17 Limitations herein may 
primarily be the result of impaired body functions. Although many adults with CP indicate 
independency in performing self-care activities, the level of need of help may increase 
over time.35 This increase in need for help is even more marked in activities of mobility like 
walking or moving around in a wheelchair.35
Physical behavior
Physical behavior refers to an individuals’ behavior in terms of body postures, movements, 
and/or daily activities, and encompasses both physical activity and sedentary behavior.36 
Physical activity is recognized as important health-promoting behavior throughout the 
lifespan of every individual. However, due to the health issues associated with the condition, 
participating in physical activity is often challenging for people with CP. Indeed, physical 
activity levels are low and sedentary behavior is high in those with CP.27, 29, 37, 38 Interventions 
to improve this physical behavior are moderately effective,39, 40 which is alarming considering 
its concomitant risk of (early onset of) chronic disease and multimorbidity.
Participation
Participation is defined as involvement in life situations and includes domestic life, 
interpersonal relationships, employment, community life and recreation and leisure.17 
Despite relatively high participation levels in young adults with CP, most of them experience 
difficulties in participation.41 Restrictions in participation are also seen in middle-aged adults 
with CP; fewer individuals are employed compared to the general population.42
OUTCOME MEASUREMENT
Outcome measurement, typically referring to the measurement of health-related outcomes, 
is essential in clinical practice and health research. An outcome is defined as the construct 
or aspect of interest, or the what to measure. An outcome measurement instrument is the 
means used to quantify this outcome, or the how to measure (e.g., examinations by health 
1
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professionals, biomarkers, patient-reported questionnaires, or performance-based tests). 
Results of these measurements can be used as a basis for clinical management.
As the number of potential outcomes and available outcome measurement instruments has 
increased dramatically over the past decades, the choice of which outcome measurement 
instrument to use for a given outcome has become more difficult. Often multiple outcome 
measurement instruments can assess the same outcome in a specific population. This leads 
to inconsistency in reporting outcomes, making it difficult to compare findings across different 
clinical studies or institutions. Consequently, research or intervention evaluations become 
less informative for clinical practice. A solution to this problem is to standardize outcome 
measurement by determining core outcomes and core outcome measurement instruments.43
Core outcomes
Core outcomes are recommendations of what should be measured and reported in clinical 
practice and health research in a specific population. For adults with CP, a large number 
of potential outcomes can be measured, which is clearly reflected in the current literature 
on this population. Inconsistency in the currently reported outcomes for adults with CP 
can be overcome by describing these outcomes in the ICF framework. Core outcomes can 
also be targeted to a specific area within a specific population, for example, risk of chronic 
diseases and multimorbidity in adults with CP.
Core outcome measurement instruments
Once an initial list of core outcomes –in a specific population or area– is identified, it should 
be determined how these outcomes can be measured and reported.43 To this end, core 
sets of outcome measurement instruments are developed, including recommendations 
and details on the instruments to use that measure the core outcomes. The development 
of a core set generally includes stakeholders representing all perspectives, including those 
from clinicians, researchers, and from the target population. After development, such a core 
set can be implemented in clinical practice and health research for the standardization of 
outcome measurement in a specific population or area.
AIMS AND OUTLINE OF THIS THESIS
Despite an increasing number of studies providing insight into the consequences of 
CP at adult age, current knowledge is limited by a lack of longitudinal studies. As such, 
there is a need for evidence describing the consequences of aging with CP. Furthermore, 
core outcomes for adults with CP are lacking, and to date no attempt has been made to 
standardize outcome measurement for (consequences of) CP in adulthood. The first aim 
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of this thesis was to improve our knowledge on the consequences of CP at (increasing) adult 
age. Secondly, it aimed to identify core outcomes for adults with CP, using the ICF framework 
as a reference. The third aim was to develop a core outcome measurement set for individuals 
with CP, focusing on chronic disease risk and multimorbidity. Figure 1.2 presents an outline 
of the aims and chapters of this thesis and their overlying concepts.
Figure 1.2 Outline of the content of this thesis.
The first part of this thesis describes the level and long-term course of outcomes across 
the ICF framework. In Chapter 2, we studied pain and its characteristics and determinants 
in adults with CP by means of a meta-analysis of individual participant data. Chapter 
3 describes a prospective cohort study exploring the long-term course of perceived 
health, health issues, self-care, and mobility in adults with CP. The long-term course of 
employment was explored for this cohort in Chapter 4, were we identified subgroups at risk 
for unemployment. Then, in Chapter 5 we broadened our scope with a systematic literature 
review that explored the core outcomes in published literature on adults with CP, again 
across the ICF. In the last part, the development of a core outcome measurement set to 
monitor risk factors of chronic diseases and multimorbidity is described. Chapter 6 presents 
the study protocol of the development of this core set, targeting the following outcomes: 
cardiorespiratory endurance, body composition, physical behavior, sleep, nutrition, blood 
pressure, and blood lipids and glucose. In Chapter 7, the selection of outcome measurement 
instruments into a preliminary core set, by means of a literature review and Delphi 
procedure with clinical and research experts, is explained. Finally, Chapter 8 discusses the 
main results of this thesis. Strengths and limitations of the studies described above, and 
clinical implications and suggestions for future research are discussed.
1
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ABSTRACT
Objective: To describe longitudinal change in perceived health, presence of health issues 
and functional level in adults with cerebral palsy (CP).
Design: Prospective cohort study.
Setting: Participants’ daily environment.
Participants: Adults (n=49) with CP (age range, 35-45y; 27 (55%) men; 36 (75%) spastic) 
formerly known in pediatric rehabilitation care participated.
Interventions: Not applicable.
Main Outcome Measures: Postal questionnaires were completed by the adults or their 
proxies (n=9). Health outcomes included perceived health (adapted from the 36-Item 
Short Form Health Survey) and presence of health issues such as pain, severe fatigue 
(dichotomized), and functional level (Barthel Index; walking performance).
Results: Over a 10-year period, the percentage of adults with CP worrying about their 
health increased (29%-54%, p=0.008) and those indicating that health problems limit their 
activities increased (19%-45%, p=0.002). In the same period, most adults continued to 
report good general health (93%-86%, p=0.148). Presence of some health issues increased 
over time, such as pain; severe fatigue was a common health issue at follow-up (32%). 
Over a 14-year period, mobility and self-care deteriorated (Barthel Index, 17.1 [SD 4.8] to 
16.3 [SD 5.6], p=0.007). Walking performance, specifically indoors, declined (83%-71%, 
p=0.010).
Conclusions: Adults with CP experienced deterioration in health outcomes in the long term. 
Most notably, perceived health and functional level decreased. Pain and severe fatigue 
were the most common health issues in adult CP. More research is required to explore 
the mechanisms at work in the process of aging in persons with CP. Systematic follow-up 
of adults with CP appears necessary to timely detect and intervene in health problems. 
and functional decline
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Long-term functioning in adults with cerebral palsy
INTRODUCTION
Cerebral Palsy (CP) describes a group of permanent disorders of movement and posture 
causing activity limitation, attributed to nonprogressive disturbances in the developing 
fetal or infant brain.1 CP affects approximately 2 in 1000 live births.2,3 Based on increases 
in survival rate and longevity of individuals with CP, currently most persons with CP are 
adults.4 Bearing in mind this demographic age distribution, it is essential to use a life span 
perspective with regard to health care services.5-7
In cross-sectional studies in adults with CP, pain and fatigue are frequently reported with a 
high prevalence and co-occurrence.8-11 Musculoskeletal problems (such as joint deformities) 
are reported in 15% to 57% of younger adults.5 Other health problems include bowel 
and bladder incontinence, feeding problems, epilepsy, depressive symptoms, and sensory 
impairments.5,12 Moreover, adults with CP experience deterioration of walking.12-15 For 
example, 52% of the adults with CP retrospectively reported walking deterioration over 
a 7-year period.14 Deteriorated walking was associated with bilateral CP, greater pain, and 
greater effect of pain on activities of daily living. The prevalence of daily pain increased over 
a 7-year period, whereas fatigue did not.14 Loss of self-care skills (e.g., eating, bathing, and 
dressing) has also been reported.16 However, in the latter studies, adults with intellectual 
impairments were excluded. Data on the course of other health problems are largely lacking.
Cieza et al.17 indicated that in several clinical populations, mobility, self-care, and pain were 
among the explanatory factors for perceived general health. For adults with CP, it remains 
unknown whether similar factors explain their perceived health. Knowledge of determinants 
of perceived health and insight into the longitudinal change of health and functioning is 
necessary to improve health care for adults with CP. Therefore, the present study aims 
to prospectively assess perceived health, self-reported health issues, and functional level 
of adults with CP and investigate the longitudinal change over 10 or 14 years. In addition, 
associations with perceived health are explored.
METHODS
A representative Dutch cohort of adults with CP, formerly treated in pediatric rehabilitation, 
was prospectively followed since 1996. At baseline, the following inclusion criteria were 
applied: (1) diagnosis of CP; (2) born between 1965 and 1974; and (3) known to the 
rehabilitation center in The Hague, a center with a regional adherence area.18 Participants 
were assessed at baseline (n=80), 4-year follow-up (n=54),5 and 14-year follow-up (n=49). 
The total cohort comprised 88 adults, because 8 adults were enrolled at 4-year follow-
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up. The present study focuses on the results of 49 participants for whom longitudinal 
data were available over a 10- or 14-year period. The study was approved by the Medical 
Ethics Committee of Reinier de Graaf Medical Center (Delft, ME 00-14). All participants 
provided informed consent.
Measurements
Fourteen-year follow-up was conducted through postal questionnaires. Participants were 
requested to self-report, with (physical) assistance if required; for another 9 persons their 
primary caregiver completed the questionnaire because of intellectual impairment. This 
enabled those with severe physical disability or intellectual impairment to participate and 
was consistent with baseline and 4-year follow-up data (methods described elsewhere).5,18 
Demographic and clinical characteristics were measured at baseline, 4-year follow-up, 
and 14-year follow-up unless otherwise stated. Perceived health and health issues were 
measured at 4- and 14-year follow-up; functional level at baseline and 14-year follow-up.
Demographic and clinical characteristics
The following characteristics were recorded: age, sex, marital status, having children, level of 
education, type and laterality of CP, and gross motor function. Type of education, assessed 
at inclusion, was used as an indicator for intellectual impairment: adults who either had no 
primary education or attended day centers or special education for children with severe 
learning difficulties were classified as having an intellectual impairment.19 Level of education 
was categorized as low (prevocational practical education or lower, including intellectual 
impairment), medium (prevocational theoretical education and upper secondary vocational 
education), or high (secondary education, higher education, and university).20 The subtype 
of CP (spastic or nonspastic) and its laterality (unilateral or bilateral) were collected from 
the medical files at inclusion. The level of gross motor function was classified at the 4-year 
follow-up according to the Gross Motor Function Classification System (GMFCS).21 For 
those not participating in 4-year follow-up, the GMFCS level was determined post hoc 
using baseline information on walking function, climbing stairs, and use of assistive mobility 
devices; these scores were dichotomized (level I-III vs level IV-V).
Perceived health
Perceived health was assessed by 3 questions similar to the 36-Item Short Form Health 
Survey items that address personal evaluation of health and role limitations, including 
current health, health outlook or worry, and interference of health with daily activities.22 
Questions were as follows: “Do you usually feel healthy?” “Do you worry about your 
health?” and “Do problems with your health limit your activities?” and these were answered 
either yes (1) or no (0).5
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Health issues
Three components of the McGill Pain Questionnaire (MPQ)23 were assessed: (1) presence 
of pain; (2) pain intensity; and (3) pain effect. Presence of pain was scored either yes or 
no; least and worst pain intensity were scored on a horizontal 100-mm visual analogue 
scale; and pain effect was assessed by the McGill Pain Questionnaire- Quality of Life Index 
(MPQ-QLI) (range, 0-27), with higher scores indicating a higher effect.23 Medication use in 
the past 2 years defined whether experiencing epilepsy, respiratory, and gastrointestinal 
problems. Participants were asked whether they had regular constipation or problems 
with swallowing. Bowel and bladder incontinence were derived from the scores on the 
corresponding items of the Barthel Index.24,25 At 4-year follow-up, these two items were 
derived from the Functional Independence Measure and converted to Barthel scores.5,26 
Severity of fatigue was assessed with the Fatigue Severity Scale,27 consisting of 9 statements 
concerning severity and effect on a 7-point Likert scale. Based on the mean score, severe 
fatigue (Fatigue Severity Scale, ≥5.1) was assessed.28 Limitations in vision and hearing were 
assessed by 4 questions derived from the physical limitations indicator developed by the 
Organization for Economic Cooperation and Development.29 Speech problems addressed 
speech intelligibility and were assessed by asking participants whether their speech was 
comprehensible over the telephone. Presence of the above health issues were coded either 
yes (1) or no (0). At 4-year follow-up, severe fatigue was not assessed and methods to assess 
swallowing, speech, vision, and hearing problems deviated from 14-year follow-up.5 Hence, 
only data at 14-year follow-up were available for these health issues.
Functional level
Functional level addressed both mobility and self-care (Barthel Index) as well as walking 
performance. The Barthel Index24,25 measures independence in performance of mobility 
and self-care activities, resulting in a sum score (range, 0-20), with higher scores indicating 
more independence. Two domain scores differentiated between mobility and self-care items. 
The mobility domain (range, 0-8) includes transfer, mobility and stairs. The self-care domain 
(range, 0-8) includes dressing, bathing, grooming, feeding, and toileting.30 We assessed walking 
performance (1=walking, if required with assistive devices; 0=not walking) for 3 distances: 
<10m (indoors), 10-100m (short distances outdoors), and >100m (long distances outdoors).
Statistical analyses
Descriptive statistics were used to present sample characteristics and outcomes. Logistic 
regression analysis explored loss to follow-up. To explore longitudinal change in perceived 
health, health issues, and functional level, we performed generalized estimated equation 
analyses with exchangeable correlation structures.31 Time was entered as predictor of the 
outcomes in each model; parameter estimates (B) with 95% confidence intervals (CIs) were 
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determined for both dichotomous and continuous outcome variables. Complementary to 
generalized estimated equation models for dichotomous variables, proportions of change 
(increase and decrease) between the 2 relevant time points were calculated and tested for 
significance by the 95% CI.31 We chose this method over the McNemar test because we 
were interested in proportions of participants changing in a specific direction. The results 
of longitudinal data analyses were validated for robustness by performing the analyses 
excluding those participants using proxy reports.
At 14-year follow-up, associations with perceived health were explored cross-sectionally 
by logistic regression analyses performed in 2 steps. First, univariate models tested 
associations for participants’ characteristics, health issues, and functional level. Second, 
multivariate models were performed entering a significant (p<0.05) factor from the first 
step, with adjustment for intellectual impairment and GMFCS level. To accommodate the 
sample size, separate models were tested for each factor one at a time. Data were analyzed 
using SPSS version 21.0 (IBM SPSS Statistics, Armonk, NY, USA).
Table 3.1. Characteristics of participants at 14-year follow-up (n=49).
Characteristics Participants (n=49)
Males/females, n 27/22
Age, mean (SD) 39.8 (3.0)
Age, range 35-45y
Respondent, n (%)
Self-report 30 (61)
Assisted self-report 10 (21)
Proxy 9 (18)
CP subtype,a n (%)
Spastic 36 (75)
Unilateral 18 (38)
Bilateral 18 (38)
Non-spastic 12 (25)
GMFCS, n (%)
Level I-III 39 (80)
Level IV-V 10 (20)
Intellectual impairment, n (%) 11 (22)
Education level, n (%)
Low 31 (63)
Medium 11 (22)
High 7 (14)
Marital status,a n (%)
Single 32 (67)
Married/cohabitating 16 (33)
Having children, n (%) 10 (21)
a Missing data for CP subtype (n=1) and marital status (n=1). GMFCS, Gross Motor Function Classification 
System.
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RESULTS
Of the 88 adults invited for 14-year follow-up, 64 were reached (23 unknown addresses, 1 
deceased). Six returned blank questionnaires, and 9 did not respond for unknown reasons. In 
total, 49 adults (56% of cohort; 77% of eligible persons) consented to participate and completed 
the questionnaire, of whom 10 with assistance and 9 proxies. There were no differences 
between respondents and nonrespondents with regard to age, sex, laterality, GMFCS level, 
or intellectual impairment (χ2(1)=1.86, p=0.17). Of these 49, 18 had not participated in 4-year 
follow-up, therefore, longitudinal data of perceived health and health issues were available 
for a subsample of 31 (6 proxy). One participant had no baseline data; therefore, longitudinal 
data of functional level were available for 48 (8 proxy). Characteristics of the study sample 
are summarized in Table 3.1.
Perceived health, health issues and functional level
Table 3.2 presents the longitudinal change for perceived health and health issues (10-year 
period) and functional level (14-year period). Percentages and mean scores at 2 time points 
are shown in Figure 3.1, including health issues with data only at 14-year follow-up. Over 
a 10-year period, there was an increase in worrying about health (29% increase, p=0.008) 
(see Figure 3.1A) and being limited in activities because of health problems (26% increase, 
p=0.002). Most adults continued to report good general health.
Over a 10-year period, the percentage of adults reporting pain increased to 71% (16% 
increase, significant proportion of change) (see Figure 3.1B). The level of least pain intensity 
increased (4.2 [SD 9.5] to 15.1 [SD 17.0], p=0.006); the worst experienced pain did not 
change (68.5 [SD 29.4] to 74.9 [SD 19.3], p=0.470). The effect of pain on daily life remained 
stable (MPQ-QLI 3.0 [SD 4.4] to 5.3 [SD 5.6], p=0.138). The increase in gastrointestinal 
problems was significant in the complementary analysis (17% increase). Presence of 
epilepsy, respiratory problems and constipation, and bowel and bladder incontinence 
were unchanged. At the 14-year follow-up, 32% was severely fatigued (see Figure 3.1B). 
All adults with severe fatigue also reported pain; among the 22 adults with pain, severe 
fatigue was prevalent in 46%.
Over a 14-year period, the Barthel Index decreased (17.1 [SD 4.8] to 16.3 [SD 5.6], 
p=0.007) (see Figure 3.1C); 13 adults (28%) declined at least two points on the 0 to 20 
scale. Scores of both the mobility and the self-care domains decreased (6.8 [SD 2.4] to 6.5 
[SD 2.7], p=0.048 and 6.6 [SD 2.1] to 6.2 [SD 2.4], p=0.013, respectively). The percentage 
of adults walking indoors decreased (12% decrease, p=0.010); also, the percentage walking 
short distances outdoors decreased (13% decrease, significant proportion of change). The 
percentage walking long distances outdoors remained stable (see Figure 3.1C).
3
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Table 3.2. Longitudinal change in perceived health, health issues, and functional level.
GEE Model* Complementary Method
Outcome
B 95% CI p
Proportions of 
change† (%)
95% CI
Perceived health (n=31)
Usually feel healthy -0.80 -1.89, 0.29 0.148 - 7
0
-0.02, 0.16
NA
Worry about health 1.14‡ 0.30, 1.98 0.008 - 4
+ 29§
-0.03, 0.10
0.12, 0.45
Health problems limit activities 1.23‡ 0.45, 2.02 0.002 0
+ 26§
NA
0.10, 0.41
Health issues (n=31)
Pain 0.57 -0.09, 1.23 0.092 - 3
+ 16§
-0.03, 0.09
0.03, 0.29
Least intensity 9.43‡ 2.72, 16.14 0.006 NA
Worst intensity 6.20 -10.62, 23.02 0.470 NA
Impact (MPQ-QOL) 1.91 -0.61, 4.43 0.138 NA
Epilepsy 0 NA NA 0
0
NA
NA
Respiratory problems 0 NA NA - 3
+ 3
-0.03, 0.09
-0.03, 0.09
Gastrointestinal problems 0.45 -0.72, 1.62 0.446 - 10
+ 17§
-0.01, 0.21
0.03, 0.30
Constipation -0.26 -1.14, 0.62 0.563 - 7
+ 3
-0.02, 0.15
-0.03, 0.09
Bowel incontinence 0.44 -0.42, 1.30 0.313 0
+ 3
NA
-0.03, 0.09
Bladder incontinence 0 NA NA - 3
+ 3
-0.03, 0.09
-0.03, 0.09
Functional level (n=48)
Barthel Index -0.81‡ -1.40, -0.22 0.007 NA
Mobility -0.39‡ -0.77, -0.01 0.046 NA
Self-care -0.30‡ -0.53, -0.06 0.013 NA
Walking indoors (<10m) -0.72‡ -1.27, -0.17 0.010 0
- 12§
NA
0.03, 0.22
Walking outdoors (10-100m) -0.28 -0.82, 0.26 0.313 + 6
- 13§
-0.01, 0.13
0.03, 0.22
Walking outdoors (>100m) 0 NA NA + 8
- 8
0.01, 0.16
0.01, 0.16
Perceived health, health issues over a 10-year period (n=31), functional level over a 14-year period (n=48); 
parameter estimates (B) are unstandardized. * Logistic GEE models for dichotomous outcome variables 
(health issues, walking performance; yes=1, no=0); linear GEE models for continuous outcome variables 
(pain intensity and effect, Barthel Index). † Proportions of decrease (-) and increase (+) for dichotomous 
outcomes. When the proportion equaled zero, the 95% CI could not be determined. ‡ p<.05. § Significant 
by means of 95% CI. GEE, generalized estimating equation; NA, not applicable.
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Figure 3.1. Perceived health, health issues and functional level over time.
(A) Perceived health over a 10-year period (n=31). (B) Health issues over a 10-year period (n=31). (C) 
Functional level over a 14-year period (n=48). * Significant change in generalized estimating equation 
analysis (p<.05). † Significant proportion of change (increase or decrease).
Robustness
Additional analyses excluding those participants using proxy reports showed similar results, 
except for a trend for longitudinal change in the Barthel Index (17.7 [SD 4.3] to 17.1 [SD 4.9]; 
B= -0.55, 95% CI -1.15 to 0.05, p=0.07) and no significant change in the mobility domain 
(6.7 [SD 2.1] to 6.5 [SD 2.3]; B= -0.23, 95% CI -0.62 to 0.17, p=0.26).
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Determinants of perceived health
At 14-year follow-up, being worried about health was significantly associated with 
presence of pain and severe fatigue and a higher functional level (Barthel Index and walking 
performance on short distances) in the univariate models (Table 3.3). Adults with intellectual 
impairment were less likely to be worried. In the models adjusted for intellectual impairment 
and GMFCS level, only pain and severe fatigue remained significant. Similarly, pain and 
severe fatigue were associated with health problems limiting activities. Associations with 
usually feeling healthy were not explored because of skewed distribution.
DISCUSSION
In this adult study population, perceived health decreased considerably, presence of some 
health issues increased, and functional level deteriorated slightly. Although most adults 
continued to report good general health, adults with CP became increasingly more worried 
about their health and perceived more effect of their health problems on activities of daily 
living. Pain and severe fatigue were the most common health issues and were associated 
with perceived poor health.
Thus, at adult age, persons with CP are facing new or increasing health problems, which 
may lead to reduced functional independence and decreased quality of life in persons aging 
with CP.32 In the general population, neither of these changes seem to occur before middle 
age.33 This suggests that people with CP may experience accelerated aging. However, it is 
yet unknown to what extent this is directly related to CP itself.
Pain was reported in 71%, which is in accordance with reported pain prevalences in adults 
with CP of 62% to 83%.11,14,34-36 In line with Opheim et al.,14 who surveyed adults with CP 
without intellectual impairment, pain prevalence increased over time. Those authors found 
no change in pain intensity, whereas we observed an increase of the least pain intensity. 
Moreover, they found an increasing impact of pain on daily activities,14 whereas we did 
not. This may be explained by a difference in scales used. Prevalence and co-occurrence of 
pain and severe fatigue were comparable to those in adults with spastic bilateral CP,11 thus 
adding to the evidence of a pain/fatigue complex in adults with CP. Associations between 
fatigue and pain, as well as exertion as cause of increased pain, have been reported in adults 
with CP.36,37 Our results support this, since all severely fatigued adults also reported pain.
Independence in mobility and self-care decreased over time. Although the changes were 
small, such decrease has previously been reported.16 This is consistent with our clinical 
experience that at increasing age, adults with CP may have a greater need for assistance 
in these activities. 
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Furthermore, we observed a significant proportion of adults who deteriorated in their walking 
performance at short distances. A recent systematic review showed that in 25% or more 
of persons with CP, walking decline occurs in early adulthood and is related to increasing 
age.15 However, where the review referred to walking decline in several circumstances, 
the present study specifically demonstrated a walking decline at short distances. For 
most participants, overall walking performance at long distances remained limited, 
indicating that from young adulthood many preferred other mobility modes over walking.
The present results indicate that most adults with CP continue to experience good general 
health, notwithstanding the increasing consequences of their disability and worries about 
their health. The items we used to assess perceived health were broad, and, in addition 
to the commonly used single item of perceived general health,17,38 we also focused more 
specifically on the perceived health concerns and interference with activities of daily living. 
The above disparity between both evaluations can possibly be understood similar to the 
disability paradox: many people with chronic disabilities are known to report good general 
quality of life (in this study: general health), despite the specific consequences of their 
disability and health problems.39,40 We found that presence of pain and severe fatigue, 
adjusted for intellectual impairment and GMFCS level, were associated with perceived poor 
health. Also mobility, self-care, and walking performance were univariately associated with 
being worried about health. Similar associations seem evident in other clinical populations, 
such as stroke or spinal cord injury, and in the general population.17
Although health issues and functional decline among adults with CP have been addressed 
more frequently in the past decade,11-16,38 future longitudinal studies are required to further 
evaluate deterioration of health and functioning in the long term. Current research-focused 
and population-based surveillance programs for CP are being continued into adulthood.41,42 
The present study underlines the need for such regular patient monitoring, as targets 
for prevention and treatment can be explored. Moreover, translational research appears 
necessary to understand the mechanisms at work in the process of aging and to what 
extent it may be related to CP or its accompanying secondary consequences. Several 
concepts are conceivable. For example, increasing secondary consequences may be caused 
by worsening primary impairments or by an increasing load of these primary impairments 
over decades. Alternatively, changes that affect the aging population in general may be 
accelerated or the effect of these changes may be greater in aging persons with CP.
Study Limitations
First, results are based on a small sample, limiting statistical power. This was a prospective 
cohort study, so invitations for 14-year follow-up were limited to those in the cohort. Also, 
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perceived health and health issues were not assessed at baseline, reducing the number 
of longitudinal data for these outcomes. Nevertheless, the response rate was relatively 
high. Given that there was no selective loss to follow-up and that the distribution of 
clinical characteristics was similar to large population studies,43 the present sample appears 
representative. Second, the pooling of self-reports and proxy reports in the data analyses 
may have biased the results. However, results seemed robust as verified by the additional 
analyses excluding those with proxy reports. Proxy reports are assumed to be the best 
alternative to self-reports in persons with intellectual impairment,44,45 although the direction 
of its potential bias may comprise both under- and overestimation.38,46,47 Third, because 
the present follow-up was performed in adults aged 35 to 45 years, long-term problems 
in older adults are outside the scope of the present study. Fourth, subgroups at increased 
risk for early deterioration could not be explored because of the sample size. The cross-
sectional analyses, however, demonstrated some indicators for increased risk of perceived 
poor health, namely, no intellectual impairment, and presence of pain and severe fatigue.
CONCLUSION
This study provides insight into the longitudinal change of perceived health, health issues, 
and functional level of adults with CP over a 10- to 14-year period. In the long term, adults 
with CP experienced deterioration of these health outcomes. Possibly, persons with CP 
experience an accelerated aging process, whether or not directly related to CP. Pain and 
severe fatigue are the most common health issues in adult CP and are explanatory for 
perceived poor health. Although most adults with CP remain largely independent in their 
activities of daily living, the need for personal assistance in mobility and self-care increases 
over time. Moreover, adults with CP demonstrate walking decline on short distances. 
Systematic follow-up of adults with CP is required to timely detect and intervene in health 
problems and functional deterioration. The present findings reaffirm the importance of 
lifespan care for persons living with CP.
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ABSTRACT
Aim: To explore the course of employment in adults with cerebral palsy (CP) over 14 years, 
and to identify subgroups at risk for unemployment.
Method: Sixty-five adults with CP (33 (52%) men, 31 (48%) women; baseline age, 25.7 [SD 
3.16]; intellectual impairment 25%; bilateral CP 65%) participated in a prospective cohort 
study. Self-reports of employment and work hours per week in 1996, 2000 and 2010 were 
documented. The course of employment (including sheltered work) and work hours per 
week were analyzed, using generalized estimating equations (GEE).
Results: Overall, employment rate was stable over time (38%-45%, p=0.413), but lower 
than in the general population (75%-86%, p<0.001). Employment rates were specifically low 
in adults with intellectual impairment, bilateral CP, and in adults with Gross Motor Function 
Classification System (GMFCS) levels IV and V. Work hours per week declined (35.0 [SD 
7.9] to 31.2 [SD 10.3], p=0.033), especially among females (32.3 [SD 6.4] to 23.4 [SD 7.4], 
p<0.001). Similar to the general population, females often worked part-time.
Interpretation: Employment was low compared with the general population, but 
remained stable in the long term; however, work hours per week decreased. Adults with 
intellectual impairment, bilateral CP, and GMFCS levels IV and V are subgroups at risk for 
unemployment.
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INTRODUCTION
Cerebral Palsy (CP) describes a group of permanent disorders of movement and posture 
causing activity limitation, attributed to non-progressive disturbances in the developing 
fetal or infant brain.1 Based on increased survival rates and longevity of persons with CP, 
currently the majority are adults.2 As a result, a lifespan perspective for persons with CP 
is required to provide them with appropriate support.3-5
Employment is one of the life areas in which adults with CP experience restrictions in 
participation.3,6 Employment rates of adults with CP vary between 29% to 53%, which 
is lower than those of the general population in Western countries.3,6-10 Among persons 
with CP, those with intellectual and severe physical disability, epilepsy and lower levels of 
education are at increased risk for being unemployed.3,7,8 In the Netherlands, employment 
rates of the working-age population with chronic conditions or physical disabilities are 23% 
to 33%, compared to 67% of the general population.11 In addition, persons in this population 
work fewer hours per week, 24.6 hours, compared to 30.3 hours per week in the general 
population. Furthermore, both employment rates and work hours seem to decline from 
the age of 40 years onwards.11
For adults with CP, little is known about the course of employment in the long term. In 
a 7-year follow-up study in Norway,12 the employment rate appeared stable (39%-43%), 
while in Sweden decreasing participation in inclusive employment (83%-64%) was reported 
in a 12-year follow-up study.13 In previous studies, information on work hours a week was 
limited. Moreover, subgroups of adults with CP who are at increased risk for unemployment 
have not yet been studied in a longitudinal design.
The primary aims were to investigate, over a 14-year period, the course of employment 
status and work hours per week in adults with CP, including persons with intellectual 
impairment, and to explore whether courses differ between subgroups. Secondary aims 
were to identify subgroups at risk for unemployment and to investigate whether specific 
subgroups work relatively few hours, by exploring associated factors with employment 
status and work hours per week.
METHODS
Participants and measurements
A representative cohort of Dutch adults with CP was prospectively followed since 1996. 
Adults were recruited from the rehabilitation center in The Hague, a center with a regional 
4
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function. Inclusion criteria were (1) a diagnosis of CP, (2) born between 1965 and 1974, and 
(3) known to the rehabilitation center.14 Participants were assessed at baseline,14 at 4-year 
follow-up,4 and at 14-year follow-up. Data were collected using self-report questionnaires 
(baseline and 14-year follow-up) or semi-structured interviews (4-year follow-up). The 
study was approved by the Medical Ethics Committee of Reinier de Graaf Medical Center 
(Delft, ME 00-14). All participants provided informed consent.
Sociodemographic and clinical characteristics
We collected the following socio-demographic and clinical characteristics: sex, age, level 
of education, laterality of CP, gross motor function, marital status, living status and having 
children. Level of education was used as an indicator for intellectual impairment: adults who 
either had no primary education or attended day centers or special education for children 
with severe learning difficulties were classified as having an intellectual impairment, all 
others were classified as average intelligence or higher.15 Level of education was categorized 
as low (prevocational practical education or lower, including intellectual impairment), 
medium (prevocational theoretical education and upper secondary vocational education) 
or high (secondary education, higher education and university).15 Data on laterality of 
CP (bilateral/unilateral) were collected from the medical files at baseline and checked at 
4-year follow-up.4,14 The level of gross motor function was classified according to the 
Gross Motor Function Classification System (GMFCS)16 at 4-year follow-up.4 For those 
who not participated at 4-year follow-up, GMFCS level was determined post hoc based 
on baseline information on walking function, climbing stairs and use of assistive mobility 
devices. For analyses, education level (low vs medium/high), and GMFCS level (IV and V 
vs I to III) were dichotomized. Marital status was dichotomized as single versus married or 
cohabitating. Living status was dichotomized as living with parents, in a sheltered home or 
institution versus living alone or with a partner. Participants indicated whether they had 
children (yes/no).
Employment
Employment was assessed by questions addressing daily occupation and employment 
situation (type of market, work hours). Being employed – either on the open labor market 
(competitive) or sheltered – was defined as performing paid work for 12 or more hours 
per week.17 For those employed, we assessed work hours per week. Adults with CP 
were compared with reference values of the age-matched Dutch general population: the 
proportion employed in the Dutch working-age population, and work hours per week were 
derived from Statistics Netherlands for 1996 (20-30y), 2000 (25-35y), and 2010 (35-45y).17
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 65
65
Course of adult employment in cerebral palsy
Statistical analysis
Descriptive statistics were used to describe sample characteristics and outcomes; logistic 
regression analysis explored loss to follow-up. To study course of outcomes over time, we 
performed generalized estimating equations (GEE) analyses with exchangeable correlation 
structures, an appropriate method for handling missing data. Outcomes were employment 
status (no=0, yes=1), and – for those employed – work hours per week. Hence, both logistic 
and linear models were used. First, we entered time as sole factor in each model to explore 
course over time. Secondly, we added one subgroup factor and its interaction (time´subgroup) 
to compare course over time between specific subgroups. Subgroup comparisons were 
made, one at a time, for sex, education level, intelligence, laterality and GMFCS level. 
When course over time differed between subgroups (i.e. the interaction was significant), 
we also presented within-group estimates. Estimates of the interactions thus represent 
between-group differences in course over time, whereas estimates for specific subgroups 
represent course over time within that subgroup. Furthermore, we were interested in 
overall associations of factors with employment status and work hours per week. Therefore, 
models with specific subgroups as sole factor explored associations with these outcomes; 
female, low education level, intellectual impairment, bilateral CP and GMFCS levels IV 
and V were the reference categories. For all GEE analyses, we additionally re-estimated 
models for education level and GMFCS level by excluding or correcting for participants with 
intellectual impairment. Finally, employment status and work hours were compared with the 
age-matched Dutch general population, using one-sample binomial tests (for proportions) 
and one-sample t-tests (for means). All analyses were performed using SPSS version 21.0 
(IBM SPSS Statistics, Armonk, NY, USA); the level of significance was p<0.05 (two-tailed).
RESULTS
A total of 80 adults with CP were enrolled at baseline, eight additional adults were enrolled 
in the cohort at 4-year follow-up. Of these 88 adults, 65 had employment data on at least 2 
assessments: 64 at baseline (98%), 47 at 4-year follow-up (72%), and 49 at 14-year follow-
up (75%). Accordingly, one participant was enrolled at 4-year follow-up, 18 had intermittent 
missing data and 16 were lost to 14-year follow-up. Missing data were not selective to age, sex, 
level of intelligence, laterality or GMFCS level (χ2=3.26, df=1, p=0.071, Nagelkerke R2=0.06). 
Characteristics of the participants at the three time points are presented in Table 4.1.
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Table 4.1. Characteristics of participants (n=65).
Characteristics Baseline, 1996 
(n=64)
4y follow-up, 2000 
(n=47)
14y follow-up, 2010 
(n=49)
Males/females, n 33/31 22/25 27/22
Age, mean (SD) 25.7 (3.2) 30.2 (3.4) 39.8 (3.0)
Age, range 21-31y 25-36y 35-45y
Education level,a n (%)
Low 45 (73) 30 (65) 31 (63)
Medium 12 (19) 8 (17) 11 (22)
High 5 (8) 8 (17) 7 (14)
Intelligence,b n (%)
Intellectual impairment 16 (25) 14 (30) 11 (22)
Average intelligence 48 (75) 33 (70) 38 (78)
Laterality of CP,a n (%)
Bilateral 41 (65) 34 (72) 28 (58)
Unilateral 22 (35) 13 (28) 20 (42)
GMFCS, n (%)
Level IV-V 18 (28) 17 (36) 10 (20)
Level I-III 46 (72) 30 (64) 39 (80)
Marital status,a n (%)
Single 56 (88) 38 (81) 32 (67)
Married/cohabitating 8 (12) 9 (19) 16 (33)
Living status,a n (%)
Living with parents/in a sheltered 
home/institution
39 (61) 28 (60) 21 (44)
Living alone/with partner 25 (39) 19 (40) 27 (56)
Having children, n (%) 4 (6) 5 (11) 10 (21)
a Missing data for education level (baseline n=2, 4y follow up n=1), laterality of CP (baseline n=1, 14y follow-
up n=1), marital status (14y follow-up n=1) and living status (14y follow-up n=1). b Intellectual impairment 
was estimated from their level of education: adults who either had no primary education or attended 
day centers or special education for children with severe learning difficulties were classified as having an 
intellectual impairment. GMFCS, Gross Motor Function Classification System.
Course of employment over time
Table 4.2 presents the results for employment status and work hours per week over 
time in adults with CP (upper part). Proportions of persons employed (competitive or 
sheltered) are depicted in Figure 4.1. Modelled data are presented in Table 4.3. For the 
total cohort, employment was stable over time. There was, however, difference in course 
over time between subgroups of intelligence and laterality. Employment remained stable 
in adults with average intelligence or higher, while adults with intellectual impairment had 
increased odds on employment over time. Adults with unilateral CP had non-significant 
decreased odds on employment over time (p=0.070), whereas adults with bilateral CP had 
increased odds. All other subgroups remained stable, including both levels of education 
when participants with intellectual impairment were excluded (between-group difference 
education level: odds ratio (OR) 1.13, 95% confidence interval [CI] 0.68-1.87, p=0.637).
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Figure 4.1. Proportions of adults with cerebral palsy (CP) employed over time for the total cohort, 
and specified per subgroup.
Proportions of adults with CP employed are presented for the total cohort (a), and for the subgroups sex (b), 
education level (c), intelligence (d), laterality (e), and Gross Motor Function Classification System (GMFCS) (f). 
Bars further indicate job type; the solid stacks represent competitive employment, and the striped stacks 
represent sheltered employment.
Among those employed, work hours significantly declined over time. This decline was 
different between subgroups of sex: work hours remained stable for males, whereas females 
declined. Work hours also declined in adults with GMFCS levels I to III, and adults with 
average intelligence or higher had a non-significant decline in work hours (p=0.050). Estimates 
of interactions for intelligence and GMFCS level were not conclusive as distributions of 
subgroups were skewed; within-group estimates are not presented for intellectual impairment 
and GMFCS levels IV and V due to too small subgroups (n≤5; Table 4.3).
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Employment and associated factors
Employment status was significantly associated with intelligence, laterality, and GMFCS 
level. Adults with average intelligence or higher (OR 9.40, 95% CI 2.64-33.46, p=0.001), 
unilateral CP (OR 4.12, 95% CI 1.56-10.91, p=0.004) and GMFCS level I to III (OR 9.02, 95% 
CI 2.31-35.13, p=0.002) had consistently higher employment rates compared with their 
counters (Table 4.2, Figure 4.1); the latter also when corrected for intellectual impairment 
(OR 6.01, 95% CI 1.39-35.13, p=0.016). No associations were found with sex, nor with 
education level, nor if excluding participants with intellectual impairment.
Among those employed, work hours were associated with sex (b 8.09, 95% CI 3.06-13.13, 
p=0.002). There was a non-significant trend for an association with laterality (b 5.32, 95% 
CI -0.43 to 11.07, p=0.070). Associations with intelligence and GMFCS level were not 
analyzed because of too small subsamples of persons employed (n≤5).
Employment compared with the general population
Proportions employed in the age-matched Dutch general population, both total as well as 
specified for sex are presented in Table 4.2 (lower part). Significant differences between 
adults with CP and the general population are indicated. Employment was consistently 
lower in the CP cohort compared with the general population. This was also true when 
females and males were compared separately. Work hours per week were comparable: the 
mean differences between adults with CP and the general population were +1.6, -2.8 and 
-2.6 hours per week for the studied time points. Also, no differences in work hours were 
found for females and males separately.
DISCUSSION
This is the first prospective cohort study to investigate employment in adults with CP over 
a long period of time. The follow-up period comprised the age range of 21 to 45 years, 
regarding a period in which employment plays a central role in life. The major finding was 
that overall the employment rate of adults with CP was stable over 14 years. However, work 
hours seemed to decline over time from a young age onwards, specifically in females with 
CP. The results confirm that overall employment rates were consistently lower compared 
with the general population. Employment rates were particularly low among adults with 
more severe intellectual and physical impairments.
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Only some other studies focused on the long-term course of employment in individuals 
with CP. Over a 12-year period, Törnbom et al.13 identified a decreased employment 
rate in middle-aged adults with physical disability (mainly CP) and average intelligence. 
In a 7-year follow-up, Opheim et al.12 presented employment rates similar to baseline 
in a broad age range. Thus, results appeared inconsistent. In our research group, over a 
4-year period, Verhoef et al.10 reported increasing employment in emerging adults with 
CP entering the labor market. Although a moderate part was still studying, in the same 
period unemployment in CP also increased, indicating that persons with CP are already 
at risk for unemployment from young adulthood onwards. Verhoef et al.10 expected a 
further increase in employment after the age of 20 to 24 years, since at that age range a 
proportion was still studying. However, based on the present results, employment rates of 
adults with CP seem to stabilize between 21 to 45 years. This is in accordance with Mitchell 
et al.,9 who found in a cross-sectional study the highest employment rates for individuals 
with disabilities (including CP) in their twenties and thirties (56% and 60% respectively) 
while from their forties onwards, employment showed a decline (42%-28%). Moreover, 
individuals with disability seem more engaged in part-time work than their non-disabled 
peers.18 Our longitudinal study was confined to the age of 45 years, thus a further course 
of employment in adults with CP remains unclear. However, we already demonstrated a 
decline in work hours before the age of 45.
The observed decline in work hours might be linked to worsening health problems and 
mobility decline,19 likely reflecting a reduced work capacity in adults living with CP. 
Moreover, we observed a strong decline in work hours among females with CP. A similar 
pattern of growing part-time employment was observed among females of the Dutch 
general population,11,20 likely explained by a cultural feature of females in a dual role as 
worker and primary caregiver. Females that become mothers often follow a course of 
intermittent work across the lifespan.20 Additional analyses showed that, in our study, 
females that became mothers decreased their work hours. This dual role seems to apply 
to females with CP as well.
In contrast to some earlier findings, we found no association between employment and 
education level. A high education level has found to be significant for achieving competitive 
employment in adults with CP.7,21 In our analyses, we did not differentiate competitive from 
sheltered employment, which may have precluded such an association. However, the figure 
shows that the most substantial contrast between competitive and sheltered employment 
lies between subgroups with different education levels. At the time of study, there was a 
relatively high density of sheltered employment and financial resources in the Netherlands 
4
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compared with other European countries.22 Present results seem to reflect this, since a fair 
proportion of employed adults with CP had sheltered employment.
Notwithstanding the above, adults with intellectual impairment or with severe gross motor 
problems were often unemployed. The subgroup GMFCS level IV and V reflects a group of 
individuals with severe activity limitations, and half of them had intellectual impairment (10 
out of 19). Of these 10 adults, only two were employed at one point in time. This confirms 
that having both a physical disability and intellectual impairment represents ‘double 
jeopardy’ in terms of employment.23 In the present study, adults with unilateral CP were 
more often employed, and tended to work more hours per week than those with bilateral 
CP. Previous studies reported that adults with unilateral CP were often competitively 
employed, whereas in bilateral CP, sheltered employment was more common.3,6 Our results 
seem to confirm this (Figure 4.1). At the same time, we demonstrated that employment rates 
in adults with bilateral CP showed a positive course and stabilization, whereas in unilateral 
CP a decrease may appear over time. It seems that persons with unilateral CP gradually 
no longer succeed in maintaining their functional level, which is in line with our clinical 
experience. Alternatively, part-time work could be beneficial, as it provides good balance 
between personal or health needs and working life.18 Nowadays, employers are obliged 
to help individuals with disability, which provides the opportunity to remain employed by 
means of part-time employment. Moreover, reintegration and health care services may 
support adults with CP by vocational interventions aiming at balancing personal capabilities, 
helping with an ergonomic workplace, and other environmental support.
A limitation of our study is the relatively small sample size, although partly met by the 
repeated measurements. Response rates at the follow-up assessments were quite high (72% 
and 75% respectively) and there was no selective loss to follow-up. Moreover, given that 
the distribution of clinical characteristics was similar to those reported in large population 
studies,24 we assumed that the present cohort was representative for the population of 
adults with CP. For smaller subgroups (intellectual impairment and GMFCS level IV and 
V), results should be interpreted with care. Furthermore, we had no documented data on 
employment in the periods between follow-up, during which participants may have entered 
or exited their jobs. Although the follow-up period enabled us to describe the course of 
employment up to the age of 45, the further course of employment for persons aging 
with CP remains unclear. Nonetheless, this was the first long prospective cohort study to 
investigate employment in adults with CP and results significantly add to our knowledge 
on employment in the long term. In future longitudinal research, these limitations could 
be addressed by studying different age cohorts, and conducting follow-up assessments 
at shorter intervals.
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ABSTRACT
Aim: In the context of the development of an International Classification of Functioning, 
Disability and Health (ICF) Core Set for adults with cerebral palsy (CP), this systematic 
review sought to identify the outcome measures used in studies on adults with CP, to 
examine their content using the ICF as a reference, and to demonstrate the most studied 
areas in this population.
Method: Embase, MEDLINE, Web of Science, PsycINFO, CINAHL, Cochrane, and Google 
Scholar were searched for studies on adults with CP published between 2000 and 2017. 
Meaningful concepts of commonly used outcome measures were linked to the ICF, and 
frequencies of resultant ICF categories were explored.
Results: In 274 included articles, 332 outcome measures were identified of which 155 
were commonly used. In total, 4409 meaningful concepts were linked to the ICF. The 
component ‘Activities and participation’ included the most frequent categories, followed 
by ‘Body functions’. The most frequent categories were b280 ‘Sensation of pain’ (37.6%), 
d450 ‘Walking’ (33.3%), and d850 ‘Remunerative employment’ (27.5%).
Interpretation: The broad range of ICF categories identified in this systematic review 
emphasizes the heterogeneity of functioning and disability in adults with CP. The current 
results specifically reflect the researchers’ perspective and will serve as candidate 
categories to consider in the development of an ICF Core Set for adults with CP.
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INTRODUCTION
Cerebral palsy (CP) describes a group of permanent disorders of movement and posture 
causing activity limitations,1 and is the most common cause of physical disability in 
childhood.2 CP is caused by non-progressive disturbances in the developing fetal or infant 
brain, resulting in a motor disorder that is often accompanied by secondary impairments, for 
example cognitive or sensory impairments or communication impairments.1 In developed 
countries, CP affects 2 to 2.5 per 1000 live births.3-5 Much research in CP has focused 
on children. However, given the increasing survival rates and longevity of individuals with 
CP, with the majority experiencing adulthood,6,7 research in the past two decades has 
increasingly focused on the impact of CP throughout the lifespan.
Research on health-related status of adults with CP describes a broad range of outcomes.8 
Physical and cognitive impairments, activity limitations, and participation restrictions 
are well recognized as disabling consequences in adults with CP. The extent of these 
consequences often depends on the type and severity of the health condition, but also on 
various contextual factors. Given the wide variety of descriptors of outcomes and related 
factors found in the literature, a uniform language to describe the impact of CP in adulthood 
is desirable. In 2001, the World Health Organization (WHO) launched the International 
Classification of Functioning, Disability and Health (ICF),9 now an internationally accepted 
standard for describing functioning and disability. In the ICF, functioning and disability are 
seen as the universal human experience of the complex interaction between a person’s 
health condition and contextual factors. Whereas functioning is described by what the 
body does (i.e. body functions), body structures, tasks or actions an individual performs, and 
involvement in major life activities (i.e. activities and participation), disability is an umbrella 
term referring to body impairments, activity limitations, and participation restrictions. 
Contextual factors encompass environmental factors, describing the physical, social, and 
attitudinal environment in which people live, and personal factors, comprising features of 
an individual that are not part of the health condition such as age, sex, or coping style.9
Systematic assessment of physical and cognitive impairments, and activity limitations and 
participation restrictions in relevant life areas, is essential in health care settings to identify 
problems in health and functioning, and to plan effective interventions.10 Several outcome 
measures have been used to evaluate different areas of functioning and disability in adults 
with CP. However, there is no consensus on the most important areas to assess in these 
adults, nor is it clear how to select the most appropriate outcome measures. For clinicians 
and researchers to develop and provide optimal care for adults with CP, it is vital to have 
consensus on the outcomes to assess and on a universal language that describes those 
5
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outcomes. The ICF is suitable for this purpose; however, with more than 1400 categories 
describing all areas of functioning, its applicability for everyday use in clinical settings 
is challenging. To address this challenge, WHO and the ICF Research Branch created a 
methodology for developing Core Sets of ICF categories.11 An ICF Core Set can facilitate 
the description of the functioning of individuals with a specific health condition in everyday 
practice by providing a limited list of essential categories selected from the entire ICF. It 
can provide guidance for clinical assessments, planning of interventions, and selecting 
measures for evaluation. Moreover, ICF Core Sets offer the possibility to compare clinical 
data between patients, institutions, and countries, and may serve as a basis to improve 
communication between professionals and settings on an international level.12
So far, ICF Core Sets have been developed for various health conditions.13 Among the 
35 ICF Core Sets is one for children and young people with CP.14-18 Since life experiences 
of individuals with CP naturally changes from childhood to adulthood,19 and since health 
issues seem to deteriorate throughout the lifespan,20 the ICF Core Set for children and 
young people with CP is considered insufficiently applicable to adults with CP. To address 
this issue, our research group initiated a project to develop an ICF Core Set for adults with 
CP across different types and severity levels.
ICF Core Sets are developed by means of a three-phase, multi-method scientific process.11 
The first phase is designed to collect current evidence, which involves four preparatory 
studies: a systematic literature review, a qualitative study, a multicentre cross-sectional 
study in a clinical setting, and a global expert survey. These are meant to consider the 
perspectives of researchers, patients, and clinicians, and to capture their views on relevant 
aspects of health and functioning. The second phase comprises an international consensus 
conference with experts and health care professionals. The final phase involves validating 
and implementing the first version of the ICF Core Set.11 In the present article, we report 
on the systematic literature review, capturing the perspective of researchers on CP in 
adulthood by identifying a list of ICF categories that are most commonly addressed in the 
literature on adults with CP.21 These categories will serve as candidate categories for the 
international consensus conference, during which the first version of the ICF Core Set for 
adults with CP will be finalized.
The objective of this systematic literature review was to identify this list of candidate 
categories. Specific aims were to: (1) identify all outcome measures used in published 
studies on adults with CP over the past decades, (2) uncover the functioning content of 
those measures using the ICF, and (3) pinpoint the most frequently addressed areas of 
functioning and contextual factors in adults with CP using the ICF.
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METHODS
Search strategy and eligibility criteria
Seven electronic databases (Embase, MEDLINE, Web of Science, PsycINFO, CINAHL, 
Cochrane, Google Scholar) were searched for literature published between January 2000 
and January 2017. The search strategy was developed in consultation with an information 
specialist and included three major themes: ‘cerebral palsy’, ‘adult’, and ‘outcome 
assessment’. Key terms were mapped to controlled headings and expanded to include 
free-text terms, as appropriate for the specific database.
Results from the searches were gathered in EndNote and duplicates were removed. In a 
first round, titles and abstracts were screened for eligibility. Subsequently, full-text articles 
of the included abstracts were retrieved and screened for eligibility. Studies were included 
according to the following five criteria: (1) Observational and experimental study designs, 
and excluding meta-analyses, reviews, case studies, qualitative studies, comments, and 
study protocols; (2) Describing individuals with CP only, or in case–control design; (3) 
Describing more than 10 adults who were at least 18 years of age at time of the first 
measurement or at follow-up. Studies describing both children and adults with CP were 
included when at least 50% (and at least 10 participants) of the sample were adults, 
or in case this was unclear, the mean sample age was at least 18 years; (4) Reporting 
on outcomes of functioning, and excluding studies reporting on evaluations of services; 
for example evaluation of transition services, or complications and adverse events of 
surgery; and (5) Inclusions were limited to full-paper peer-reviewed journal articles written 
in English. Multiple publications on the same study sample, including follow-up studies, 
were combined and counted as one study (‘unique study’) to avoid duplication of outcome 
measures. Publications of a study on a specific subset of a larger sample, using clearly 
distinct outcome measures, were not combined.
The first two authors (JB, SN) independently performed title/abstract and full-text 
screening. Disagreement about inclusion was discussed and resolved between the two 
reviewers. Any discrepancies were discussed with a third reviewer (RBE) until consensus 
was reached.
Data extraction
From each included study we extracted information on country, study design, and 
participant characteristics, using a standardized electronic data record sheet. The country 
where the study was conducted was allocated to one of the six WHO regions, whereby 
we further distinguished between North and South America.9 Design of the study was 
5
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 82
82
Chapter 5 
recorded according to the Cochrane Consumers and Communication Review Group Study 
Design Guide,22 and grouped into observational or experimental designs. Participant 
characteristics included sample size, age, sex, CP subtype, and level of gross motor 
functioning. The subtype of CP was classified according to the diagnostic classification 
system of the Surveillance of Cerebral Palsy in Europe,23 and for movement and posture 
abnormality: spastic, dyskinetic, ataxic, or mixed. Spastic CP was further distinguished 
for limb distribution if applicable, namely unilateral or bilateral spastic CP. Gross motor 
functioning was classified according to the Gross Motor Function Classification System 
(GMFCS).24,25 For studies with multiple publications, participant characteristics were 
extracted from the largest (often baseline) sample.
All outcome measures used in the included studies were recorded, and the number of 
studies in which the individual measures were used was documented. For studies with 
multiple publications, the outcome measures used were counted only once. We identified 
single-item and multiple-item measures. A single-item measure, for example, is the Modified 
Ashworth Scale, a clinical assessment. A multiple-item measure, for example, is the Short 
Form Health Survey, a patient-oriented measure containing 36 individual items. Outcome 
measures comprised patient-oriented measures (i.e. self- or proxy-report questionnaires), 
clinical assessments (including those requiring specialized equipment), and non-tool 
measures (often single-patient-oriented questions) mentioned in the text of publications. 
From the outcome measures that were used in at least two studies (‘common measures’), 
we extracted all individual items before linking each item to the ICF.
Linking to the ICF
Before starting the linking process, three reviewers (JB, SN, and CL) acquired thorough 
knowledge of the refined ICF linking rules by consulting the eLearning tool,26 and during 
practice sessions including a tutorial with an expert (MS) from the ICF Research Branch. 
On the basis of experience gathered over several years for various projects by many 
clinicians and researchers around the world, refinements were made to the original linking 
rules,27,28 addressing linking of all concepts within an item instead of only the most relevant 
one, linking to the most precise ICF category, and the use of the ‘other specified’ and 
‘unspecified’ categories.21
For each item extracted from the common measures, we identified the meaningful 
concepts. A concept was defined as one separate meaningful entity; one or more concepts 
could be identified from a single item. For example, the item ‘during the past 4 weeks, 
how much did pain interfere with your normal work’ from the Short Form Health Survey 
contains two meaningful concepts: ‘pain’ and ‘work’. The meaningful concepts were then 
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linked to the most precise ICF category in the components of ‘Body functions’ (denoted 
by the letter ‘b’), ‘Body structures’ (s), ‘Activities and participation’ (d), and ‘Environmental 
factors’ (e).21 Concepts were also linked to ‘Personal factors’ (pf) although these are not 
yet classified in the ICF. An ICF code starts with the letters b, s, d, or e, followed by a 
numeric code. The ICF is organized hierarchically: the first level is made up of chapters (first 
digit of the numeric code), and each chapter consists of second-level categories (second 
and third digit), followed by more detailed third-level and, for some cases, fourth-level 
categories (subsequent digits), as can be seen in the following example from the component 
‘Body functions’: (1) first-level chapter: b2, ‘Sensory functions and pain’; (2) second-level 
category: b280, ‘Sensation of pain’; (3) third-level category: b2801 ‘Pain in body part’; (4) 
fourth-level category: b28013, ‘Pain in back’. Some concepts were assigned the code nd 
(not definable), for example for ‘general health’ (code nd-gh) as this is too general to link 
to an ICF category. Finally, a few concepts could not be linked since the information was 
beyond the scope of the ICF. In that case, the code nc (not covered) was used, for example 
for ‘quality of life’ (code nc-qol).
Since some of the identified measures were previously linked in other projects,21 existing 
linking results were obtained from the ICF Research Branch and independently checked 
by two reviewers (JB, SN). Concepts identified in clinical assessments were pre-linked 
by a third reviewer (CL), a physician in physical medicine and rehabilitation. The first two 
reviewers independently checked the pre-linked ICF categories.
The linking process was performed independently by the same two reviewers (JB, SN). Results 
were compared, and disagreement was resolved by discussion. A minority of the discrepancies 
were discussed with a third reviewer (CL) until final agreement was reached. Initial interrater 
agreement of the independent linking conducted before consensus or consultation with the 
third linker in case of disagreement was determined for second-level categories (see data 
analysis below) by calculating Cohen’s κ.29
Data analysis
Frequency analysis was used to examine the total number of outcome measures and 
linked ICF categories that the common measures contained, along with corresponding 
percentages relative to the number of studies in which they were used. If an ICF category 
was repeatedly assigned within one multiple-item measure, or within one study, it was 
counted only once. ICF categories found in at least 5% of the studies were included in the 
list of candidate categories.11 To be consistent with previous ICF Core Set studies, we only 
report the second-level categories; concepts linked to a more specific third- or fourth-level 
category were reported at their corresponding second-level category.
5
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RESULTS
Study selection and characteristics
The initial search yielded 5472 records (Figure 5.1). After title and abstract screening, full-
text articles of 685 records could be retrieved and were reviewed. A total of 274 articles 
(5.0%) finally met the eligibility criteria. Of these, 113 eligible articles included multiple 
publications of 38 unique studies and 161 were single publications. Therefore, 199 unique 
studies were finally included for further review.
Figure 5.1. Flow diagram of article selection process.
Over half of the studies were published in the previous 6 years (Table 5.1). The 199 studies 
included 176 with an observational design and 23 experimental studies. Most studies were 
conducted in Europe (39.7%), Northern America (27.1%), and the Western Pacific (25.6%).
Sample sizes ranged from 11 to 14806 (median 33, interquartile range 20–69). Overall, 
55.2% of the participants were male, and the mean age was 31 years, indicating that mainly 
younger adults were studied. A total of 139 studies (69.8%) reported participants’ CP 
subtype and 91 studies (45.7%) used the GMFCS to classify their participants (see Tables 
5.1 and 5.2 for all study and participant characteristics).
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Table 5.1. Characteristics of included studies (n=199).
Study characteristics n %
Publication year
 2000–2010 94 47.2
 2011–2016 105 52.8
World Health Organization regions
 Europe 79 39.7
 North America 54 27.1
 Western Pacific 51 25.6
 South America 11 5.5
 Africa 2 1.0
 Eastern Mediterranean 2 1.0
Study design
 Observational 176 88.5
 Case series 30 15.1
 Cross-sectional 103 51.8
 Cohort 16 8.0
 Case–control 27 13.6
 Experimental 23 11.6
 Randomized controlled trial 10 5.0
 Others 13 6.6
Sample sizes
10–20 58 29.1
21–50 74 37.2
51–100 34 17.1
101–500 27 13.6
501–1000 2 1.0
>1000 4 2.0
Outcome measures
The studies used a total of 332 outcome measures, including 204 single-item and 128 
multiple-item measures. Table 5.3 presents the single- and multiple-item outcome measures 
most often used in the 199 studies. Single-item measures included single (172) and multiple 
(32) types of measurement. For example, walking included multiple types of measurement 
as it was clinically assessed by the Six Minute Walk Test and self-reported on the Wilson 
Mobility Scale. A total of 242 types of single-item measure were identified; 20 (8.3%) were 
patient-oriented, 94 (38.8%) were clinical assessments, and 128 (52.9%) were non-tool 
measures. Multiple-item measures included 92 (71.9%) patient-oriented measures and 36 
(28.1%) clinical assessments.
5
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Table 5.2. Participant characteristics (n=32 933).
Participant characteristics n %
Age (n=10 841, 32.9%) Mean age, y Range, y
 Mean age of samples 31.0 18–58
 Minimum age of samples 18.5 5–57
 Maximum age of samples 51.1 20–84
Sex (n=32 443, 98.5%)
 Male 17 916 55.2
 Female 14 527 44.8
Cerebral palsy subtype (n=8 236, 25.0%)
 Spastic 6413 77.9
 Unilateral spastic 1367 16.6
 Bilateral spastic 3748 45.5
 Unspecified 1298 15.8
 Dyskinetic 1028 12.5
 Ataxic 100 1.2
 Mixed types 330 4.0
 Unknown 365 4.4
GMFCS level (n=4 337, 34.5%)a
 Level I 758 17.5
 Level II 905 20.9
 Level III 697 16.1
 Combined levels I–III 260 6.0
 Level IV 712 16.4
 Level V 748 17.2
 Combined levels IV–V 221 5.1
 Unknown 36 0.8
Data are n (%) unless otherwise stated. a One study was deliberately not included here, because its large 
sample only of persons classified in Gross Motor Function Classification System (GMFCS) level V (n=747) 
affected the distribution of the GMFCS.
In the single-item measures, assessment of pain was most frequent, measured by patient-
oriented (52.5%) and non-tool measures (47.5%). Mobility of joints and spasticity were 
also frequently addressed, often measured by clinical assessments (86.2% and 82.8%, 
respectively). Also, walking, muscle power, gross motor function, and hip displacement 
were used in more than 10% of the studies. In the multiple-item measures, the Short Form 
Health Survey (5.5%) was the most frequently used patient-oriented measure, followed 
by the Barthel Index (4.0%), Assessment of Life Habits (2.5%), and the Fatigue Severity 
Scale (2.5%). The most common clinical measures among multi-item measures were the 
Functional Independence Measure (4.0%), Gross Motor Function Measure (3.5%), the 
Functional Mobility Scale (3.0%), and Japanese Orthopaedic Association score (3.0%).
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 87
87
Review ICF outcomes in adult cerebral palsy
A total of 156 out of 332 outcome measures were identified in at least two studies; these 
common measures were reported in 189 (95.0%) of the included studies. One multiple-
item measure could not be retrieved in English. In the end, 114 single-item measures and 
1044 items from 41 multiple-item measures (total of 1158 items) were linked to the ICF.
Table 5.3. Most frequent single- and multiple-item outcome measures used in studies (n=199) on adults 
with cerebral palsy.
Outcome measure Type Items in 
measure
Used in 
number of 
studies, n (%)
Single-item measures
Pain Patient-oriented, non-tool 1 40 (20.1)
Mobility of joints Clinical, non-tool 1 29 (14.6)
Spasticity Clinical, non-tool 1
Walking Patient-oriented, clinical, non-tool 1 27 (13.6)
Muscle power Clinical, non-tool 1 25 (12.6)
Gross motor function Patient-oriented 1 22 (11.1)
Hip displacement Patient-oriented, clinical, non-tool 1
Multiple-item measures
Short-Form Health Survey Patient-oriented 36 11 (5.5)
Barthel Index Patient-oriented 10 8 (4.0)
Functional Independence Measure Clinical 18
Gross Motor Function Measure Clinical 88 7 (3.5)
Functional Mobility Scale Clinical 3 6 (3.0)
Japanese Orthopaedic Association 
Score
Clinical 4
Assessment of Life Habits Patient-oriented 80 5 (2.5)
Fatigue Severity Scale Patient-oriented 9
Representation of the most frequent single- and multiple-item outcome measures obtained from 199 
studies.
ICF categories
The 1158 items of the common measures revealed a total of 4409 meaningful concepts that 
were linked to the ICF. Overall, 24 concepts (0.5%) were linked to an ICF component, 106 
concepts (2.4%) to first-level ICF categories (chapters), and 3956 concepts (89.7%) to second-, 
third-, or fourth-level ICF categories. The other 323 concepts were regarded as personal 
factors (74, 1.7%), not covered (131, 3.0%), or not defined (118, 2.7%). The Cohen’s κ of 0.61 
(95% confidence interval 0.59–0.63) indicated moderate interrater agreement between the 
independent linkers.
5
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Table 5.4. Relative frequency of first-level categories (chapters) identified in studies using common measures 
(n=189).
ICF code Chapter Used in number of 
studies, n (%)
b Body functions
b1 Mental functions 52 (27.5)
b2 Sensory functions and pain 85 (45.0)
b3 Voice and speech functions 17 (9.0)
b4 Functions of the cardiovascular, haematological, 
immunological and respiratory systems
35 (18.5)
b5 Functions of the digestive, metabolic and endocrine 
systems
37 (19.6)
b6 Genitourinary and reproductive functions 31 (16.4)
b7 Neuromusculoskeletal and movement-related 
functions
83 (43.9)
s Body structures
s7 Structures related to movement 60 (31.7)
d Activities and participation
d1 Learning and applying knowledge 28 (14.8)
d2 General tasks and demands 22 (11.6)
d3 Communication 26 (13.8)
d4 Mobility 105 (55.6)
d5 Self-care 66 (34.9)
d6 Domestic life 34 (18.0)
d7 Interpersonal interactions and relationships 39 (20.6)
d8 Major life areas 52 (27.5)
d9 Community, social and civic life 38 (20.1)
e Environmental factors
e1 Products and technology 50 (26.5)
e3 Support and relationships 25 (13.2)
e5 Services, systems and policies 23 (12.2)
pf Personal factors 37 (19.6)
nc Not covered 51 (27.0)
nd Not defined 33 (17.5)
Only International Classification of Functioning, Disability and Health categories measured in ³5% of 
all studies applying common measures are presented. Categories are ordered numerically within each 
component.
Tables 5.4 and 5.5 show the chapters and second-level categories respectively, identified in at 
least 5% of the studies using common measures. Second-level ICF categories present in at least 
15% of the studies are depicted in the ICF model in Figure 5.2. ‘Body functions’ included seven 
chapters, of which b2 ‘Sensory functions and pain’ (45.0%) and b7 ‘Neuromusculoskeletal 
and movement-related functions’ (43.9%) were the most frequent (Table 5.4). More 
specifically, b280 ‘Sensation of pain’ (37.6%) and b710 ‘Mobility of joint functions’ (19.0%) 
were the most frequent second-level categories (Table 5.5). In ‘Body structures’, only 
chapter s7 ‘Structures related to movement’ was identified; herein s750 ‘Structure of lower 
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extremity’ (21.7%) was most frequently measured. ‘Activities and participation’ was the 
most covered component overall, including nine chapters and 43 second-level categories. 
Among these, chapters d4 ‘Mobility’ (55.6%), and d5 ‘Self-care’ (34.9%) were the most 
frequent, and d450 ‘Walking’ (33.3%) and d850 ‘Remunerative employment’ (27.5%) were 
the most frequent second-level categories. Four chapters were identified in ‘Environmental 
factors’, of which e1 ‘Products and technology’ (26.5%) was the most frequent. More 
specifically, e120 ‘Products and technology for personal indoor and outdoor mobility and 
transportation’ (16.9%) was most frequent. In ‘Personal factors’, sociodemographic concepts 
were common (15.9%). Frequently used concepts that were not covered or not defined 
by the ICF included those related to body composition (10.1%) and general health (9.5%).
DISCUSSION
This systematic review identified and quantified the most studied areas of functioning and 
disability reported in an extensive number of published studies on adults with CP using the 
ICF as a reference.21 Most of the items of common outcome measures could be translated 
into the universal language of the ICF. The results summarize the functioning concepts 
addressed in studies pertaining to adults with CP so far. Accordingly, the results represent 
the researchers’ perspective in the development of an ICF Core Set for adults with CP.
In line with the definition of CP,1 ICF categories referring to mobility and movement-
related functions were among the most frequently studied at adult age. ‘Mobility’ (d4) 
was the most frequently addressed ICF chapter—a chapter that includes ‘Walking’ (d450), 
‘Moving around’ (d455), and ‘Changing and maintaining body positions’ (d410 and d415); 
these activities are all reflected in the GMFCS.24 ‘Sensory functions and pain’ (b2) was 
the second most frequent chapter, almost completely represented by the overall most 
frequent second-level category of ‘Sensation of pain’ (b280). Furthermore, we found high 
frequencies of categories in chapter b7 ‘Neuromusculoskeletal and movement-related 
functions’, namely ‘Functions of joint mobility’ (b710), ‘Muscle power and tone’ (b730 and 
b735), ‘Gait pattern’ (b770), and ‘Voluntary movement’ (b760). Pain, limited joint mobility, 
decreased muscle power, and increased muscle tone are regularly observed in clinical 
practice. According to the ICF model, these (impairments in) ‘Body functions’ may affect 
the level of relevant activities and participation in major life areas, such as walking and 
self-care, and consequently employment and social and domestic life. The high frequency 
of concepts addressing ‘Activities and participation’ emphasize their importance. Regarding 
‘Contextual factors’, ‘Products and technology for mobility or for use in daily living’ (e1) 
were frequently reported, which can both facilitate or hinder the aforementioned ‘Body 
functions’ and ‘Activities and participation’.
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Table 5.5. Relative frequency of second-level categories identified in studies using common measures (n=189).
ICF code Chapter Used in number of studies, 
n (%)
b Body functions
b280 Sensation of pain 71 (37.6)
b710 Mobility of joint functions 36 (19.0)
b620 Urination functions 30 (15.9)
b730 Muscle power functions 30 (15.9)
b735 Muscle tone functions 27 (14.3)
b152 Emotional functions 26 (13.8)
b455 Exercise tolerance functions 23 (12.2)
b525 Defecation functions 23 (12.2)
b770 Gait pattern functions 22 (11.6)
b760 Control of voluntary movement functions 21 (11.1)
b130 Energy and drive functions 20 (10.6)
b134 Sleep functions 20 (10.6)
b144 Memory functions 20 (10.6)
b126 Temperament and personality functions 19 (10.1)
b140 Attention functions 14 (7.4)
b164 Higher-level cognitive functions 13 (6.9)
b114 Orientation functions 12 (6.3)
b320 Articulation functions 12 (6.3)
b235 Vestibular functions 11 (5.8)
b210 Seeing functions 10 (5.3)
s Body structures
s750 Structure of lower extremity 41 (21.7)
s760 Structure of trunk 27 (14.3)
s730 Structure of upper extremity 13 (6.9)
s770 Additional musculoskeletal structures related to 
movement
10 (5.3)
d Activities and participation
d450 Walking 63 (33.3)
d850 Remunerative employment 52 (27.5)
d855 Non-remunerative employment 47 (24.9)
d510 Washing oneself 42 (22.2)
d540 Dressing 42 (22.2)
d455 Moving around 40 (21.2)
d920 Recreation and leisure 38 (20.1)
d410 Changing basic body position 35 (18.5)
d440 Fine hand use 35 (18.5)
d520 Caring for body parts 34 (18.0)
d640 Doing housework 32 (16.9)
d445 Hand and arm use 31 (16.4)
d550 Eating 31 (16.4)
d420 Transferring oneself 29 (15.3)
d415 Maintaining a body position 28 (14.8)
d460 Moving around in different locations 28 (14.8)
d760 Family relationships 28 (14.8)
d465 Moving around using equipment 27 (14.3)
d530 Toileting 26 (13.8)
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Table 5.5. Continued
ICF code Chapter Used in number of studies, 
n (%)
d430 Lifting and carrying objects 24 (12.7)
d750 Informal social relationships 24 (12.7)
d630 Preparing meals 19 (10.1)
d330 Speaking 17 (9.0)
d570 Looking after one’s health 17 (9.0)
d650 Caring for household objects 17 (9.0)
d770 Intimate relationships 15 (7.9)
d240 Handling stress and other psychological demands 14 (7.4)
d166 Reading 13 (6.9)
d210 Undertaking a single task 13 (6.9)
d350 Conversation 13 (6.9)
d360 Using communication devices and techniques 13 (6.9)
d560 Drinking 13 (6.9)
d870 Economic self-sufficiency 13 (6.9)
d910 Community life 13 (6.9)
d175 Solving problems 12 (6.3)
d345 Writing messages 12 (6.3)
d470 Using transportation 12 (6.3)
d177 Making decisions 11 (5.8)
d310 Communicating with - receiving - spoken messages 11 (5.8)
d335 Producing nonverbal messages 11 (5.8)
d475 Driving 11 (5.8)
d620 Acquisition of goods and services 11 (5.8)
d930 Religion and spirituality 10 (5.3)
e Environmental factors
e120 Products and technology for personal indoor and 
outdoor mobility
32 (16.9)
e110 Products or substances for personal consumption 23 (12.2)
e115 Products and technology for personal use in daily living 21 (11.1)
e580 Health services, systems and policies 19 (10.1)
e399 Support and relationships, unspecified 13 (6.9)
pf Personal factors
pf-sd Personal factors, sociodemographics 30 (15.9)
pf Personal factors, unspecified 25 (13.2)
nc Not covered
nc-bc Not covered, body composition 19 (10.1)
nc Not covered, unspecified 18 (9.5)
nc-hc Not covered, health condition 16 (8.5)
nd Not defined
nd-gh Not defined, general health 18 (9.5)
nd Not defined, unspecified 14 (7.4)
nd-pb Not defined, physical behavior 14 (7.4)
nd-ph Not defined, physical health 11 (5.8)
nd-funct Not defined, functioning 11 (5.8)
Note. Only ICF categories measured in ³5% of all studies applying common measures are presented. 
Categories are ordered according to their relative frequency within each component.
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Figure 5.2. International Classification of Functioning, Disability and Health (ICF) framework,9 including 
the most frequent categories studied in adults with cerebral palsy.
Note. Only second-level ICF categories present in ≥15% of the studies are depicted here; those present in 
≥20% of the studies are underlined.
The patient-oriented measures and clinical assessments found in the literature presumably 
reflect the instruments and assessments that are used in clinical practice. The Short Form 
Health Survey, Barthel Index, and Functional Independence Measure are the most widely 
used outcome measures in adults with CP, and have a common focus on ‘Mobility’ (d4) and 
‘Self-care’ (d5). These instruments are also widely used in other populations with physical and 
mental disabilities such as stroke and traumatic brain injury.30,31 Recently, the ICF Research 
Branch developed a generic set of categories that can be applied for documenting functioning 
in clinical (rehabilitation) settings.32 Comparable to the present results, 21 of the 30 categories 
in the ICF Generic-30 Set (often also called ICF Rehabilitation Set) are from the component 
‘Activities and participation’, whereby 13 are ‘Mobility’ (d4) and ‘Self-care’ (d5) categories. 
Furthermore, 89% of the body function categories included in the ICF Generic-30 Set 
corresponds to the ‘Body functions’ frequently reported in the studies included in this 
review. This match of categories and consistency with clinically relevant instruments 
supports the notion that the ICF provides a universal language that can be used to describe 
outcomes of adults with CP. Nevertheless, since the population of adults with CP is very 
heterogeneous and presents itself with very specific and often increasing health-related 
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issues that go beyond the aspects of functioning addressed by the ICF Generic-30 Set,20 
a CP-specific ICF Core Set would have added value in clinical practice. For example, this 
review identified certain sensory functions and functions related to fatigue, or activities 
such as fine hand use, that are not included in the ICF Generic-30 Set.
We identified only few ‘Body structures’ in the literature on adults with CP. In this 
component, only structures related to ‘Movement’ (s7), most frequently the trunk and 
lower extremities, were regularly measured, usually by clinical assessments with specialized 
equipment (i.e. radiography). These body structures were mainly measured in adults with 
CP with lower-functioning GMFCS levels; this is no surprise given the more severely 
affected deformities that are common in people whose gross motor function is more 
impaired.33 Likewise, few concepts were linked to ‘Personal factors’, which suggests a lack 
of representation of important interactions between personal characteristics and functional 
status in published studies on adults with CP, or may reflect the type of studies included in 
this review. Most of these were conducted in rehabilitation settings and included outcome 
measures that describe functioning or determine treatment efficacy, potentially explaining 
the focus on body functions and activities and participation outcomes. Another concern may 
be that personal factors are still not classified in the ICF. Finally, some concepts were unable 
to link to the ICF. For example, 6% of the concepts were not covered by the ICF or were 
insufficiently defined to allow linking to an ICF category. Notably, concepts such as physical 
behaviour – often measured by accelerometry – or those related to body composition (e.g. 
waist circumference) were often measured but could not be linked to the ICF.
A population-specific ICF Core Set facilitates the development of standards. This review 
presents a state-of-the-art of research in adults with CP. The total of 332 different outcome 
measures identified reflects the large variation in outcomes that are considered relevant 
to study in adults with CP, but at the same time it indicates a lack of standardization for 
frequent outcomes. Among the large quantity of outcome measures, we found several that 
were CP-specific, such as the GMFCS and Manual Ability Classification System. The GMFCS 
and the Manual Ability Classification System are, however, intended to classify the level of 
an individual’s gross motor function and manual performance respectively.24,34 Some of the 
included studies used the GMFCS as an outcome measure though. Consequently, this may 
have affected the present overview, since the GMFCS represents ICF categories in chapter 
d4 ‘Mobility’. Including them as outcome measures may therefore have slightly overestimated 
the frequency in this chapter. However, in almost half of the studies, the GMFCS was applied 
as a participant characteristic and thus was not included in our frequency analysis.
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Systematic reviews with ICF linking of outcome measures have been previously conducted 
for other conditions addressing physical and cognitive disabilities.30,31,35 While some of 
these used random samples of the literature or included only clinical trials,30 others linked a 
selection of the identified measures on the basis of a relatively high occurrence rate or type 
of measure.31,35 In the current systematic review, all eligible literature from a comprehensive 
sample was selected and a variety of study designs were included. For the linkage of outcome 
measures, a bottom-line occurrence rate (i.e. used in two or more studies) was considered, 
regardless of its type. We were able to demonstrate by which type of measure the relevant 
areas of functioning and disability were most commonly addressed. Clinical assessments 
were often applied to study cognitive functions, neuromusculoskeletal and movement-related 
functions, and structures related to movement, whereas patient-oriented and non-tool 
measures were used to study activities and participation, mainly chapters d4 to d9.
The present methodology was in line with the systematic review conducted for the ICF 
Core Sets for children and young people with CP.14 Minor differences were, however, 
present. For example, our literature search was more comprehensive (5472 vs 698 
screened). On the other hand, Schiariti et al.14 linked every outcome measure, although in 
some cases only the domains or purposes of measures were linked. Despite only linking the 
common outcome measures, we linked all items included in these measures. Finally, Schiariti 
et al.14 used the ICF for Children and Youth, whereas we linked the extracted concepts to 
the 2001 reference version of the ICF. Apart from these differences in methodology, the 
distinction between the children/young people and adult populations with CP was mainly 
demonstrated by the results of both reviews. For example, control of voluntary movement 
was by far the most studied body function in children and young people, whereas for 
adults sensation of pain was most common. In ‘Activities and participation’, walking was 
the most frequent category in both populations. However, for children and young people, 
other ‘Mobility’ categories (d4), such as ‘Moving around’ or ‘Changing and maintaining body 
positions’, continued to be most frequent, whereas for adults we identified ‘Employment’ 
(d8), ‘Self-care activities’ (d5), and ‘Recreation’ (d9) as the most frequent categories after that 
of ‘Walking’. With regard to the differing ICF frameworks, the ICF Core Sets for children 
and young people with CP contain eight categories that only exist in the ICF for Children 
and Youth. However, we did not expect to find these categories (e.g. ‘Acquiring language’) 
in research on the adult population. In the end, the shared focus on movement-related 
functions, mobility, and self-care strengthens the idea that these domains are relevant for 
individuals with CP throughout the lifespan. Nevertheless, each stage of life has its own 
areas of attention. Our findings highlight that when young people with CP transition into 
adulthood, there is a shift of attention on specific aspects of functioning, namely towards 
participation in major life areas. A recent follow-up study of individuals with CP aged 
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between 16 and 34 years demonstrated that, in young adulthood, housework, employment, 
and intimate relationships became much more relevant, while education and selected 
recreational activities became less relevant.19 At the same time, difficulty in participation 
increased during the transition into the mid- and late-twenties.19 Comparing the results of 
the literature reviews on children/young people and adults with CP emphasizes the shifting 
of relevant outcomes for individuals with CP when entering adult life.
This systematic literature review shows that functioning of adults with CP is an emerging 
field of research, as evident by the increasing number of articles published on this topic 
during the 16-year timeframe of this review. A small part of this research seems to be 
experimental: only 5% involved randomized controlled trials. Considering individuals with 
CP receive most of their treatment during childhood, it is not surprising that research 
examining the effects of interventions, such as randomized controlled trials, is not frequently 
found in the literature on adults with CP. On the other hand, from a clinical perspective, 
it is surprising to find that the rehabilitation-oriented studies included relatively young 
participants (median 31y), as young adults with CP generally do not receive rehabilitation 
care.36 Nevertheless, it can be concluded that there is a paucity of intervention studies 
targeting the long-term consequences of living with CP.
Some limitations should be considered when interpreting the results of this review. First, 
our selection was limited to studies and outcome measures in English, and to studies 
published between 2000 and 2017. Also, qualitative studies were not included, since this 
is considered a separate preparatory study in the ICF Core Set development process. 
These criteria were in line with the ICF methodology,11 but some important concepts 
were potentially missed since qualitative research captures direct experiences of persons 
in their natural setting, often referring to environmental and personal factors. Similarly, 
certain concepts that only recently received attention in the scientific literature might have 
been missed. Second, most studies were conducted in Europe, North America, and the 
Western Pacific. Any concepts that might be specifically relevant in low- and middle-income 
countries were therefore missed. Finally, initial agreement on ICF categories between 
the reviewers was modest. However, a strength of this review was that each step was 
conducted independently by two reviewers, and discussions with a third reviewer always 
led to consensus. As this is the first study in the development of an ICF Core Set for adults 
with CP, these limitations will presumably be levelled out in the other preparatory studies. 
For example, in the expert survey all six WHO regions will be represented, so aspects of 
functioning in both low- and high-income countries will be captured.
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CONCLUSION
This systematic review identified the most frequent outcomes used in studies of adults 
with CP, of which pain, mobility, self-care, employment, and recreation were most frequent. 
The broad range of ICF categories identified in this study emphasizes the heterogeneity of 
functioning and disability in adults with CP, but there is limited focus on environmental and 
personal factors in research, supporting the need to explore other perspectives as well. The 
present results will be combined with the results of the other preparatory studies. Together, 
all four preparatory studies capture the complementary perspectives of researchers, 
patients, and clinicians, and will serve as the scientific basis for the development of an ICF 
Core Set for adults with CP for use in both research and clinical practice.
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ABSTRACT
Background: Estimates of multimorbidity, defined as the presence of at least two chronic 
conditions, some of which attributable to modifiable behaviours, are high in adults with 
cerebral palsy (CP). An assessment protocol evaluating multimorbidity risk is needed 
in order to develop and evaluate effective interventions to optimize lifelong health in 
individuals with CP. The aim of this protocol paper is to describe the development of a 
core outcome set (COS) for assessing multimorbidity risk in adolescents and adults with 
CP, to be used in clinic and research.
Methods: The expert consortium will first define the target population and outcomes to be 
measured. Through a process of literature review and an international Delphi survey with 
expert clinicians and researchers, we will then determine which outcome measurement 
instruments (OMIs) can best measure those outcomes. The resulting OMIs will be used 
in a feasibility study with adolescents and adults with CP from an international clinical 
research network. Finally, a face-to-face stakeholder meeting with adolescents and adults 
with CP, their families/caregivers and researchers and clinicians who are experts in CP, will 
be organized to reach final agreement on the COS.
Discussion: This COS will guide clinicians and researchers in assessing multimorbidity risk 
in adolescents and adults with CP. The inclusion of experts and individuals with CP from 
international locations for establishing the COS lends strong support to its generalizability. 
Evidence of its feasibility and approval from all stakeholders will enable implementation in 
clinical practice, and guide future research using the COS in individuals with CP.
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BACKGROUND
Cerebral palsy (CP) is a well-recognized neurodevelopmental disability commencing in 
early childhood and continuing throughout life, and is the most common motor disability 
in childhood.1 The disability itself results from non-progressive disturbances to the 
developing fetal or infant brain, and the resultant motor disorders are often accompanied by 
disturbances of cognition, behaviour and communication, to name only a few.2 Population-
based studies report prevalence estimates of CP ranging from 1.5 to greater than 3 per 
1000 live births.3-7 As CP presents itself early in life, much research has focused on children 
with CP; however, given the longer lifespan apparent in most persons with CP,8 clinicians 
and researchers have started to focus on the impact of CP and associated health issues 
with a lifespan approach. Indeed, adults with CP are a growing community who are now 
recognized as outnumbering children 3:1 in some countries.9
A prominent concern for individuals with CP is their physical behaviour and reduced 
cardiorespiratory endurance.10-12 Physical behaviour is defined as the behaviour of a person 
in terms of body postures (e.g. sitting and standing), movements (e.g. walking and cycling) 
and/or daily activities (e.g. sports and gardening) in his/her own environment, and therefore 
consists of both physical activity and sedentary behaviour.13 Cardiorespiratory endurance 
is the capacity of the body to perform physical activity, which is dependent mainly on the 
aerobic or oxygen-requiring energy systems.10 Adolescents and adults with CP have reduced 
cardiorespiratory endurance,14 which is a risk for cardiovascular disease and cardiovascular-
related mortality.11 Also, children, adolescents and adults with CP engage in significantly less 
physical activity and increased sedentary behaviour compared to typically developing peers.15-
19 Low levels of physical activity and increased sedentary behaviour can partly be explained 
by reduced mobility following from the condition itself, as well as accompanying physical pain 
and fatigue that progressively worsen with aging.20 Among individuals with CP, differences 
exist in physical activity levels21 and obesity prevalence22, which are contingent upon the 
functional status of individuals, as determined by the Gross Motor Function Classification 
System (GMFCS).23 Reduced cardiorespiratory endurance and physical activity, and increased 
sedentary behaviour, are associated with risk for cardiovascular (i.e. coronary heart disease, 
cerebrovascular disease, peripheral arterial disease) and cardiometabolic (i.e. diabetes 
and obesity) disease in persons with CP,17,24,25 which may become higher later in life.26,27 
Recent research in middle-aged adults with CP revealed high-estimates of multimorbidity, 
which were significantly more prevalent among obese versus non-obese persons with CP.12
Multimorbidity has been defined as the presence of at least two chronic conditions.12 
Among individuals with CP, chronic conditions apart from CP itself, such as hypertension, 
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dyslipidemia, hyperglycemia, insulin resistance, and obesity are emerging in the 
literature.17,24,26 Results from a population-representative sample of adults with CP showed 
that this population had significantly greater age-adjusted prevalence of hypertension 
(30.0% vs 22.1%) and obesity (41.4% vs 29.7%) compared to adults without CP.28 Despite 
the significant progression of disability that is known to occur during the aging process 
in CP,20 there has been a lack of attention devoted to understand the pathophysiology to 
develop multimorbid conditions in adolescents and adults with CP, beyond those stemming 
from the primary brain injury in infancy. Multimorbidity risk could be attributed to a shared 
number of modifiable behaviours such as physical inactivity and/or sedentary lifestyles, 
poor diet, and inadequate sleep.29 This highlights the importance of screening for, and 
understanding of risk exposures for multimorbidity in individuals with CP.
Over the last decade, a number of generic and CP specific instruments and protocols 
assessing multimorbidity risk factors have been developed. As a result, studies evaluating 
these risk factors in adolescents and adults with CP are using a variety of outcome 
measurement instruments (OMIs) (e.g., self-report questionnaires, accelerometry-based 
activity monitors, biomarkers and performance-based tests), which might possibly be 
measuring the same outcome, and thus causing difficulty synthesizing knowledge from 
the published literature and when generalizing findings.30 Moreover, the psychometric 
quality (i.e. reliability, validity, sensitivity) of OMIs tends to vary and/or published evidence 
is lacking. Altogether making it inconvenient for clinicians and researchers to select the 
most appropriate OMIs for the outcome of interest. In order for clinicians and researchers 
to work with individuals with CP on plans for effective interventions – including advice 
pertaining to physical behaviour, nutrition and sleep – to reduce multimorbidity risk, it is 
vital to reach consensus on the outcomes to assess, the ways to assess them, and ultimately 
leading to routine clinical practice.
Lately, there is an increasing recognition for identifying core sets of outcomes that enable 
comparison of clinical trials for a particular condition. Moreover, establishing a core outcome 
set (COS) may be useful for routine health screening. Currently, there is no established 
COS for adolescents and adults with CP for the purpose of evaluating multimorbidity risk 
factors. A search of “cerebral palsy” through the Core Outcome Measures in Effectiveness 
Trials (COMET) database resulted in six matches, all of which focus on children with 
CP.31 Common Data Elements (CDEs) exist for CP through a joint effort between the CP 
CDE Working Groups and the National Institute of Neurological Disorders and Stroke.32 
Within the CDEs is a summary of core and supplemental recommendations that is highly 
recommended as a start-up resource for clinical research in this population. Although this 
set of CDEs was recently developed (2016), it only applies to children and adolescents 
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aged 0 to 18 years and does not specify instruments specific to adults with CP or measures 
that assess multimorbidity risk.33
The aim of this protocol paper is to describe the process of developing a COS of OMIs for 
multimorbidity risk in adolescents and adults with CP to be used in clinic and research. This 
work includes (1) identifying what outcomes should be measured; (2) determining how to best 
measure those outcomes; and (3) measuring these outcomes in an international cohort of 
individuals with CP. The final COS will be made in consultation with individuals with CP and 
their families and caregivers and with representatives of the clinical and research community 
who are working with people with CP. The inclusion of adolescents and adults with CP and 
their families and caregivers is critical to ensure that OMIs are meaningful, appropriate, and 
acceptable to inform decisions about assessment of multimorbidity risk in this population. 
We will include adolescents with CP in the assessments of multimorbidity risk, as this will 
capture a pivotal transition period, and may highlight the importance of engaging in positive 
behaviours early on to attenuate multimorbidity risk later in life. This study is part of a 
program of research aiming to ultimately understand, treat and prevent multimorbidity in 
adolescents and adults with CP through modifiable behaviours (e.g. physical behaviour, sleep 
and nutrition) and to develop an international database that will allow for harmonization of 
data and the ability to document changes over time in this population.
METHODS
This study protocol is registered with the COMET Initiative (http://www.comet-initiative.
org/studies/details/1130) and follows recently published guidelines from a collaboration 
between the COMET Initiative and COnsensus-based Standards for the selection of health 
Measurement INstruments (COSMIN).30 Slight adjustments were made to the original 
flowchart,30 as we chose to include a pilot testing phase (Figure 6.1). Phase 1 has begun, 
and the target population and outcomes to be measured have already been defined.
Investigators and co-investigators
Four authors (PM, JB, MR, JWG) will have an investigating role in the COS development. 
After deciding on the conceptual considerations in consultation with co-investigators 
(MP, EH, WS, AB, OV, RB), they will first perform a review of the literature and extract 
relevant OMIs. Secondly, they will carry out a consensus procedure with experts to obtain 
agreement on selected OMIs to be included in the COS. Third, they will coordinate a 
cross-sectional feasibility study in which the COS will be tested in an international cohort 
of adolescents and adults with CP at four sites. Finally, they will organize a stakeholder 
meeting to review and finalize the COS of OMIs for multimorbidity risk.
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Figure 6.1. Main steps in the COS development including roles of all involved at each step.
Schematic outline of the different phases and steps included in the development of a COS for multimorbidity 
risk assessment in adolescents and adults with cerebral palsy. Roles of all involved at each step are indicated. 
COS, core outcome set; OMI, outcome measurement instrument; CP, cerebral palsy.
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Phase 1: Selecting relevant OMIs
Step 1: conceptual considerations
We defined a target population and outcomes to be measured, in line with the COSMIN-
COMET guideline.30 This was done via an in-person meeting with the co-investigators from 
four research centres (Hamilton, Canada; Ann Arbor, USA; Rotterdam and Utrecht, The 
Netherlands), at the 29th European Academy for Childhood Disability conference (2017). 
During this meeting, the target population was defined as adolescents (14-18 years) and/
or adults (>18 years) with CP. Furthermore, the following outcomes were decided to be 
important for assessing multimorbidity risk in the target population: physical behaviour, 
nutrition, sleep, cardiorespiratory endurance, body composition, blood pressure, and lipids/
glucose. Including risk behaviours (i.e. physical behaviour, nutrition, and sleep) is important 
to identify which patients require intervention. Measuring cardiorespiratory endurance, 
body composition, blood pressure and lipids/glucose will allow clinicians and researchers 
to observe the benefits of improved risk behaviours.
Step 2: Finding existing OMIs
In order to find all existing OMIs addressing the defined outcomes, we will use three 
sources of information, including (1) existing systematic reviews, (2) literature searches, and 
(3) additional sources (e.g. conference proceedings).30 Additional sources are considered 
optional since it is unlikely that one will find OMIs of good quality that were not already 
identified from a systematic search of the literature.30
The COSMIN database of systematic reviews of OMIs will be consulted to see if systematic 
reviews, describing our target population and any of the seven outcomes, exist. Candidate 
OMIs for each outcome will further be identified by electronic searches of the following 
databases: EMBASE and Medline (Ovid), PsycINFO, and PubMed. The electronic searches 
will be carried out by two researchers with experience in conducting systematic reviews 
(PM, JB). We will develop a search strategy which will include the following major themes: 
“cerebral palsy”, “adolescent OR adult”, and each outcome on their own. Key terms within 
the search strategy will be aligned to medical subject headings and expanded to include 
more descriptive terms. Searches consistent with “measurement properties” will not be 
included in the search strategy, since evidence on measurement properties of relevant OMIs 
is expected to be limited in our target population, exposing a risk of missing relevant studies 
(see Appendix 6.1). Eligible publications will be randomized controlled trials, longitudinal 
(including experimental and cohort studies) and observational (including cross-sectional, 
cohort, and case-control studies) studies, written in English. Studies will be grouped by 
outcome and repeated where appropriate (i.e. if there is >1 outcome within a single study). 
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The two researchers will screen titles and abstracts independently and select references 
using a predetermined set of inclusion/exclusion criteria. If there are any discrepancies, 
these will be resolved by consulting other investigators (JWG, MR). Upon agreement on 
the final selection of studies, the two researchers will record each OMI for each outcome 
used in an eligible study. We will also extract characteristics of the study sample (i.e. sample 
size, mean age, sex, type of CP, and GMFCS level(s)). Data extracted will be crosschecked 
for accuracy between the two researchers.
A group of experts that will be consulted during the second phase of the COS development 
process will serve as additional sources for finding OMIs. The group will be requested to 
provide any additional OMIs that are considered relevant to an outcome but were not 
identified in existing systematic reviews or in the literature searches.
Step 3: Quality assessment of the OMIs
The quality of the OMIs that result from step 2 will be assessed in accordance with the 
COSMIN-COMET guideline.30 The quality assessment will include two parts: (1) evaluating 
the methodological quality of the studies included from the literature searches, and (2) 
evaluating the quality of the OMIs (i.e. their measurement properties). Since the literature 
search will not be limited to studies on measurement properties of OMIs, we will use a 
combination of the COSMIN checklist and the McMaster critical review form.34,35 The 
COSMIN checklist will be applied for evaluating the methodological quality of studies 
on measurement properties of OMIs,34 while the McMaster critical review form will be 
applied to assess the methodological quality of the other study types (e.g. clinical trials and 
observational studies).35 The quality of the OMIs will be evaluated by applying criteria for 
good measurement properties.36 We will first evaluate the content validity of the included 
OMIs and where applicable the remaining measurement properties.30 Both researchers (PM, 
JB) will perform the OMI evaluation, and will crosscheck each other’s quality assessments 
to ensure accuracy and completeness. Evaluations of the methodological quality of the 
studies and the quality of the OMIs will be combined into a best evidence synthesis, grading 
the body of evidence for each OMI.30 Feasibility aspects of the OMIs including applicability 
(for the target population), patient feasibility, assessor/clinician feasibility, and practical 
feasibility will be considered in the next phase of the study.
Phase 2: Consensus procedures: Delphi & online survey
Step 4: Select an OMI for each outcome included in the COS
We will use the Delphi survey method37 as a consensus procedure to obtain agreement on 
the selected OMIs included in developing a COS using experts in the area of multimorbidity 
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risk in adolescents and adults with CP. In a Delphi procedure, interactions between 
experts occur via a series of individual surveys, preserving both anonymity and balance in 
participation from the experts.38 In contrast to an in-person consensus method, a Delphi 
procedure can be conducted via email survey and is therefore accessible to participants 
regardless of location and involves no cost.39
Experts
To remain consistent with the international aspect of the protocol, we will include a group 
of eight experts that consist of clinical and research experts in this field. The experts will be 
from Canada (n=2), USA (n=2), and The Netherlands (two locations, n=4). The investigators 
(PM, JB, MR, JWG) discussed and confirmed a priori that each international location must 
consist of at least one clinical and one research expert. To be considered a clinical expert, 
the individual must have worked with adolescents and/or adults with CP for at least 5 
years. To be considered a research expert, the individual must have published one or 
more articles related to an identified outcome of multimorbidity risk in this population 
(adolescents and/or adults with CP).
Delphi survey
The initial stage of the Delphi survey will be a pre-round to obtain a list of OMIs that is 
as complete as possible. Based on the results from the literature searches performed by 
the two researchers, a list of studies with OMIs will be identified and divided into the 
seven defined outcomes: (1) physical behaviour, (2) nutrition, (3) sleep, (4) cardiorespiratory 
endurance, (5) body composition, (6) blood pressure and (7) lipids. Experts will be provided 
the results from the literature searches via e-mail, and requested to provide any additional 
OMIs that are relevant to an outcome but are not identified in the literature searches. These 
could include OMIs that are being used in clinical practice, ones used by a colleague, and/
or ones that were read in an abstract or article or in a student’s thesis. Any proposed OMIs 
will be required to have a reference or abstract attached, to allow the two researchers to 
evaluate the quality of both the study and the OMI as per Step 3.30
In round 1 of the Delphi survey, experts will receive an updated list of OMIs pertaining to 
each of the seven outcomes, which will be delivered by e-mail. The investigators will provide 
the experts with a spreadsheet consisting of seven tabs, one for each outcome. Every tab 
will include all associated OMIs that were obtained during step 2 and the Delphi pre-round, 
accompanied by a brief note of the methods/equipment used, a short description of the 
samples in which the OMI was used and graded evidence of the OMI resulting from step 3. A 
detailed description of the characteristics of each included study will be provided separately 
to assist experts in reviewing the OMIs. Study characteristics will include author and year 
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of publication, the outcome(s) studied, the sample characteristics extracted in step 2, and 
the methodological quality of the study evaluated in step 3. Experts will be given detailed 
instructions and an instructional video outlining how to score each OMI on a 1–10 scale 
(1=lowest, 10=highest) for five different aspects of feasibility: applicability, patient feasibility, 
clinician feasibility, practical feasibility and overall rating. A comment box will be provided 
to allow experts the option to provide additional information to the researchers (i.e. explain 
responses or raise concerns), or to indicate that they are ignorant or uncertain. Experts will 
have 2 weeks to score the OMIs for feasibility. Reminder e-mails will be sent after 1 week 
and at 1 day before the end of the 2-week period. Mean scores will be calculated after 
receiving and aggregating the expert scores. OMIs with a mean overall score ≥7 will be 
retained, those with scores <6 will be omitted and those with scores of 6–7 will be discussed 
among the investigators using the expert comments and quality scores. Moreover, we will 
examine differences between clinician and researcher scores and describe these results.
In subsequent rounds of the Delphi survey, experts will be presented the results from the 
previous round. All experts will see aggregated scores for each OMI, and a synopsis of 
the comments made by each expert (if applicable). Experts will be asked to consider the 
feedback (i.e. aggregated scores and comment synopsis) and again score the feasibility 
aspects for the remaining OMIs with an option to provide their rationale in a comment 
box. In these rounds, experts also will be asked to identify their preferred OMI for each 
outcome and to explain why. Similar to round 1, experts will have 2 weeks to score the 
OMIs for feasibility with reminder e-mails provided at the same time points. The expert 
scores will be processed in a similar fashion and extended with preferred OMI scores. This 
process will continue until a single OMI per outcome is selected, based on ≥70% agreement 
among experts. The investigators will attempt to identify a provisional COS pertaining to 
the seven outcomes from the scores after two rounds. This will be based on aggregated 
scores (mean and median), expert opinion (i.e. rationales and additional information from 
the comments), and the quality of the studies and OMIs. The provisional COS will be 
presented to all experts, who will be asked whether they agree or disagree with the OMI 
for each outcome in the COS. If an expert disagrees with the suggested COS, they will 
be asked to provide their comments and reasons for disagreement.40 From the decisions 
and comments made by the experts, a provisional COS will be presented and evaluated 
for final agreement. The COS will only become final after feasibility testing (phase 3) and 
stakeholder engagement (phase 4) (see below).
Step 5: patient/family judgement on relevance and completeness of selected outcomes
We will conduct a short online survey with patients with CP or families/ caregivers of 
people with CP, to rate the importance of each outcome as something they would like their 
family doctor to measure and discuss with them.
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 111
111
Protocol core outcome set for multimorbidity risk
Phase 3: feasibility study
Step 6: feasibility test of the COS in the target population
After developing a COS for multimorbidity risk assessment for use in clinical research and 
practice, the next stage will be to test the feasibility of the COS in a cohort of adolescents 
and adults with CP. Aspects of feasibility to be assessed from the perspectives of the 
clinicians and researchers will include ease of assessment, time required for completion 
and their confidence in the COS to assess multimorbidity risk. Time requirement and 
interpretation of results will be assessed (see below) to determine feasibility from the 
patient perspective.
Participants
The feasibility study will focus on adolescents and adults aged 14 years and over, with a 
diagnosis of CP. We will include individuals with CP across all GMFCS levels (levels I–V), 
from three different international locations: Hamilton, ON, Canada; Ann Arbor, MI, USA and 
Rotterdam and Utrecht (combined), The Netherlands. The knowledge to be gained from this 
multinational study will be far superior to the minimal information that would be gained if 
we were to conduct the study at a single site, which has constrained the generalizability 
of research in this area.41
Recruitment strategy
Individuals with CP will be recruited during clinical visits to an adult rehabilitation centre or 
a child and youth clinic in Hamilton, ON, Canada; Ann Arbor, MI, USA and Rotterdam and 
Utrecht, The Netherlands. During clinical visits, a physician (JWG, EH or WS) or a study 
coordinator (PM or JB) from our research team will introduce the study to the patient, at 
which point the patient will have an opportunity to consent to participate in the study. 
Members of our team have used a similar recruitment strategy successfully in the past,26 
and we are confident in achieving a total sample size of 75 (25 per geographical region) for 
testing the feasibility of the COS. As feasibility testing of the COS will be cross-sectional 
in nature, we will not include a control group at this time. We plan for a future grant 
application to fund an intervention study using the findings of our feasibility study, which 
will incorporate a control group.
Sample size
An a priori criterion for success of this feasibility study is that a subsequent intervention trial 
would be feasible if the outcome variables were collected for ≥70% of participants. Using 
a 95% confidence interval (CI) for the proportion of eligible participants who complete the 
assessment, a margin of error of 0.05, a lower bound CI of 0.70 and an expected completion 
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rate of 75%, the required sample for the feasibility study will be at least 75 participants. 
We aim to recruit five participants per GMFCS level per location (i.e. 5 participants * 5 
GMFCS levels * 3 locations), for a total of 75 participants. As this is a cross-sectional study 
(i.e. single time commitment), we will not factor in the attrition rate.
Assessments
Eligible participants who have provided written consent to participate in the feasibility 
study will be assessed. Participants will be invited to visit the relevant setting, in which 
we will execute the OMIs selected for the COS. Assessments will be conducted by the 
clinicians and researchers involved, where applicable with support from research/laboratory 
assistants. Based on the outcomes that have been identified in step 1, we estimate that it 
will take 3–4h to conduct the total set of OMIs. Naturally, the collected data will provide 
insight into the risk profile of the individual participant. We hope that the measures will 
be integrated into clinical care as much as possible. It is conceivable that the total data 
collection time may be spread over a single assessment or multiple assessments (e.g. body 
composition and blood pressure measurements in clinic, but an additional session for 
measurement of cardiorespiratory endurance). The total time required will be explored in 
our feasibility study. The COS will be qualitatively evaluated to examine its acceptability 
as a whole, by both the participants and clinicians/researchers. After the measurements 
the participants will be asked about their experience of the COS, including time required 
to complete the assessments, via a short survey. Upon completion of all measurements, 
we will question the clinicians and researchers who conducted the assessments about 
the ease of assessment, completion time and their confidence in the COS, also via a short 
survey. Together with the collected data, the feedback from the participants, clinicians 
and researchers will provide a clear indication of the feasibility of the COS for future use 
in clinical research and practice.
Phase 4: patient and family/caregiver engagement
Step 7: final agreement on the COS among stakeholders
As a final step and after taking into consideration the qualitative evaluations from study 
participants, clinicians and researchers, we will organize a face-to-face stake- holder 
meeting to reach final agreement on the COS. Adolescents and adults with CP and their 
families and/ or caregivers, as stakeholders in this project, will be recruited with support 
from the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) 
family/participant education forum. The AACPDM education forum is held annually at the 
AACPDM conference. Prior to the meeting, we will work with the AACPDM administrative 
leaders to have an advertisement positioned on their website asking for adolescents and 
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adults with CP (and their families/caregivers) to participate in a meeting to help review 
and finalize a COS for multimorbidity risk. We will invite four adolescents and four adults 
with CP of varying GMFCS levels, who did not participate in the feasibility study, and their 
families and/or caregivers (if applicable), to take part in the meeting, which will occur during 
the AACPDM 2018 conference (9–13 October 2018).
Dissemination
Details of the finalized COS will be disseminated through publication in a scientific journal, 
presentation(s) at international scientific conferences and research rounds at clinics and 
academic institutions at each international location.
DISCUSSION
The aim of this project is to develop and test the feasibility of a COS to assess multimorbidity 
risk in adolescents and adults with CP. Ultimately, the COS will be used to understand, 
treat and prevent multimorbidity in this population, while being utilized in a clinical and/
or research setting. The development of this COS is expected to have the potential to be 
generalized to other types of child-onset neurodevelopmental disabilities.
A strength of the proposed work is the inclusion of clinical and research experts in this field 
(COS development) and individuals with CP (feasibility study), from international locations. 
The knowledge to be gained from an international study will be significant and meets a 
major limitation in multimorbidity risk research in this population (i.e. studies of small 
sample sizes that are geographically isolated). If we are able to conduct the feasibility 
study successfully and receive positive feedback from individuals with CP, their families/
caregivers and clinicians and researchers, our next step will be to apply for funding to 
conduct an intervention study in this population aiming to prevent multimorbidity risk, 
including other geographic locations worldwide. In the meantime, the development and 
feasibility testing of a COS for adolescents and adults with CP will improve the consistency 
of CP research moving forward. Ultimately, we aim to utilize the COS in clinic to work 
towards developing a database that will allow for harmonization of data and the ability 
to document changes over time, which will enhance and accelerate our understanding 
of multimorbidity risk and presentation in this population, and will help to overcome the 
issues of current small-scale studies. As well, performing the COS assessment in clinic will 
allow us to obtain a risk profile for the patient, which can help inform an individualized 
treatment plan.
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A challenge we faced with this protocol was selecting when to engage individuals with 
CP and their families/ caregivers as key stakeholders in COS development. Ideally, we 
would have included these stakeholders throughout the study from the very beginning 
to the end. Despite not including individuals with CP in phase 1 of the project, we believe 
that the outcomes we selected align with the top research priorities identified in part by 
individuals with CP and their families: understanding how to prevent secondary impairments 
related to aging with CP and identifying effective long-term exercise strategies to improve 
activity and health across their lifespan.42 Moreover, in addition to the Delphi survey 
among professionals, we will also conduct an online patient/family survey to inform us 
whether the target population agrees that the outcomes to measure are relevant. Due 
to the focus on knowledge synthesis in the Delphi survey with research rigor and the 
terminology involved in quality assessments of studies and OMIs, we decided it would 
be more pragmatic to develop a provisional COS amongst clinicians and researchers, and 
then bifurcate to feasibility testing and a stakeholder meeting, to incorporate perspectives 
from individuals with CP and their families/caregivers and come to a final agreement on 
the COS. A former study that attempted to develop a COS with patient perspectives from 
the onset of the idea was reported as challenging.43
Despite an effort to include expert clinicians and researchers working with adolescents 
and adults with CP who are knowledgeable of multimorbidity, none of these individuals 
considered themselves as experts in the outcomes of nutrition and sleep in CP. This 
identifies an important gap in clinical research in this population; if nutrition and sleep are 
to be considered important components of multimorbidity risk prevention in people with 
CP,44 clinicians and researchers need to be trained in these outcomes in order to assess 
and manage these components of health.
Trial status
At the time of submission, we have included experts for the Delphi survey. Recruitment 
for the feasibility study will start in June 2018 subject to the ethics approval from all 
institutions involved.
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Appendix 6.1. Complete search strategy for Embase.
Population of interest: adolescents and adults with cerebral palsy
(‘cerebral palsy’/exp/mj OR (((cerebral* OR brain OR spastic) NEXT/2 (pals* OR paralys* 
OR hemipleg* OR diplegi* OR paresis)) OR ‘encephalopathia infantilis’):ab,ti) AND 
((‘adolescence’/exp OR ‘adolescent’/de OR (teenage* OR puberty):ab,ti) OR (‘adult’/exp 
OR (adult* OR elderly OR older OR aging OR pensioner OR retiree OR (grow* NEXT/1 
up*)):ab,ti))
AND
Construct of interest (2,3): body size and body composition
(‘anthropometric parameters’/exp OR ‘body composition’/exp OR obesity/exp OR ‘BMI 
(body mass index)’ OR ‘body mass index’ OR ‘Quetelet index’ OR adiposit* OR obesit* 
OR overweight OR ((body) NEAR/1 (height OR mass OR size OR composition OR fat OR 
lipid)) OR ((fat OR adipose) NEAR/2 (distribution OR mass OR tissue)) OR ((waist OR hip 
OR waist-hip) NEAR/1 (circumference OR ratio)):ab,ti)
OR
Construct of interest (4): physical behavior
(‘physical activity’/exp OR ‘physical inactivity’/exp OR ‘sedentary lifestyle’/exp OR 
sitting/exp OR ‘energy expenditure’/exp OR ‘motor activity’/de OR accelerometer/de 
OR accelerometry/de OR actimetry/de OR ((sedentary OR physical OR motor) NEAR/1 
(lifestyle OR activit* OR inactivity)) OR ((caloric OR energy) NEAR/1 (expenditure)) OR 
sitting OR acceleromet* OR actimetry OR actigraph* OR ((activity) NEAR/1 (monitor OR 
tracker)):ab,ti)
OR
Construct of interest (5): sleep
(sleep/exp OR ‘sleep disorder’/exp OR sleep* OR dream* OR dyssomnia* OR hyposomnia* 
OR hypersomnia* OR insomnia* OR parasomnia* OR sleeplessness OR sleepiness OR 
somnolence OR tiredness OR tired OR ((sleep) NEAR/2 (disorder* OR disturbance OR 
paralysis)):ab,ti)
OR
Construct of interest (6): nutrition
(nutrition/exp OR ‘feeding behavior’/exp OR ‘dietary intake’/exp OR feeding OR nutrition 
OR diet OR dieting OR ((diet* OR nutrition*) NEAR/1 (survey* OR assessment OR state 
OR status)) OR ((food OR feed OR energy OR calor* OR dietary OR nutrient) NEAR/1 
(uptake OR intake OR consumption)) OR ((feeding OR eating OR drinking OR alimentary 
OR nutrition*) NEAR/1 (behavior* OR habit* OR pattern*)):ab,ti)
OR
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 119
119
Protocol core outcome set for multimorbidity risk
Construct of interest (7): blood pressure
(‘blood pressure’/exp OR ‘blood pressure monitoring’/exp OR ‘abnormal blood pressure’/
exp OR ‘blood pressure measurement’/de OR ‘hypertension encephalopathy’/de OR ‘blood 
pressure monitor’/exp OR (((blood OR vessel* OR vascul* OR intravascul* OR venous OR 
arter*) NEAR/3 (pressure OR tension*)) OR hypotens* OR hypertens* OR prehypertens* 
OR normotens*):ab,ti)
OR
Construct of interest (8): blood lipids
(dyslipidemia/exp OR hyperlipidemia/exp OR hypolipemia/exp OR cholesterol/exp OR 
triacylglycerol/de OR dyslipid* OR hyperlipid* OR hypolip* OR cholester* OR triacylglycerol 
OR triglyceride* OR ‘lipid profile’:ab,ti)
NOT
Limitations
([animals]/lim NOT [humans]/lim) NOT ([Conference Abstract]/lim OR [Letter]/lim OR 
[Note]/lim OR [Editorial]/lim)
Note. Construct of interest (1) cardiorespiratory endurance was not included in the search strategy, since 
an existing, up-to-date systematic review was already identified. The search strategy was translated for 
MEDLINE/Ovid, MEDLINE/Pubmed, and PsychINFO. 6
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ABSTRACT
Objective: To identify existing outcome measurement instruments (OMIs) assessing risk 
factors for cardiometabolic disease in adolescents and adults with cerebral palsy (CP) 
reported on in the literature or used in the field.
Data Sources: The COnsensus-based Standards for the selection of health Measurement 
INstruments database of systematic reviews and 4 electronic databases (Embase, 
MEDLINE/Ovid, MEDLINE/Pubmed, PsychINFO) were searched up to June 19, 2017, that 
yielded 2594 articles. Experts in the field were consulted to identify any additional OMIs.
Study Selection: Two reviewers independently applied inclusion criteria to select eligible 
studies using or evaluating measurement properties of OMIs assessing 1 of 8 outcomes: 
cardiorespiratory endurance, body size, body composition, physical behavior, sleep, 
nutrition, blood pressure, and blood lipids and glucose. Studies with an experimental or 
observational design including ³10 adolescents or adults with CP were included.
Data Extraction: One reviewer extracted data that were summarized for study and sample 
characteristics, outcomes, OMIs used, and if applicable data on measurement properties. 
Two reviewers rated the methodological quality and the quality of the OMIs. Feasibility 
for clinical practice and research was rated by experts in the field.
Data Synthesis: Ninety OMIs were identified from 56 included articles and by the experts. 
Seventy OMIs pertained to cardiorespiratory endurance, body size, body composition, 
and physical behavior, whereas only 5 were identified for sleep and nutrition. Overall 
synthesis revealed that there is moderate to poor evidence for good quality of OMIs in 
this population. Based on feasibility for clinical practice, experts agreed on a single OMI 
per outcome (and 2 for cardiorespiratory endurance) to be included in a core set.
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INTRODUCTION
Emerging literature is demonstrating that individuals with cerebral palsy (CP) have a higher 
prevalence of chronic conditions and multimorbidity compared to the general population, 
including cardiometabolic diseases.1-3 Traditional risk factors like high blood pressure are 
common among adults with CP,3 but other factors like health-related fitness and lifestyle 
behaviors are also known to contribute to the risk for cardiometabolic disease.4-6 For some 
individuals with CP this may be the inevitable consequence of their mobility impairments,7 
but it may also relate to secondary conditions resulting from their primary condition,8 such 
as musculoskeletal problems or fatigue. Age further increases the risk of cardiometabolic 
disease in adults with CP.9 Since individuals with CP are living longer lives,10 it becomes 
important to develop specialized assessment and prevention strategies focusing on 
multimorbidity risk, and in particular, cardiometabolic health of people with CP
Cardiovascular diseases and metabolic conditions share a number of modifiable risk 
factors.11 According to the World Health Organization, lifestyle behavior changes are 
important ways to minimize the risk of cardiometabolic disease. In people with CP, 
promotion of health-related fitness and physical activity has gained much focus recently.12-17 
More recently, sleep and nutrition have been suggested as additional factors to optimize 
the overall health status of individuals with CP.18 Recommendations for exercise and daily 
physical behavior (physical activity and sedentary behavior19) specific to persons with 
CP were recently described,20 but recommendations pertaining to sleep and nutrition 
still require further research.18 In addition, multi-factorial lifestyle intervention programs 
focusing on health-promoting behaviors (exercise, physical behavior, sleep, and nutrition), 
taking into account the different primary and secondary consequences of CP, have not 
yet been developed.
The management of cardiometabolic health is focused on reduction of risk factors through 
primary prevention, or by screening persons on risk factors for cardiometabolic disease 
followed by lifestyle intervention programs.21 Given the high prevalence of cardiometabolic 
disease in adults with CP, screening them from an early age onwards is a critical strategy 
in their health management.2,22,23 However, screening programs for individuals with CP 
focusing on risk for cardiometabolic disease are lacking. Furthermore, there are no clear 
recommendations regarding the outcome measurement instruments (OMIs) to assess risk 
factors for cardiometabolic disease for use in this particular, heterogeneous population. 
Such recommendations are essential because healthcare providers need OMIs that are 
closely related to their (lifestyle) intervention programs. Developing a core set of evidence-
based and feasible OMIs will facilitate the standardization of assessment (i.e., screening 
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and monitoring) in people with CP. It will also minimize inconsistencies in reporting and 
facilitate comparison across clinical sites or studies.24,25 Broader uptake of such a core set 
will allow for the development of larger databases of longitudinal information,26 which can 
be aggregated for statistical purposes to improve our understanding of risk for chronic 
conditions in this population.
The multisite CP – Multimorbidity risk Assessment and Prevention consortium intends 
to develop a core set of OMIs assessing risk factors multimorbidity (i.e., the presence of 
multiple chronic diseases) in CP, including cardiometabolic disease, in which perspectives of 
all stakeholders (clinicians, researchers, and individuals with CP and/or their caregivers) are 
captured.27 In order to do so, an overview of existing OMIs and their quality first needs to 
be provided. The present study aimed to (1) identify all existing OMIs assessing outcomes 
related to cardiometabolic health in adolescents and adults with CP; (2) select 1 OMI for 
each outcome based on quality and feasibility for clinical practice and research.
METHODS
This study was performed as part of a larger project on the development of a core set of OMIs 
for multimorbidity risk in adolescents and adults with CP, of which details can be found in the 
study design.27 We followed recently published guidelines from a collaboration between the 
Core Outcome Measures in Effectiveness Trials (COMET) Initiative and COnsensus-based 
Standards for the selection of health Measurement INstruments (COSMIN)28 and report 
according to the Core Outcome Set–STAndards for Reporting (COS-STAR) Statement.29
Conceptual considerations
The target population and outcomes were determined by the CP – Multimorbidity risk 
Assessment and Prevention consortium during an in-person meeting among clinicians and 
researchers with leading expertise in this field in May 2017 in Amsterdam, the Netherlands. 
The target population was defined as post pubertal adolescents (14-18 years) and adults 
(>18 years) with CP. The following 8 outcomes were selected, representing health-related 
fitness, lifestyle behaviors, and traditional (bio)markers of cardiometabolic health: (1) 
cardiorespiratory endurance; (2) body size; (3) body composition; (4) physical behavior; (5) 
sleep; (6) nutrition; (7) blood pressure; (8) blood lipids and glucose.27
Systematic literature review
As our first source, we consulted the COSMIN database of systematic reviews to identify 
existing, up-to-date systematic reviews of OMIs measuring any of the determined outcomes 
in the CP population.
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 125
125
Core outcome set for cardiometabolic disease risk
As our second source, 4 electronic databases (Embase, MEDLINE/Ovid, MEDLINE/Pubmed, 
PsychINFO) were searched from January 1, 2000, until June 19, 2017, by combining search 
terms for the CP population with terms for the determined outcomes. Two reviewers (JB, 
PM) independently screened titles and abstracts of the resultant references, followed by 
full-text reviews of eligible articles, and finally, manual checking of reference lists of included 
studies. Inclusion criteria: studies using, or evaluating measurement properties of, an OMI 
measuring at least 1 of the outcomes; including ≥10 adolescents (14-18 years) or ≥10 adults 
(>18 years) with CP; experimental or observational study design; and English peer-reviewed 
publications. Studies were excluded if the participants’ mean age was <14 years, when no 
relevant OMIs were used or accurately defined, or when none of the outcomes were reported 
as an endpoint. Therefore, studies that reported an outcome solely as sample characteristic 
(e.g., body height and weight) but did not define how the outcome was measured were 
excluded. Reference lists of included studies were checked to find other candidate OMIs.
As our third source, prior to the consensus rounds of the Delphi procedure, experts were 
invited to propose additional OMIs that were not obtained from existing systematic reviews 
or in the literature search after they were informed on the results. These additional OMIs 
could have been ones that were being used in clinical practice, ones used by colleagues, 
ones used in a different population but deemed appropriate, or from a conference abstract 
or student’s thesis. Proposals had to be accompanied by a reference, abstract, or student’s 
thesis, in order for the reviewers to determine the quality.
Quality assessment
The first reviewer (JB) extracted relevant data from included studies, which was checked by 
the second reviewer (PM). To avoid duplication, multiple articles on the same study sample 
were combined. Study and participant characteristics (including CP type and severity), 
reported outcomes, and each OMI were recorded. Type of CP was defined as spastic 
unilateral, spastic bilateral, ataxic, dyskinetic, or mixed.30 The severity of motor impairment 
was determined by the Gross Motor Function Classification System (GMFCS)31,32.
The 2 reviewers conducted a 2-part quality assessment to assess (1) methodological quality, 
and (2) quality of the OMIs. Overall quality of each OMI was determined by combining the 
results of the 2 parts into a best-evidence synthesis.28
Methodological quality of studies on measurement properties was assessed using the 
COSMIN checklist.33 For each box corresponding to a measurement property that was 
reported on, items were rated as excellent, good, fair or poor.34 In line with recent adaptations 
to the checklist,35 the item concerning sample size (requiring n≥30 for a fair rating) was 
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ignored. Instead, we reported this as an additional comment to the methodological quality 
score. Methodological quality of randomized controlled trials (RCTs) or observational studies 
was assessed using 13 or 10 items of the McMaster critical review form, respectively.36 
Three items were only applicable to RCTs, 2 other items concerning measurement 
properties were ignored because we used more comprehensive criteria (part 2, quality of 
the OMIs). Items were rated as yes (meets criterion), no (does not meet criterion), or na 
(not applicable).36 For RCTs, sum scores of 13, 11-12, 9-10, and 8 or lower were considered 
excellent, good, fair, and poor; in observational studies this was 10, 9, 7-8, and 6 or lower.
Quality of the OMIs was assessed by rating results on measurement properties as positive, 
negative, or unknown (Table 7.1, upper panel).37 Content validity was rated first, because it 
should be clear that all content of the OMI was relevant, comprehensive, and comprehensible 
with respect to the outcome of interest and target population.28 If content validity was 
rated negative or unknown, the OMI was excluded from further consideration. Other 
measurement properties were also assessed if data were available from the included studies.
The overall quality of each OMI was constructed by a best-evidence synthesis, taking 
into account the number of studies using the OMI, the methodological quality of these 
studies, and the consistency of the results on measurement properties of the OMI.37 This 
information, along with a summary table of included studies, was presented to the experts 
in our Delphi surveys (Appendix 7.1).
Delphi procedure
A purposeful sample of experts from 4 clinical sites in Canada, the United States, and the 
Netherlands was invited to participate based on their clinical and research experience in the 
field of cardiometabolic health in adolescents and adults with CP, including pediatric and 
adult physiatrists and physical therapists, and those with expertise in the field of exercise 
physiology and physical behavior. Their role was to review and evaluate all OMIs on quality 
and feasibility, and eventually anonymously agree on the most suitable OMI per outcome 
for use in clinical practice and research.
In round 1, each expert was sent the complete list of OMIs, a summary table of included 
studies, and scoring instructions. The OMIs, sorted per outcome, were clarified by a 
short description, characteristics of study population in which they were applied, and the 
overall quality score. Experts were instructed to critically consider the quality and study 
population, and subsequently rate each OMI on a 10-point numeric rating scale (1=lowest, 
10=highest) for 4 aspects of feasibility and 1 overall rating (Table 7.1, lower panel). A 
comment box allowed experts to explain responses or raise concerns, or to indicate they 
were not familiar with or uncertain about a given OMI or outcome.
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Figure 7.1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow 
diagram of article selection process.
After receiving the experts’ scores, mean ratings were calculated and a synopsis of the experts’ 
comments was composed for each OMI. OMIs with mean overall feasibility scores ≥7 were 
classified appropriate, those with scores below 6 were classified inappropriate, and those 
with scores 6–7 were regarded uncertain. The investigators (JB, PM, JWG, MR) discussed 
the uncertain OMIs and determined whether or not they were appropriate, taking into 
account the experts’ comments, overall quality, and applicability across subgroups based on 
CP type and GMFCS level. OMIs classified as inappropriate, based on experts’ ratings and 
after discussion among investigators, were omitted. In the subsequent rounds, a modified list 
and feedback from the previous round was sent to the experts, who then, using the same 
approach, rated the remaining OMIs. In these rounds, experts were also instructed to consider 
the feedback and asked to identify their preferred OMI for each outcome and to explain why.
Achievement of final consensus was indicated by ≥70% agreement among experts on a 
single OMI for each outcome. This cutoff value was determined by the investigators a priori, 
based on varying cutoffs of 50% to 80% reported in the literature,38 and in consideration 
of the panel size. Accounting for possible lack of familiarity or uncertainty among 1 of the 
experts, agreement among 6 of 8 (75%), or 5 of 7 (71%) experts, would indicate consensus.
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Statistical analysis
Results for each round were collated and descriptive statistics (i.e., mean and standard 
deviation) were performed on the feasibility scores using Microsoft Excel 2010.
RESULTS
Existing OMIs
Two systematic reviews were found.39,40 The first included only studies of adolescents 
(10-18 years) with CP.39 The second included studies of adolescents (14-18 years) and 
adults (≥18 years) with CP.40 Only the latter was selected for inclusion due to age eligibility, 
from which 5 eligible articles were derived.40 A total of 2594 records were screened after 
the database search, before selecting another 49 eligible articles (Figure 7.1). Two other 
articles were included after experts’ additional OMI proposals.41,42 Finally, 56 articles were 
included: 32 were single articles of individual studies, and 24 represented multiple articles 
of 6 studies. Therefore, a total of 38 unique studies including 3699 individuals with CP 
were represented by the included articles (characteristics presented in Appendix 7.1).
The 8 selected outcomes were reported 78 times; a total of 90 OMIs were obtained 
(Table 7.2). Body size, body composition, and physical behavior were the most frequently 
measured outcomes, while sleep and nutrition were least frequently measured. Eight OMIs 
were excluded based on poor content validity. Overall quality syntheses were constructed 
for the remaining 82 OMIs.
Figure 7.2. Flow diagram of outcome measurement instrument selection process.
OMI, outcome measurement instrument.
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Table 7.2. Outcomes and outcome measurement instruments obtained from literature and through experts
Outcome Frequency of reports, n (%) OMIs obtained, n
Physical behavior 16 (43%) 17*
Objective system 8*
Self-report 9
Nutrition 2 (5%) 3
Sleep 2 (5%) 3*
Cardiorespiratory endurance 9 (24%) 11*
Laboratory 8
Field 2*
Body size 20 (54%) 20*
Body composition 16 (43%) 22
Circumferences 5
Density measures 17
Blood pressure 7 (19%) 8
Manual 1
Automated 5
Novel measures 2
Blood lipids and glucose 6 (16%) 6
Fasting 4
Non-fasting 2
Sum 78 90
Note. Relative frequency of reports (%) is relative to the number of included study samples (i.e. the 
denominator is 38). The number of reports and the number of OMIs obtained from literature do not 
always correspond, since (1) some studies reported multiple OMIs for the same outcome, and (2) the same 
OMI was sometimes reported in multiple studies. *OMIs were proposed by experts for this outcome. OMI, 
outcome measurement instrument.
Delphi rounds
All experts completed a total of 3 surveys between December 2017 and April 2018, 
with successive rounds resulting in truncated surveys. Figure 7.2 presents the number 
of OMIs that remained after each round for each outcome. After round 1, 40 OMIs were 
classified as appropriate, 4 as inappropriate, and 38 as uncertain. After consideration by 
the investigators a total of 46 OMIs remained. After round 2, 22 OMIs were appropriate 
and 24 were uncertain, of which 4 were considered appropriate, hence 26 remained. Of 
these, 13 were preferred and agreed-on by the experts, 6 were undecided and 7 were 
not preferred thus also excluded. Consensus was reached for sleep (n=1, 100%), nutrition 
(n=1, 86%), and blood lipids and glucose (n=1, 71%). Consensus was also reached for 
body size (n=3, 88%), body composition (n=5, 88%), and blood pressure (n=2, 100%), 
where multiple methods were acceptable for a similar OMI. For example, systolic and 
diastolic blood pressure should be measured with an automated sphygmomanometer 
(i.e., 1 OMI), regardless of the actual device (i.e., multiple methods). Hence, 10 agreed-on 
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methods reflected 3 agreed-on OMIs. Consensus was not yet reached for cardiorespiratory 
endurance (n=3; 50%, 33% and 17%, respectively), nor for physical behavior (n=3; 63%, 
25% and 12%, respectively). After reviewing the experts’ comments and considering the 
subgroups in which these 6 remaining OMIs were applied, the investigators selected 3 
(cardiorespiratory endurance, n=2; physical behavior, n=1), which were then proposed 
together with the other 6 agreed-on OMIs (including 10 methods for 3 OMIs) in round 3. 
Again, no consensus was reached for cardiorespiratory endurance (n=2; 57% and 43%, 
respectively). For the other 7 outcomes, all experts agreed on the proposed OMIs without 
opposing arguments. Table 7.3 presents the final selection; the obtained OMIs and selection 
process are described in more detail below.
Health-related fitness
1. Cardiorespiratory endurance: 11 OMIs were obtained, but 1 was excluded over poor 
content validity. Despite certain advantages of a field test, a laboratory test on a 
bicycle or arm-crank ergometer was preferred. Similarly, a maximal exercise test was 
preferred over a submaximal test, mainly because of reported negative criterion 
validity of the latter.43 Two OMIs were selected with the caveat that local, practical 
feasibility would be a deciding factor: (1) the continuous incremental protocol14,44,45 
with 12-second workload increments requires automated control of the ergometer, 
while (2) the McMaster all-out protocol5,46,47 with 2-minute workload increments can 
be conducted by manual control of the ergometer.
2. Body size: dependent on sample characteristics, different methods for the same 
outcome parameters were identified from the literature (20 OMIs). Height and 
weight were selected: for persons with GMFCS level I-II, they should be measured in 
a standing position (stadiometer, digital standing scale), and for persons with GMFCS 
level III-V in supine lying or seated positions (digital [wheel] chair scale). In case 
of contractures, height should be measured segmentally. Body mass index can be 
calculated, but the experts emphasized not to use it as a surrogate of body composition 
because of its underestimation of body fat particularly in this population.48
3. Body composition: similar to body size, different methods for the same parameters 
were identified from the literature (22 OMIs). These parameters included body density 
measures, such as skinfold thickness measurements, bioelectrical impedance analysis 
or dual-energy x-ray absorptiometry body scans. Body circumference measures 
were, however, rated more feasible. Waist circumference was selected: it should be 
measured in supine lying position, after expiration, at the narrowest part of the torso.
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Lifestyle behaviors
4. Physical behavior: 17 OMIs were obtained, but 5 had poor content validity. Self-
report questionnaires were considered practically feasible, but their overall quality 
was limited. Two self-report questionnaires were still included in round 2 (the Physical 
Activity Scale for Individuals with Physical Disabilities49 and the Physical Activity 
Recall Assessment for people with Spinal Cord Injury50); however, objective activity 
monitoring systems were rated higher. Following experts’ comments, the Activ841 was 
selected because of low cost, wearability during bathing and swimming, and its ability 
to measure types of physical behavior on top of volume and intensity.41
5. Sleep: 2 OMIs were obtained from the literature, and the Pittsburgh Sleep Quality 
Index (PSQI)51-54 was proposed by experts. Despite a lack of publications using it in our 
target population, the PSQI was rated highest and preferred by all experts.
6. Nutrition: 3 OMIs were obtained, but 1 was excluded over poor content validity. A 
Food Frequency Questionnaire (FFQ)55 was rated more feasible than a 3-day Food 
Diet History56.
Traditional (bio)markers
7. Blood pressure: 8 OMIs were obtained from the literature. Automated sphygmomanometers 
were preferred over a manual apparatus since the former do not require trained personnel. 
The actual device does not need to be uniform across sites, as long as it is regularly 
calibrated and a proper cuff size is used on the patient. Measurements should be 
performed in a seated position, after 10 minutes of rest, on the least affected side.
8. Blood lipids and glucose: 6 OMIs were obtained, but 1 was excluded over poor content 
validity. Venous blood measurements in a fasting state scored slightly higher on 
applicability than in a non-fasting state, however, the latter was selected to prioritize 
overall feasibility. Experts indicated to standardize the measurement with respect to 
timing (>1h after last meal) and diet (avoid high fat content meals). Preferred markers 
to obtain from the non-fasting venous blood measurement are total cholesterol, high-
density lipoprotein cholesterol, low-density lipoprotein cholesterol, TC/HDL-C ratio, 
triglycerides, and glucose.
DISCUSSION
This study aimed to identify all existing OMIs measuring risk factors of cardiometabolic 
disease in adolescents and adults with CP, and to select 1 OMI for each outcome based 
7
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 134
134
Chapter 7 
on quality and feasibility, before establishing a preliminary core set of OMIs for risk factors 
of cardiometabolic disease in this population. A systematic literature review identified 
90 OMIs with generally poor evidence on their quality in adolescents and adults with 
CP. Clinical and research experts gave informed comment on the feasibility of each OMI 
and came to an anonymous consensus on 9 OMIs pertaining to 8 outcomes related to 
cardiometabolic health for use in clinical practice and research.
In regard to measuring cardiorespiratory endurance, lab-based maximal exercise tests were 
more frequently reported in the literature compared to field-based tests, and these were 
also selected by the experts. In line with the systematic review of Lennon et al.40 and 
the Delphi study of Verschuren et al.57, this type of testing was preferred over an easier, 
minimal expertise requiring field-based test. Expressing preference between an extensive 
lab-based test, or a basic field-based test, reflects balancing between best-evidence 
measures and clinical utility. The current study had a strong emphasis on clinical utility, but 
in the end, the evidence we found on clinimetric properties of cardiorespiratory endurance 
test protocols was decisive in the selection of this OMI. Despite the agreement with the 
literature, however, lab-based tests might already be regularly applied in the clinical work 
setting of our experts, which could also explain their preference. This was not the case 
for body composition, where measurements such as dual energy X-ray absorptiometry or 
bioelectrical impedance analysis were not preferred, but this possibly also reflected experts’ 
inaccessibility or unfamiliarity with these instruments. Despite providing a more objective 
assessment, evidence for the quality of these OMIs was more limited than evidence for waist 
circumference. This quick and easy to use OMI has already been adopted in the general 
population, and according to Ryan et al.48, among other measures waist circumference is the 
best predictor of cardiometabolic risk in adults with CP regardless of age and GMFCS level.
Feasibility seemed to have less effect on selecting an OMI for the assessment of physical 
behavior, where an objective activity monitoring system was selected. Regarding the 
practical and assessor feasibility (i.e., costs, analyses and interpretation), one might expect 
a self-report questionnaire to score higher than an activity monitoring system. However, 
we found limited positive evidence for criterion validity of self-report questionnaires, 
which largely explained the choice of the experts. The modest set of OMIs we identified 
for measuring physical behavior and cardiorespiratory endurance in persons who rely on 
a wheelchair for daily mobility (GMFCS levels IV-V) was a concern. Fortunately, positive 
evidence for the Activ8 system to identify wheelchair propulsion was recently reported,58 
but further validation of this OMI in the non-ambulatory CP population is still needed. 
With regard to cardiorespiratory endurance, some experts suggested to translate the 
protocols for a bicycle ergometer to arm- or wheelchair ergometers. In the next phase of 
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our core set development,27 we will aim to determine whether the selected protocols can 
be performed on different ergometers by non-ambulatory persons with CP. Similarly, for 
physical behavior, we will aim to determine whether the Activ8 is feasible and provides 
valid results in the non-ambulatory population.
Results of our literature review confirmed that there has been an increasing interest 
in health-related fitness and physical activity promotion in people with CP, while sleep 
management and nutritional studies have received little attention to date.18 Comments 
from the experts confirmed that OMIs for the latter 2 outcomes were relatively unknown, 
despite our encouragements to request information directly from colleagues who might 
have more expertise in these areas. A recent systematic review in children with CP revealed 
that there are no psychometric data on currently used sleep measures in these youth.59 
We concluded that this also holds true for adolescents and adults with CP. Nevertheless, 
the currently selected questionnaire (PSQI) has positive construct validity in the general 
population and in other populations with a physical disability.53,54 Regarding nutrition, 
various assessment methods are available for the general population, with accompanying 
risk of misreporting.60 No validated tool to measure nutrition in adolescents and adults 
with CP was found in the literature. Because of this lack of evidence, the selection was 
thus mainly based on feasibility aspects. To our knowledge, the next phase of our core set 
development (i.e., feasibility study) will presumably be the first to apply an FFQ in a sample 
of adolescents and adults with CP.
As hypertension, hyperlipidemia, and hyperglycemia are among the key metabolic changes 
that increase the risk of cardiovascular disease,11 assessment of blood pressure and blood 
lipids and glucose had to be part of the core set. With the current selection of an automated 
sphygmomanometer, standard measurement of blood pressure in clinical practice and 
research is considered to be very feasible. Measuring levels of blood lipids and glucose 
requires more expertise and specialized analysis, and, particularly for younger individuals, 
blood draws may not always be feasible for the patient.
Towards a core set of OMIs for risk factors of multimorbidity
A core set generally recommends what should be measured and reported in all clinical trials 
of a specific population.61 Comprehensive core sets based on the International Classification 
of Functioning, Disability and Health have been developed for children and youth with CP of 
different age ranges, and recommendations for OMIs have also been published.62 These sets 
can be used on a population-wide basis, but only in age ranges 0 to 18 years. Similarly, the 
recently developed set of Common Data Elements (CDEs) for CP does not consider specific 
CDEs for adults.63 For those individuals with CP at transition or adult ages, Core Outcome 
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Sets are not yet available. Moreover, both the International Classification of Functioning, 
Disability and Health Core Sets for children and youth with CP and the CP CDEs are broad-
ranging. Trial developers thus still need to select their primary outcomes and OMIs of 
interest. In contrast, the current core set of OMIs with a focus on cardiometabolic disease 
is being developed as part of a larger project to assess multimorbidity risk in adolescents 
and adults with CP.27 In clinical practice, however, it might not be feasible to apply the total 
set that was currently selected. Moreover, as existing OMIs may be further validated and 
new OMIs may be developed, the ones selected for the current, preliminary core set might 
need to be reconsidered and replaced when new evidence becomes available.28
Perhaps even more important than a recommendation for research, our ultimate aim is to 
establish a core set that is feasible for clinical practice that can be used to screen, monitor, 
and intervene on risk factors for multimorbidity in CP. Follow-up programs for children 
with CP have already demonstrated their value in preventing and reducing the number 
of specific health issues.64-66 Such effects might also be achievable for multimorbidity risk 
in the next decades, but this requires further investigation of prevention strategies and 
multi-factorial (lifestyle) interventions. Although some of the selected OMIs still require 
further validation in the CP population –particularly body composition, sleep and nutrition– 
this initial selection already provides an evidence- and consensus-based starting point 
for further discussion and refinement. In a next publication we will report on a survey 
among adolescents and adults with CP addressing the importance of the outcomes, as 
well as an empirical multisite study to evaluate the feasibility of the selected OMIs in 
a clinical setting.27 These steps are expected to result in a final core set that, in future, 
enables screening for risk factors in clinical practice, as well as merging (prospectively) 
collected data into larger databases and performing meta-analyses.26 Taken together, this 
harmonization of measured outcomes will improve our understanding of multimorbidity, 
specifically cardiometabolic disease, in this population.
Study limitations
Certain limitations must be mentioned. Because we only selected studies published since 
2000 and in English, it is possible that studies were missed. Our aim was to find all OMIs 
that were being used in current clinical practice and research, hence the publication year 
cutoff. Moreover, additional OMIs were proposed by experts themselves. Clinimetric and 
psychometric data were limited. As such, we had to rely on experts’ individual views on 
feasibility and clinical utility of each OMI, which was in line with our aim of developing a 
feasible COS. Although the guideline provided a systematic approach, clear directions for 
consensus procedures were not defined.28 In addition, standardized methods for conducting 
and scoring a Delphi procedure are generally lacking. Finally, our sample of only 8 experts 
may not reflect a broad international perspective. Their fields of practice and research 
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directly relate to cardiometabolic health in the CP population, but for example including 
internists or dieticians may have strengthened our results. Views of patient stakeholders 
were not yet represented. We purposefully invited clinicians and researchers to participate 
in this preliminary work, as we assumed that quality ratings of OMIs would be hard to 
understand for patients. Therefore, the preliminary set will now be tested in a clinical 
setting and validated by patients and their families or caregivers.
CONCLUSIONS
Literature suggests that there are many different OMIs available to measure risk factors 
for cardiometabolic disease in adolescents and adults with CP. However, evidence of good 
quality is often lacking and feasibility for daily practice varies greatly. Moreover, OMIs to 
measure sleep and nutrition in this population are very limited. Nonetheless, clinicians 
and researchers with an expertise in this field have anonymously agreed on a preliminary 
core set of OMIs measuring risk factors for cardiometabolic disease: (1) a continuous 
incremental maximal exercise test on a bicycle-, arm-, or wheelchair ergometer (12-second 
or 2-minute intervals) to measure cardiorespiratory endurance; (2) standing or supine/
seated height and weight to measure body size; (3) supine waist circumference to measure 
body composition; (4) the Activ8 system to measure physical behavior; (5) the PSQI to 
measure sleep; (6) an FFQ to measure nutrition; (7) an automated sphygmomanometer to 
measure blood pressure; (8) a non-fasting venous blood measurement to measure blood 
lipids and glucose. This preliminary core set will now be evaluated by the target population 
and tested in clinic, before any final recommendations can be made.
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Chapter 8
Advances in healthcare have contributed to almost normal life expectancies for individuals 
with cerebral palsy (CP), with the majority living into later adulthood. Recently, lifespan issues 
and longitudinal research in adults with CP have received increased interest from researchers, 
healthcare professionals, and patients. Accordingly, this thesis focused on the level and long-
term course of functioning, disability, and health in adults with CP, and on standardization of 
outcome measurement in this population. First, we aimed to improve our knowledge on the 
consequences of CP at (increasing) adult age. Second, we identified the most studied outcomes 
for adults with CP, using the International Classification of Functioning, Disability and Health 
(ICF)1 framework. Finally, we developed a preliminary core outcome measurement set specifically 
for risk factors of chronic disease, specifically cardiometabolic disease, in individuals with 
CP. The current chapter discusses the main findings in the context of existing literature and 
describes methodological considerations. Furthermore, some guidance on how to adopt 
these findings into practice is provided, and directions for future research are described.
MAIN FINDINGS
The main findings of this thesis are summarized in Figure 8.1. We found that pain is a 
highly prevalent health issue in adults with CP, which increases from people’s thirties to 
their forties. Besides age, prevalence and characteristics of pain were associated with sex 
and the level of physical disability classified by the Gross Motor Functioning Classification 
System (GMFCS)2; females and those with GMFCS level II and IV had pain more frequently. 
Fatigue was the second most common health issue, which often co-occurred with pain. 
Other health issues remained stable over time, as did their perceived general health. 
Nevertheless, adults with CP had increasing concerns about their health and perceived 
an increasing impact of their CP on daily functioning activities. This was reflected in a 
decrease in independency in self-care and mobility on the long-term. We also found a 
decline in walking performance. In their forties, the majority of ambulant adults with CP no 
longer covered short distances by foot but opted for a wheelchair. Furthermore, we found 
that employment status remained stable over time, but weekly work hours decreased and 
employment was much lower compared to the general population. Females, adults with 
GMFCS level IV-V, and those with intellectual disability experienced (a) poorer (course 
of) employment outcomes. The most studied outcomes for adults with CP, according to 
literature published in the past decades, were: pain (body functions), walking, moving 
around, washing, dressing (activities), employment, and recreation/leisure (participation). 
Since adults with CP are known to have increased risk for developing cardiometabolic 
disease, we developed a core outcome measurement set for risk factors of cardiometabolic 
disease. We found that evidence for quality of measurement instruments is often lacking 
and that feasibility for clinical practice varies greatly. Clinicians and researchers with 
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expertise in this area, however, anonymously agreed on a core set that will be evaluated 
in 2019 in clinical sites in different countries.
In line with the content of this thesis (Figure 8.1), this general discussion contains two 
sections. The first section is entitled “Functioning, disability, and health of aging adults with 
CP” and discusses the main findings of Chapters 2-4. In these chapters, we studied the 
long-term consequences of CP at adult age and for individuals of different sex, GMFCS 
level, or intellectual disability, focusing on common health issues, self-care, mobility, 
and employment. The second section is entitled “Towards standardization of outcome 
measurement in adults with CP” and discusses the core outcomes for adults with CP we 
identified in Chapter 5, as well as the development of the core outcome measurement set 
for monitoring risk factors of chronic disease in CP (Chapter 6-7).
FUNCTIONING, DISABILITY, AND HEALTH OF AGING ADULTS 
WITH CP
Health issues
Pain is one of the most common secondary health issues in individuals with CP,3-6 but a reliable 
prevalence estimate was lacking nor was it clear whether pain changed with increasing age. 
In Chapters 2-3, we found that pain was highly prevalent in adults with CP and increased with 
age. Our meta-analysis (Chapter 2) demonstrated that pain is prevalent in 70% of adults with 
CP. This reliable estimate, determined in a large international sample of 1,243 adults with CP, 
is much higher compared to the general population, in which pain is prevalent in around 20%.7 
Women were more likely to report pain than men, and a higher risk of pain was demonstrated 
for adults with GMFCS level II and IV. Age or the presence of intellectual disability did not 
affect the overall mean pain prevalence. Adults with CP reported pain predominantly in the 
legs, while in the general population, pain is most commonly located in the back.7 Clinically, 
this may be explained by walking limitations with increased biomechanical strain causing an 
overload to the musculoskeletal functions of the legs.4, 8 This assumption is supported by the 
increased risk of pain in the legs in adults with GMFCS level III, a subgroup of individuals with 
CP with abnormal biomechanics and joint loading in walking. Pain was slightly less prevalent 
in the back/neck, and even less in the arms in adults with CP. Prevalence of pain in the arms 
increased with age, which could be explained by increased use of walking aids or wheelchairs 
as a consequence of the walking decline that is observed with aging in CP.9 Direct causes of 
pain were not studied in this meta-analysis and are still considered to be versatile in the CP 
population.10
8
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Figure 8.1. Schematic overview of the main findings of this thesis.
Although we did not find an association between overall pain prevalence and age in our 
meta-analysis, we demonstrated that pain increased after a 10-year follow-up period in our 
prospective cohort study (Chapter 3), from 58% in people’s thirties to 71% in their forties. 
Unfortunately, reliable longitudinal subgroup analyses were impossible due to the small sample 
size. Whether the above-mentioned associations between pain and sex and GMFCS level also 
are also longitudinal thus remains unknown. To date only one other longitudinal study reporting 
on pain in adults with CP also observed an increase in pain after a 7-year follow-up period.4 
Population based research showed that pain is already prevalent in one-third of children and 
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adolescents with CP and increases with age.11 So even before entering adulthood, pain seems to 
be a highly prevalent health issue for individuals with CP. Health professionals should therefore 
aim to monitor and treat pain from an early age onwards, and researchers should attempt to 
identify the primary causes and update treatment and therapies for pain in individuals with CP. 
This research idea is supported by researchers, health professionals, and adults with CP, who 
ranked it as the number one idea on a recent patient-centered research agenda.12
Chapter 3 also investigated the long-term course of other health issues that are common 
in CP. No changes were observed over time for presence of epilepsy, respiratory problems, 
constipation, or bowel and bladder incontinence, but gastrointestinal problems were 
reported more frequently at follow-up. Severe fatigue, only measured at follow-up, was 
present in 32% of adults with CP and co-occurred with pain in 46% of those reporting 
pain. Co-occurrence of pain and fatigue has previously been reported for adults with 
CP,6 and also for the general population.13 Possible explanations for this co-occurrence of 
fatigue next to pain include having a chronic condition such as arthritis, side effects of pain 
medication, or the association with anxiety or depression.13 In both the general population 
and for adults with CP, depression is more common in persons who report both pain and 
fatigue.6, 13 Although we did not study any psychological symptoms, we found that both 
pain and fatigue were explanatory for a poorer perceived health. Adults with CP became 
increasingly more worried about their health and perceived greater impact of their health 
problems on activities of daily living, despite that the majority continued to report good 
general health. This ambiguous finding confirms the existence of a “disability paradox” that 
can be explained by response shift phenomena, referring to a change in the meaning of 
one’s perception of the measured construct general health.14, 15 Individuals with CP seem 
to deal with their health issues and functional limitations as part of their lifelong disability, 
and thus rate their general health as any other.
Self-care and mobility
Earlier studies of adults with CP have demonstrated that limitations are present in activities of 
daily living such as self-care and mobility,9, 16, 17 but longitudinal reports were scarce. In Chapter 
3, we objectively studied the long-term course of self-reported self-care and mobility, and found 
that the independency to perform these activities deteriorated in adults with CP. Although most 
of our study participants reported similar levels of self-care and mobility performance around 
their forties compared to their thirties, almost 30% reported they became less independent 
in performing these activities as they aged. Possibly, the (increasing) presence of secondary 
health issues may have played a role here. Previous research has shown that pain and fatigue 
contribute to decreasing mobility in adults with CP,4 and that epilepsy, urinary incontinence, 
and gastrointestinal problems are also associated with lower functional status.18
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Focusing on the walking performance of adults with CP over time, we observed that walking 
short distances at home decreased with age, and that walking longer distances outdoors was 
already limited at a young adult age. This walking decline is frequently reported in people 
with CP, and indeed initiates early in adulthood.9 Besides an older age, walking decline has 
been associated with a person’s initial walking ability, distribution of motor impairment (i.e. 
unilateral or bilateral), and presence of pain or fatigue.9 Environmental factors that typically 
change in early adulthood, such as a person’s social environment or vocational pursuits, may 
result in additional stress and demands on walking. Walking decline is thus a multidimensional 
construct that includes changes in body functions, secondary health issues, participation, 
and contextual factors. Moreover, it is difficult to interpret due to the diversity of outcome 
measures used to capture walking. We investigated what adults with CP actually did in their 
daily environment (performance), not their capacity to walk, although these are known to be 
related.19 Performance change is potentially more sensitive to alterations in contextual factors, 
whereas capacity change may be more sensitive to alterations in body functions. The degree 
to which impaired body functions, secondary health issues (pain, fatigue), participation, and 
contextual factors are explanatory for the walking decline over the lifespan in adults with 
CP has to be further investigated. Nonetheless, our findings provide evidence for functional 
deterioration in aging with CP.
Employment
Employment is an important life area in which adults with CP experience restrictions in 
participation.20-23 Chapter 4 described the long-term course of employment in adults with 
CP and identified subgroups at risk for unemployment. Adults with CP showed a stable 
employment rate over a 14-year period of around 40% from their late twenties to their forties. 
Employment rate was consistently lower compared to the general population (around 80%), 
and particularly low among adults with GMFCS levels IV-V and among those with intellectual 
disability. Somewhat unexpected, we did not find any associations between employment and 
educational level. Others have reported that a high educational level was predictive of achieving 
competitive employment in adults with CP.21, 24 Implications for a link between a higher 
education level and having competitive work, as opposed to sheltered work, could be made 
from our study, but more detailed subgroup analyses were impossible due to the sample size.
Despite a long follow-up period, we studied employment until only halfway the expected 
working life. Literature suggests that employment decreases in adults with physical 
disabilities (including CP) from their forties onwards.23, 25 We found some reason to 
confirm this scenario, since weekly work hours decreased with increasing age. This, in 
turn, is complementary to literature describing that individuals with disability are more 
engaged in part-time work than their non-disabled peers.26 Subgroup analyses in our study 
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 153
153
General Discussion
demonstrated that this particularly holds for women, whereas men remained stable full-
time work hours. This phenomenon of growing part-time employment among women is 
also observed in the general population, likely explained by a cultural feature of women in 
a dual role of employee and primary caregiver.27
Lifespan perspective
The findings of Chapters 2-4 discussed above, and shown in Figure 8.1, clearly fits with the 
structure of the ICF framework. Despite its potentiality to describe functioning, disability, 
and health in a broad biopsychosocial context, the ICF does not allow us to describe 
any longitudinal consequences of a specific health condition. To better understand the 
consequences of CP at (increasing) adult age, it is important to also apply a temporal 
perspective on important outcomes for this population. The ‘lifespan approach to 
health’28, 29 may provide this perspective and is consistent with the ICF. In this conceptual 
model, outcomes of functioning and health can be depicted as a trajectory that can be 
influenced by contextual factors. Figure 8.2 presents proposed trajectories for people with 
CP and subgroups at risk that were studied in Chapters 2-4 of this thesis, supported by 
complementary literature. Although full trajectories are hard to create, this figure offers an 
initial attempt to approach the consequences of CP at adult age from a lifespan perspective.
Figure 8.2. Proposed lifespan perspective on important outcomes of functioning, disability, and 
health for adults with CP.
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The bandwidth of the CP trajectory indicates that functioning and health may vary across a 
range, dependent on certain personal characteristics. For example, employment is influenced by 
sex (i.e. women represent the lower limit of the bandwidth). Furthermore, adults with GMFCS 
levels IV-V and those with intellectual disability were at risk for unemployment, depicted by an 
“at risk” trajectory. Figure 8.2 also includes a horizontal bar representing the disability threshold. 
This bar indicates that, at a certain point in life, functional decline may reach a disabling level. The 
health issues and activity limitations we observed in our studies – whether or not interrelated – 
may cause an accelerated decline in functioning and health. Some adults with CP though state 
that their participation in life does not depend on maintaining independency, but on being able 
to manage and control their environment.30
One of the key aspects of the lifespan approach to health is the influence from the 
environment.28 In early adulthood, changes will occur in a person’s social environment 
or vocational, which may affect their functioning in a positive or negative sense. Positive 
influence from the environment can also be exerted by healthcare providers who may 
assist, through treatment and therapy, to counter a functional decline in individuals with CP. 
With that in mind, it is worrying that funding for studies of clinical interventions comprised 
only 19%, and CP in adulthood only 4%, between 2001 and 2013.31 Our own extensive 
literature review of publications on adults with CP (2000-2017, Chapter 5) demonstrated 
that only 11% of studies concerned intervention research. This means that the vast majority 
of research on adults with CP has been observational to date; this thesis is no exception. 
Recently, an American community of people living with CP and those providing healthcare 
to people with CP established a research agenda for CP.12 Similar actions are currently being 
undertaken by the Dutch CP-Net. The number one priority on the American research 
agenda was “investigate the issues around aging with CP, to understand not only how to 
treat adults now, but also to update our treatments and therapies (for children with CP) to 
prevent secondary healthy issues and functional loss”. This confirms the importance of a 
lifespan perspective and the demand for new evidence of effective interventions. Another 
highly prioritized research topic concerned “which outcomes are important to monitor/
treat early on in life to prevent development of health problems later on in life?”. In the 
next section, this question will be addressed.
TOWARDS STANDARDIZATION OF OUTCOME MEASUREMENT 
IN ADULTS WITH CP
Core outcomes
The results of Chapter 5 showed that, based on the existing literature, the most studied 
outcomes for adults with CP address pain, neuromusculoskeletal functions, mobility, self-
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care, employment and recreation/leisure. As such, the prevalence and long-term course 
of pain, mobility, self-care, and employment that were studied in the first part of this 
thesis provide important knowledge on functioning of adults with CP. This comprehensive 
systematic review also demonstrated that to date, mostly young adults with CP are studied; 
the mean age of all included study samples was only 31 years.
For children and youth with CP, movement-related body functions, mobility, and self-
care were also highly relevant outcomes in the ICF.32 However, pain and employment, 
as the most studied body impairment and participation outcome in adults with CP, were 
not often studied in children and youth with CP. Furthermore, outcomes addressing the 
ICF component activities and participation were more prevalent in the adult population 
compared to children and youth. These findings can be understood from the physiological 
and emotional differences that exist between children and adults. Children require attention 
to growth and experience developmental issues that are not typically present in adults; 
hence the difference in focus of (clinical) research. Each phase of the lifespan has its 
specific developmental challenges and therefore demands priority to specific outcomes, 
which is evident from the multiple ICF core sets for children and youth with CP (<6 years, 
6-13 years, and 14-18 years32, 33). The increasing attention for transition to adulthood is 
an important contribution to our knowledge and treatment approach. In the Netherlands, 
supported transition to adult roles is emerging, with modular interventions focused on 
participation outcomes showing promising effects.34-37
Our finding of a strong focus on the ICF component activities and participation is in line 
with the advances in rehabilitation medicine in the last decades.38, 39 Where the approach 
was initially mainly biomedical, nowadays a client-centered approach is often used and 
treatment goals are aimed at participation in major life areas.39 Adults with CP may, however, 
not benefit from these advances, indicated by the large decline in use of rehabilitation 
services after pediatric care.40, 41 The findings of the first part of this thesis indicate motives 
to visit an adult rehabilitation specialist. Adequate access to adult care is thus important18 
but requires better recognition and knowledge of the consequences of CP with advancing 
age, as well as appropriate follow-up and treatment to optimize functional status of people 
with CP. In addition to rehabilitation medicine, adults with CP eventually also visit other care 
providers. The ability to use a core set of outcomes in a universal language such as the ICF is 
then very valuable, both for interdisciplinary communication and to indicate the core areas.
It must be emphasized that the most studied outcomes identified in Chapter 5 only 
represent the perspective of researchers. To develop an ICF core set, perspectives of 
health professionals and of adults with CP should also be reflected.42 After all, there must 
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be agreement on what adults with CP want from their healthcare, what clinicians are aiming 
to achieve, and what researchers are focusing on. In addition to the present systematic 
review, qualitative and empirical studies are currently being conducted in order to develop 
an ICF core set for adults with CP.43 A previous qualitative study reported on experienced 
problems of young adults with CP to determine relevant topics for healthcare providers 
to target. The most frequent experienced problems included functional mobility, self-
care activities, active recreation, and employment.37 So far, these are in line with the 
researchers’ perspective described in Chapter 5. From the lifespan perspective to health, 
it can be expected that healthcare needs of adults with CP change over time, necessitating 
routine follow-up.44 Ongoing and future research can help to identify the core outcomes 
for adults with CP from all perspectives, before determining how these outcomes can 
best be measured.
Outcome measurement instruments
The total amount of 332 different outcome measurement instruments used in research on 
adults with CP (Chapter 5) not only reflects the large variation in outcomes that are considered 
relevant, but also indicates the lack of standardization in outcome measurement. This lack of 
standardization was already apparent in Chapter 2. Although we only studied one outcome (i.e. 
pain), we had to include a variety of measurement procedures in our meta-analysis. A similar 
variety in pain assessment tools for children with CP was recently found.45 We were able to 
dichotomize presence of pain and to convert scales of pain interference and pain intensity 
to common ones. Other outcomes of functioning and health, however, are more difficult 
to quantify and there are various measurement instruments to reflect them. This causes 
inconsistencies in reporting and induces difficulties in comparing and/or combining findings.46 
Moreover, quality of the instruments varies and the feasibility for clinical practice also differs 
considerably.47 Standardizing outcome measurement, in other words developing core outcome 
measurement sets, can be a solution to this problem.48 An example of this approach is the 
development of a core outcome measurement set for cardiometabolic disease risk.
Core outcome measurement set for cardiometabolic disease risk
Emerging evidence demonstrates that individuals with CP have a high prevalence of chronic 
diseases, including cardiometabolic conditions, compared to the general population.49-51 
Management of cardiometabolic health encompasses reduction of risk factors through 
prevention or by screening on risk factors potentially followed by (lifestyle) intervention 
programs.52 Therefore, in Chapter 7, we established a preliminary core outcome measurement 
set for risk factors of multimorbidity, focusing on cardiometabolic disease. Prior to identifying 
and selecting outcome measurement instruments, we selected the outcomes by a minimal 
approach (i.e. only researchers and clinicians were involved) since there is consensus on 
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risk factors of cardiovascular disease and metabolic conditions that are similar across 
populations.53 The selected outcomes and outcome measurement instruments, selected 
by means of a Delphi survey with international clinical and research experts, were (1) a 
continuous incremental maximal exercise test on a bicycle-, arm-, or wheelchair ergometer 
(12-second or 2-minute intervals) to measure cardiorespiratory endurance; (2) standing or 
supine/ seated height and weight to measure body size; (3) supine waist circumference to 
measure body composition; (4) the Activ8 system to measure physical behavior; (5) the 
Pittsburgh Sleep Quality Index to measure sleep; (6) a Food Frequency Questionnaire to 
measure nutrition; (7) an automated sphygmomanometer to measure blood pressure; (8) a 
non-fasting venous blood measurement to measure blood lipids and glucose.
In the development of the core outcome measurement set, we emphasized on the quality 
of the outcome measurement instruments as well as their feasibility for clinical practice 
(Chapter 6). As in Chapters 2 and 5, we identified many different outcome measurement 
instruments for the same outcomes. Evidence of good quality of these instruments was 
often lacking. For some outcomes, results of the Delphi survey with clinical and research 
experts reflected a combination of evidence of quality and feasibility for clinical practice. 
For other outcomes, one or the other was more decisive. For example, the results of the 
Delphi survey showed that cardiorespiratory endurance should be measured by the gold-
standard maximal exercise test adjusted to persons with CP (i.e. evidence of quality, but low 
feasibility), while sleep can be measured by a generic patient-reported questionnaire (i.e. 
no evidence of quality, but high feasibility). All selected outcome measurement instruments 
are generic with slight modifications for adults with CP. This is an advantage, since use of 
generic measures facilitates comparison between patient populations. Furthermore, many 
of the measurements can be performed outside the rehabilitation clinic.
METHODOLOGICAL CONSIDERATIONS
Study designs
The first aim of this thesis was addressed by a meta-analysis and a prospective cohort 
study; two study designs that are considered high in level of evidence.54 A major strength 
of our meta-analysis is that we included individual participant data, which allowed us to 
study subgroup effects on a large scale, resulting in reliable prevalence and risk estimates. 
On the other hand, all data came from cross-sectional measurements which prevented 
cause-effect relationships from being studied. Our prospective cohort study was unique 
for its considerable follow-up length after baseline. A drawback was that certain outcome 
measurement instruments or classification systems were not yet available at baseline, hence, 
outcomes and clinical characteristics were not consistently measured at all time points.
8
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The second aim was addressed by a systematic literature review and included specific 
methods of analysis: the ICF linking rules.55 Strength of this review was the use of a 
comprehensive search strategy and inclusive selection criteria, thereby providing a complete 
overview of the literature on adults with CP in the preceding 16 years. Furthermore, despite 
moderate initial agreement in the ICF linking, each step was conducted independently by 
two reviewers. Limitations were that no methodological quality assessment on the included 
studies was performed, and that only the commonly used identified outcome measurement 
instruments were linked to the ICF.
For the third aim, another systematic literature review was conducted, followed by a Delphi 
survey. Comparable strengths can be acknowledged; a comprehensive search strategy was 
used and all steps (study selection, methodological quality, quality of measurement properties) 
were performed by two reviewers. A limitation was that the search strategy did not include 
terms consistent with “measurement properties”, and that it was designed to identify studies 
on adolescents and adults with CP. We therefore may have missed outcome measurement 
instruments that have been assessed for their measurement properties in other populations 
but are applicable to individuals with CP. However, measurement properties should preferably 
be tested in individuals with CP, and it is uncertain whether findings on measurement 
properties can be translated between patient populations. The Delphi survey allowed us 
to capture the views of clinicians and researchers internationally and anonymously, but the 
inclusion of only eight experts may have led to a selection bias. Finally, a limitation in the 
development of the core outcome measurement set was that views of patient stakeholders 
were not yet represented. But as indicated in our protocol paper as a next step the preliminary 
core set will be evaluated by the target population and tested in clinic.
Generalizability
The chapters in the first part of this thesis (Chapters 2-4) described two study samples. 
The first included a large sample (n=1,243), which is outstanding for studies on adults with 
CP. Distribution of the demographic and clinical characteristics were representative,56 and 
individual participant data were collected from multiple studies carried out in multiple 
countries, resulting in high generalizability of the results. However, the varying contexts in 
which these individual studies were done might have influenced the results of our meta-
analysis. The second cohort sample was a smaller, regional sample but presented only minor 
loss to follow-up, limiting a potential selection bias. Loss to follow-up was not selective 
regarding age, sex, CP type, GMFCS level, or intellectual disability, and the distributions 
of these characteristics were similar to those reported in large population-based studies.56 
Due to the size of the sample, however, results should be interpreted carefully, specifically 
those from subgroup analyses.
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CLINICAL IMPLICATIONS
The research described in this thesis provides important leads to awareness of the 
consequences of CP at adult age, and of early detection of secondary health issues and 
cardiometabolic disease risk. The prevalence of health issues is increased in adults with CP 
compared to the general population and some of these are associated with poorer perceived 
health and functional loss. Many of the health issues and comorbidities experienced by 
adults with CP are also commonly seen in the general population with advancing age. To 
timely prevent these, clinicians should routinely screen and treat adults with CP – not just for 
issues associated with the disability, but also for risk factors of conditions that are common 
to aging in general. Three specific implications for clinical practice are elaborated below.
Our findings suggest that for individuals with CP, the threshold for disability may be reached 
at an earlier age (Figure 8.2) as a consequence of increasing health issues and decline 
of functional status. The rate and gradient of decline in functioning and health is partly 
determined by non-modifiable personal factors, but also by some behavioral factors that 
are modifiable through prevention and intervention programs, such as a healthy lifestyle 
intervention.35, 36 Therefore, a first implication is to make such programs available to (young) 
adults with CP, evaluate them regularly, and adjust when necessary or when new evidence 
becomes available. The outpatient clinic of Rijndam Rehabilitation offers specific programs 
for adults like ‘Dealing with long-term consequences of CP’ and ‘Healthy lifestyle for brain 
injury’ (including CP).57, 58 Furthermore, our young adult team, as a transitional service for 
individuals aged 16 to 25 years, aims to (1) continue rehabilitation care, (2) monitor and 
treat the condition, (3) optimize autonomy, and (4) educate on long-term consequences.59 
These initiatives and best practices are shared between centers in The Netherlands to 
accelerate the availability of transition care throughout the country.
Second, as discussed above, outcome measurement and treatment to optimize functional 
status is a core component of healthcare shared across multiple disciplines and specialties. 
So besides ensuring adequate access to rehabilitation care for adults with CP, if possible 
access to primary care should be supported when adequate. Providers of primary care 
must be educated on specific consequences of CP, treatment options in primary care, and 
on providers and treatment options in specialized rehabilitation care. This can be done by 
sharing information on the national CP-Net website,60 or by organizing regional information 
meetings. For example, results of this thesis were used in the recent symposium ‘Impact of 
CP in adulthood’ where we also received considerable interest from primary care providers.
Third, routine outcome monitoring in adulthood should be facilitated. A combined follow-
up and treatment register for CP is currently being implemented in the Netherlands.61 
8
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 160
160
Chapter 8
Many positive experiences have been gained for the follow-up of people with CP in other 
countries. For example, Scandinavians have been able to prevent major hip surgery later in 
life by continuing to follow children with hip problems.44 We recommend that the Dutch 
CP register will expand with registrations of outcomes that are important at adult age. The 
expected ICF core set for adults with CP, of which initial results are described in this thesis, 
can serve as a scientific basis for outcome selection. The core outcome measurement set for 
risk factors of chronic disease could be implemented immediately. In fact, the feasibility of 
this core set is currently being evaluated in Rijndam Rehabilitation. This core set, however, 
focuses on cardiometabolic disease risk and other comorbid health conditions may still 
be overlooked. Evidence is also pointing towards increased risk of musculoskeletal issues 
and mental issues compared to the general population.62-64 Developing core outcome 
measurement sets for the latter conditions is recommended, so clinicians can possibly apply 
a core set of a specific cluster of health issues rather than a continuum of outcomes, which 
might offer opportunities in terms of feasibility. To further minimize cost and burden for both 
patient and clinician/therapist, outcomes may be measured from a distance. For example, 
patient-reported outcome measures can be collected through web-based applications.
DIRECTIONS FOR FUTURE RESEARCH
The previous sections already introduced some directions for future research. Briefly, 
further studies are required to preserve insight into the level and long-term course 
of functioning and health of adults with CP. Standardized monitoring of personal 
characteristics and outcome measurement of individuals with CP will serve as a basis 
for future research. Moreover, multicenter research and international collaborations are 
important ways to synthesize knowledge of effectiveness of prevention and intervention 
strategies. Finally, collaboration with patient stakeholders is essential to meet the needs 
of adults with CP across the lifespan. Some specific recommendations for future research 
are discussed below.
There is a shortage of experimental studies in this population, including those showing how pain 
can best be treated in the adult with CP. Different treatment methods to improve outcomes 
related to pain, fatigue, and early functional loss should be explored. These will not only help 
us to understand how to treat adults now, but also to update our treatment and therapies 
for children with CP to early prevent some of the secondary health issues at adult age.
This thesis further uncovered the lack of research in adults with CP above middle age, 
despite the fact that adults with CP are known to have near-normal life expectancies. More 
insight is needed into the needs and levels of functioning of adults with CP above the age 
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of 45. Longitudinal studies with lengthy follow-up are needed to explore determinants of 
healthy aging with CP.
We have demonstrated that merging data leads to better study results of outcomes and 
potential determinants. Standardization of outcome measurement will make this much 
easier, but the success of outcome standardization lies in its implementation. The Dutch 
CP register aims to develop web-based monitoring applications using GemsTracker (GEneric 
Medical Survey Tracker), enabling multi-center distribution of forms and questionnaires 
in clinical practice and research. These actions will improve the feasibility of conducting 
core outcome measurement instruments. Ongoing research will in the near future result in 
an ICF core set for adults with CP. This core set should complement the ICF core sets for 
children and youth with CP to facilitate age-specific monitoring across the lifespan. This 
may provide a base for the development of a series of core outcome measurement sets, 
of which the one for cardiometabolic disease risk is an example. Systematic development 
and selection of core outcome measurement sets is key to effectively monitor adults with 
CP, and their implementation needs to be evaluated.
8
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 162
162
Chapter 8
REFERENCES
1. International classification of functioning, disability, and health: ICF. Version 1.0. Geneva: World 
Health Organization; 2001.
2. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of 
a system to classify gross motor function in children with cerebral palsy. Developmental medicine 
and child neurology 1997;39(4):214-23.
3. Jahnsen R, Villien L, Aamodt G, Stanghelle JK, Holm I. Musculoskeletal pain in adults with cerebral 
palsy compared with the general population. Journal of rehabilitation medicine 2004;36(2):78-84.
4. Opheim A, Jahnsen R, Olsson E, Stanghelle JK. Walking function, pain, and fatigue in adults 
with cerebral palsy: a 7-year follow-up study. Developmental medicine and child neurology 
2009;51(5):381-8.
5. Hirsh AT, Kratz AL, Engel JM, Jensen MP. Survey results of pain treatments in adults with cerebral 
palsy. American journal of physical medicine & rehabilitation 2011;90(3):207-16.
6. Van Der Slot WM, Nieuwenhuijsen C, Van Den Berg-Emons RJ, Bergen MP, Hilberink SR, Stam 
HJ et al. Chronic pain, fatigue, and depressive symptoms in adults with spastic bilateral cerebral 
palsy. Developmental medicine and child neurology 2012;54(9):836-42.
7. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: 
prevalence, impact on daily life, and treatment. European journal of pain (London, England) 
2006;10(4):287-333.
8. Kerr Graham H, Selber P. Musculoskeletal aspects of cerebral palsy. The Journal of bone and joint 
surgery British volume 2003;85(2):157-66.
9. Morgan P, McGinley J. Gait function and decline in adults with cerebral palsy: a systematic review. 
Disability and rehabilitation 2014;36(1):1-9.
10. McKinnon CT, Meehan EM, Harvey AR, Antolovich GC, Morgan PE. Prevalence and characteristics 
of pain in children and young adults with cerebral palsy: a systematic review. Developmental 
medicine and child neurology 2019;61(3):305-14.
11. Alriksson-Schmidt A, Hagglund G. Pain in children and adolescents with cerebral palsy: a 
population-based registry study. Acta paediatrica (Oslo, Norway : 1992) 2016;105(6):665-70.
12. Gross PH, Bailes AF, Horn SD, Hurvitz EA, Kean J, Shusterman M. Setting a patient-centered 
research agenda for cerebral palsy: a participatory action research initiative. Developmental 
medicine and child neurology 2018;60(12):1278-84.
13. Creavin ST, Dunn KM, Mallen CD, Nijrolder I, van der Windt DA. Co-occurrence and associations 
of pain and fatigue in a community sample of Dutch adults. European journal of pain (London, 
England) 2010;14(3):327-34.
14. Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Social science 
& medicine (1982) 1999;48(8):977-88.
15. Schwartz CE, Andresen EM, Nosek MA, Krahn GL. Response shift theory: important implications 
for measuring quality of life in people with disability. Archives of physical medicine and 
rehabilitation 2007;88(4):529-36.
16. Bottos M, Feliciangeli A, Sciuto L, Gericke C, Vianello A. Functional status of adults with cerebral 
palsy and implications for treatment of children. Developmental medicine and child neurology 
2001;43(8):516-28.
17. Andren E, Grimby G. Dependence in daily activities and life satisfaction in adult subjects with 
cerebral palsy or spina bifida: a follow-up study. Disability and rehabilitation 2004;26(9):528-36.
18. Fortuna RJ, Holub A, Turk MA, Meccarello J, Davidson PW. Health conditions, functional status 
and health care utilization in adults with cerebral palsy. Family practice 2018;35(6):661-70.
19. Holsbeeke L, Ketelaar M, Schoemaker MM, Gorter JW. Capacity, capability, and performance: 
different constructs or three of a kind? Archives of physical medicine and rehabilitation 
2009;90(5):849-55.
20. Liptak GS. Health and well being of adults with cerebral palsy. Current opinion in neurology 
2008;21(2):136-42.
21. Murphy KP, Molnar GE, Lankasky K. Employment and social issues in adults with cerebral palsy. 
Archives of physical medicine and rehabilitation 2000;81(6):807-11.
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 163
163
General Discussion
22. Michelsen SI, Uldall P, Kejs AM, Madsen M. Education and employment prospects in cerebral 
palsy. Developmental medicine and child neurology 2005;47(8):511-7.
23. Mitchell JM, Adkins RH, Kemp BJ. The Effects of Aging on Employment of People With and 
Without Disabilities. Rehabilitation Counseling Bulletin 2006;49(3):157-65.
24. Huang IC, Holzbauer JJ, Lee EJ, Chronister J, Chan F, O’Neil J. Vocational rehabilitation services 
and employment outcomes for adults with cerebral palsy in the United States. Developmental 
medicine and child neurology 2013;55(11):1000-8.
25. Tornbom M, Jonsson U, Sunnerhagen KS. Work participation among middle-aged persons with 
cerebral palsy or spina bifida--a longitudinal study. Disability and health journal 2014;7(2):251-5.
26. Pagán R. Transitions to part-time work at older ages: the case of people with disabilities in Europe. 
Disability & Society 2012;27(1):95-115.
27. Damaske S, Frech A . Women’s Work Pathways Across the Life Course. Demography 
2016;53(2):365-91.
28. Kuruvilla S, Sadana R, Montesinos EV, Beard J, Vasdeki JF, Araujo de Carvalho I et al. A life-course 
approach to health: synergy with sustainable development goals. Bulletin of the World Health 
Organization 2018;96(1):42-50.
29. Kemp BJ. What the rehabilitation professional and the consumer need to know. Physical medicine 
and rehabilitation clinics of North America 2005;16(1):1-18, vii.
30. Moll LR, Cott CA. The paradox of normalization through rehabilitation: growing up and growing 
older with cerebral palsy. Disability and rehabilitation 2013;35(15):1276-83.
31. Wu YW, Mehravari AS, Numis AL, Gross P. Cerebral palsy research funding from the National 
Institutes of Health, 2001 to 2013. Developmental medicine and child neurology 2015;57(10):936-41.
32. Schiariti V, Klassen AF, Cieza A, Sauve K, O’Donnell M, Armstrong R et al. Comparing contents 
of outcome measures in cerebral palsy using the International Classification of Functioning (ICF-
CY): a systematic review. European journal of paediatric neurology : EJPN : official journal of the 
European Paediatric Neurology Society 2014;18(1):1-12.
33. Schiariti V, Longo E, Shoshmin A, Kozhushko L, Besstrashnova Y, Krol M et al. Implementation of 
the International Classification of Functioning, Disability, and Health (ICF) Core Sets for Children 
and Youth with Cerebral Palsy: Global Initiatives Promoting Optimal Functioning. International 
journal of environmental research and public health 2018;15(9).
34. Verhoef JA, Roebroeck ME, van Schaardenburgh N, Floothuis MC, Miedema HS. Improved 
occupational performance of young adults with a physical disability after a vocational rehabilitation 
intervention. Journal of occupational rehabilitation 2014;24(1):42-51.
35. Slaman J, Roebroeck M, Dallmijer A, Twisk J, Stam H, Van Den Berg-Emons R. Can a lifestyle 
intervention programme improve physical behaviour among adolescents and young adults with 
spastic cerebral palsy? A randomized controlled trial. Developmental medicine and child neurology 
2015;57(2):159-66.
36. Slaman J, van den Berg-Emons HJ, van Meeteren J, Twisk J, van Markus F, Stam HJ et al. A lifestyle 
intervention improves fatigue, mental health and social support among adolescents and young 
adults with cerebral palsy: focus on mediating effects. Clinical rehabilitation 2015;29(7):717-27.
37. Nieuwenhuijsen C, Donkervoort M, Nieuwstraten W, Stam HJ, Roebroeck ME. Experienced 
problems of young adults with cerebral palsy: targets for rehabilitation care. Archives of physical 
medicine and rehabilitation 2009;90(11):1891-7.
38. Wade DT, de Jong BA . Recent advances in rehabilitation. BMJ (Clinical research ed) 
2000;320(7246):1385-8.
39. Cardol M, De Jong BA, Ward CD. On autonomy and participation in rehabilitation. Disability and 
rehabilitation 2002;24(18):970-4; discussion 5-1004.
40. Hilberink SR, Roebroeck ME, Nieuwstraten W, Jalink L, Verheijden JM, Stam HJ. Health issues 
in young adults with cerebral palsy: towards a life-span perspective. Journal of rehabilitation 
medicine 2007;39(8):605-11.
41. Roquet M, Garlantezec R, Remy-Neris O, Sacaze E, Gallien P, Ropars J et al. From childhood to 
adulthood: health care use in individuals with cerebral palsy. Developmental medicine and child 
neurology 2018;60(12):1271-7.
8
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 164
164
Chapter 8
42. Selb M, Escorpizo R, Kostanjsek N, Stucki G, Ustun B, Cieza A. A guide on how to develop an 
International Classification of Functioning, Disability and Health Core Set. European journal of 
physical and rehabilitation medicine 2015;51(1):105-17.
43. Noten S, Benner JL, Limsakul C, Van Der Slot W, Stam H, Selb M et al. Developing an ICF Core 
Set for adults with cerebral palsy. 31st Annual meeting of the European Academy of Childhood 
Disability (EACD). Paris: Dev Med Child Neurol Suppl; 2019. p 13.
44. Alriksson-Schmidt AI, Arner M, Westbom L, Krumlinde-Sundholm L, Nordmark E, Rodby-Bousquet 
E et al. A combined surveillance program and quality register improves management of childhood 
disability. Disability and rehabilitation 2017;39(8):830-6.
45. Schiariti V, Oberlander TF. Evaluating pain in cerebral palsy: comparing assessment tools using 
the International Classification of Functioning, Disability and Health. Disability and rehabilitation 
2018:1-8.
46. Gorst SL, Gargon E, Clarke M, Smith V, Williamson PR. Choosing Important Health Outcomes for 
Comparative Effectiveness Research: An Updated Review and Identification of Gaps. PloS one 
2016;11(12):e0168403.
47. Prinsen CA, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M et al. How to select outcome 
measurement instruments for outcomes included in a “Core Outcome Set” - a practical guideline. 
Trials 2016;17(1):449.
48. Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S et al. Core Outcome Set-STAndards 
for Development: The COS-STAD recommendations. PLoS medicine 2017;14(11):e1002447.
49. Peterson MD, Ryan JM, Hurvitz EA, Mahmoudi E. Chronic Conditions in Adults With Cerebral 
Palsy. Jama 2015;314(21):2303-5.
50. Whitney DG, Hurvitz EA, Ryan JM, Devlin MJ, Caird MS, French ZP et al. Noncommunicable disease 
and multimorbidity in young adults with cerebral palsy. Clinical epidemiology 2018;10:511-9.
51. McPhee PG, Claridge EA, Noorduyn SG, Gorter JW. Cardiovascular disease and related risk 
factors in adults with cerebral palsy: a systematic review. Developmental medicine and child 
neurology 2018.
52. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P et al. Priority actions for the 
non-communicable disease crisis. Lancet (London, England) 2011;377(9775):1438-47.
53. World Health Organization. Global status report on noncommunicable diseases 2014. Geneva, 
Switzerland; 2014.
54. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. 
Chest 1989;95(2 Suppl):2s-4s.
55. Cieza A, Fayed N, Bickenbach J, Prodinger B. Refinements of the ICF Linking Rules to strengthen 
their potential for establishing comparability of health information. Disability and rehabilitation 
2016:1-10.
56. Colver A, Fairhurst C, Pharoah PO. Cerebral palsy. Lancet (London, England) 2014;383(9924):1240-9.
57.  Rijndam Revalidatie. Omgaan met langetermijngevolgen van Cerebrale Parese [10-06-2019]. 
Available from: https://www.rijndam.nl/speciale-programmas/omgaan-met-langetermijngevolgen-
van-cerebrale-parese.
58. Rijndam Revalidatie. Behandelmodule gezonde leefstijl [10-06-2019]. Available from: https://
www.rijndam.nl/speciale-programmas/behandelmodule-gezonde-leefstijl.
59. Roebroeck M, Nieuwenhuijsen C, Donkervoort M, Wiegerink D, van Meeteren J, Stam HJ. Lost in 
transition? Unmet needs and implementation of special teams for young adults with a disability. 
Developmental medicine and child neurology Supplement 2005;47(103):50.
60. CP-Net. CP-Net [10-06-2019]. Available from: URL: https://www.cp-net.nl.
61. Nederlands CP register. Website van het Nederlands CP register [10-06-2019]. Available from: 
http://cpregister.nl.
62. Whitney DG, Hurvitz EA, Devlin MJ, Caird MS, French ZP, Ellenberg EC et al. Age trajectories 
of musculoskeletal morbidities in adults with cerebral palsy. Bone 2018;114:285-91.
63. O’Connell NE, Smith KJ, Peterson MD, Ryan N, Liverani S, Anokye N et al. Incidence of 
osteoarthritis, osteoporosis and inflammatory musculoskeletal diseases in adults with cerebral 
palsy: A population-based cohort study. Bone 2019;125:30-5.
64. Smith KJ, Peterson MD, O’Connell NE, Victor C, Liverani S, Anokye N et al. Risk of Depression 
and Anxiety in Adults With Cerebral Palsy. JAMA neurology 2018.
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 165
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 166
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 167
Summary
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 168
168
Summary
SUMMARY
This thesis focuses on the consequences of aging with cerebral palsy (CP) and on outcome 
measurement of functioning and health in this population. The first part (Chapters 2-5) 
aimed to describe the level and long-term course of functioning and health in adults with 
CP, for which the International Classification of Functioning, Disability, and Health (ICF) was 
used. This framework was also used to describe the most studied outcomes in adults with 
CP since 2000, in order to identify core outcomes for this population from the researchers’ 
perspective. The last part (Chapters 6-7) focused on outcome measurement for a specific 
set of outcomes, namely risk factors for cardiometabolic disease; comorbid conditions 
for which people with CP have increased risk. Results of this thesis may contribute to 
the development of systematic follow-up of adults with CP, in which core outcomes are 
monitored and treated, ultimately allowing us to design appropriate interventions and 
prevention strategies for people aging with CP.
Chapter 1 contains a general introduction on the topics that are addressed in this thesis, 
including a description of the population, an introduction on the ICF framework to describe 
functioning and health, and some background on outcome measurement and core set 
development. This chapter concludes with the aims and outline of this thesis.
Chapter 2 describes a systematic literature review and meta-analysis of individual participant 
data addressing pain in adults with CP. Seventeen eligible studies were included from a 
comprehensive literature search. We obtained the individual participant data from 15 
studies, including a total of 1,243 adults with CP from Europe, West Asia, Australia, and 
North America. In this large pooled database, we determined a pain prevalence estimate 
of 70% in adults with CP. Women were more likely to report pain than men and adults with 
Gross Motor Function Classification System (GMFCS) levels II and IV had a higher pain 
prevalence compared to adults with GMFCS level I. Pain was mostly located in the legs, 
but also common in the neck/back and arms. Adults with GMFCS level III had increased 
risk of pain in the legs, while adults of 45 years and older had increased risk of pain in the 
arms. Pain intensity and pain interreference with daily activities and employment were 
mild on average and did not differ between subgroups. The prevalence estimate found in 
this meta-analysis is the most reliable to date and underscores the need for routine pain 
screening in adults with CP.
In Chapter 3, we studied long-term changes in perceived health, health issues, self-care 
and mobility in a representative Dutch cohort of adults with CP. Outcomes were measured 
at baseline (21-31 years), 4-year follow-up (25-35 years), and 14-year follow-up (35-45 
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years) using self-report questionnaires. Most participants continued to report good general 
health, but at a later age more adults became worried about their health and more adults 
perceived higher impact of health issues on activities of daily living. The proportion of 
adults with CP reporting pain increased from 55% to 71% in 10 years’ time. Gastrointestinal 
problems increased, while the presence of epilepsy, respiratory problems, constipation, and 
bowel and bladder incontinence did not change. Severe fatigue was present in 32% of the 
participants and often co-occurred with pain. Regarding self-care and mobility, the Barthel 
Index showed a small but significant decrease over time, and the percentage of adults with 
CP walking short distances decreased (83% to 71% inside the house). For walking long 
distances this percentage was already limited in young adulthood.
The course of employment over 14 years was studied for this cohort in Chapter 4. Overall, 
the employment rate remained stable over time (38-45%) but significantly lower compared 
to the general population (69-83%). Adults with an intellectual disability, adults with 
bilateral CP, and adults with GMFCS levels IV and V had the lowest employment rates. 
The employment rate, however, increased over time for adults with intellectual disability 
(sheltered work) and for adults with bilateral CP. Among those employed the weekly work 
hours decreased by an average of 4 hours/week as they aged, which was comparable to 
the general population. Work hours specifically decreased for women (9 hours/week).
Chapter 5 describes a systematic literature review that identified the most studied 
outcomes of functioning reported in studies on adults with CP published since 2000. Using 
a comprehensive literature search we included 199 studies, which describe a large variety 
of outcomes in a total of 32,933 adults with CP (18-84 years). The overall distribution of the 
type of CP and GMFCS was representative of the population, but the majority of studies 
included small samples of adults around the age of 30. The results further highlight a lack 
of experimental research, a limited focus of research on older adults with CP, and a wide 
variety in outcome measurement instruments used in clinical practice and research. The 
most commonly used outcome measurement instruments were linked to the ICF in order 
to determine the most studied – or core – outcomes in adult CP research so far. Pain, joint 
mobility (body functions), mobility, self-care, employment, and recreation (activities and 
participation) were the most studied outcomes.
The study protocol in Chapter 6 describes the rationale and design for the development 
of a core set of outcome measurement instruments for multimorbidity risk in adolescents 
and adults with CP to be used in clinical and research. First, the target population and the 
outcomes to be measured are defined. By means of a literature review and a Delphi survey 
with international clinical and research experts, the outcome measurement instruments 
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that can best measure these outcomes are determined. These instruments are tested in a 
feasibility study with adolescents and adults with CP from an international clinical research 
network. Chapters 7 describes the initial results of this project, that aims to standardize 
outcome measurement between centers, and ultimately to guide clinical practice and 
research (understanding, treating and preventing) on multimorbidity risk, focusing on 
cardiometabolic disease, in this population.
Chapter 7 describes the results of the first steps of the core set development. We defined 
the target population as adolescents (14-18 years) and adults (>18 years) with CP, and 
selected the following outcomes addressing eight risk factors of cardiometabolic disease: 
cardiorespiratory endurance, body composition, physical behavior, sleep, nutrition, blood 
pressure, and blood lipids/glucose. A total of 90 existing outcome measurement instruments 
for these outcomes were identified in the literature. We assessed their quality according 
to the Consensus-based standards for the selection of health measurement instruments 
(COSMIN). Results were then presented to a panel of experts who scored each instrument 
on aspects of feasibility in three iterative rounds. We found that many of the identified 
outcome measurement instruments lacked evidence of good quality in the defined target 
population of adolescents and adults with CP. Furthermore, only some instruments were 
available to measure sleep and nutrition. Feasibility scores provided clear indications of 
the application of each instrument in clinical practice. The experts anonymously agreed 
on a preliminary core set of 9 outcome measurement instruments to measure the eight 
risk factors for cardiometabolic disease.
Chapter 8 of this thesis contains the general discussion. The main findings are interpreted 
and discussed in the context of published literature on adults with CP. The importance 
of a lifecourse perspective in research and treatment of people with CP is emphasized. 
In addition, standardization of outcomes and measurement instruments, and systematic 
follow-up of people with CP is elaborated. Finally, methodological considerations and 
clinical implications are discussed, as well as directions for future research in this field.
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Dit proefschrift richt zich op de gevolgen van ouder worden met cerebrale parese (CP) 
en op het meten van uitkomsten op het gebied van functioneren en gezondheid in deze 
populatie. In het eerste deel (Hoofdstukken 2-5) wordt het niveau en het langetermijn 
beloop van functioneren en gezondheid bij volwassenen met CP beschreven, waarvoor de 
Internationale classificatie van het menselijk functioneren (ICF) werd gebruikt. Ditzelfde 
raamwerk werd gebruikt om de uitkomsten te beschrijven die sinds 2000 het meest zijn 
onderzocht bij volwassenen met CP. Hiermee konden de belangrijkste uitkomsten voor 
deze populatie worden bepaald vanuit het perspectief van onderzoekers. Het laatste 
deel (Hoofdstukken 6-7) focust zich op meetinstrumenten voor een specifieke set van 
uitkomsten, namelijk risicofactoren voor cardiometabole aandoeningen; secundaire 
aandoeningen waarvoor mensen met CP een verhoogd risico hebben. De resultaten van 
dit proefschrift kunnen bijdragen aan de ontwikkeling van systematische follow-up van 
volwassenen met CP, waarbij de belangrijkste uitkomsten op het gebied van functioneren 
en gezondheid worden gemonitord en behandeld. Dit kan ons uiteindelijk in staat stellen 
om passende interventies en preventiestrategieën te ontwerpen voor mensen die ouder 
worden met CP.
Hoofdstuk 1 bevat een algemene introductie op de onderwerpen die in dit proefschrift 
worden behandeld, waaronder een beschrijving van de populatie, een inleiding over het ICF-
raamwerk om het functioneren en de gezondheid te beschrijven en achtergrondinformatie 
over het meten van uitkomsten en het ontwikkelen van zogenaamde core sets. Het 
hoofdstuk besluit met de doelstellingen en de opzet van dit proefschrift.
Hoofdstuk 2 beschrijft een systematische literatuurstudie en meta-analyse van data 
van individuele deelnemers gericht op pijn bij volwassenen met CP. Zeventien studies 
kwamen in aanmerking na een uitgebreid literatuuronderzoek. We verkregen de data 
van individuele deelnemers uit 15 studies, waardoor in totaal 1.243 volwassenen met CP 
uit Europa, West-Azië, Australië en Noord-Amerika werden geïncludeerd. In deze grote 
samengevoegde database vonden we een nauwkeurige schatting van de prevalentie van 
pijn van 70%. Vrouwen rapporteerden vaker pijn dan mannen en volwassenen met Grof 
Motorisch Functionering Classificatie Systeem (GMFCS) niveaus II en IV hadden een 
hogere prevalentie van pijn in vergelijking met volwassenen met GMFCS niveau I. Pijn was 
voornamelijk aanwezig in de benen, maar ook vaak in de nek/rug en armen. Volwassenen 
met GMFCS niveau III hadden een verhoogd risico op pijn in de benen, terwijl volwassenen 
van 45 jaar en ouder een verhoogd risico hadden op pijn in de armen. De intensiteit van pijn 
en impact van pijn op dagelijkse activiteiten en werk waren gemiddeld mild en verschilden 
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niet tussen subgroepen van verschillend geslacht, leeftijd of GMFCS niveau. De in deze 
meta-analyse gevonden pijn prevalentie is tot op heden de meest betrouwbare schatting, 
en benadrukt dat pijn periodiek dient te worden gemonitord bij volwassenen met CP.
In Hoofdstuk 3 bestudeerden we langetermijn veranderingen in ervaren gezondheid, 
gezondheidsproblemen, zelfverzorging en mobiliteit in een representatief Nederlands 
cohort van volwassenen met CP. Uitkomsten werden gemeten op baseline (21-31 jaar), 4-jaar 
follow-up (25-35 jaar), en 14-jaar follow-up (35-45 jaar) met behulp van zelf gerapporteerde 
vragenlijsten. De meeste deelnemers bleven op de langetermijn een goede algemene 
gezondheid rapporteren, maar op latere leeftijd maakten meer deelnemers zich zorgen over 
hun gezondheid en ervoeren meer deelnemers een hogere impact van gezondheidsproblemen 
op activiteiten in het dagelijks leven. Het aantal volwassenen met CP met pijn steeg van 55% 
naar 71% over 10 jaar tijd. Gastro-intestinale problemen namen toe, terwijl de aanwezigheid 
van epilepsie, ademhalingsproblemen, constipatie en incontinentie van de darmen en de 
blaas niet veranderde met de leeftijd. Ernstige vermoeidheid was aanwezig bij 32% van de 
deelnemers, vaak samen met pijn. Zelfverzorging en mobiliteit, gemeten met de Barthel Index, 
lieten een kleine maar significante achteruitgang zien en het percentage volwassenen met 
CP dat korte afstanden lopend aflegt nam af (83% naar 71% in huis). Lange afstanden lopen 
was voor de meerderheid al beperkt vanaf een jongvolwassen leeftijd.
Ook het beloop van betaalde arbeidsparticipatie over een periode van 14 jaar werd 
bestudeerd voor dit cohort (Hoofdstuk 4). Het percentage volwassenen met CP met betaald 
werk bleef stabiel over de tijd (38-45%), maar was wel lager dan in de algemene bevolking 
(69-83%). Volwassenen met bilaterale CP, volwassenen met GMFCS niveau IV en V en 
volwassenen met een verstandelijke beperking, hadden minder vaak betaald werk. De 
kans op het hebben van betaald werk nam echter toe met de leeftijd voor volwassenen 
met bilaterale CP en voor volwassenen met een verstandelijke beperking (op een sociale 
werkplaats). De volwassenen die werkten gingen gemiddeld 4 uur/week minder werken 
naarmate zij ouder werden, maar dit was vergelijkbaar met de algemene bevolking. De 
arbeidsuren daalden vooral onder vrouwen met CP (9 uur/week).
Hoofdstuk 5 beschrijft een systematische literatuurstudie waarin de meest onderzochte 
uitkomsten van functioneren in volwassenen met CP zijn beschreven in studies die sinds 
2000 zijn gepubliceerd. Op basis van een uitgebreide zoekactie hebben we 199 studies 
geïncludeerd die diverse uitkomsten beschrijven van in totaal 32.933 volwassenen met CP 
(18-84 jaar). De verdelingen van het type CP en GMFCS niveau waren representatief voor 
de populatie, maar de meeste studies werden uitgevoerd bij kleine aantallen van vooral 
jongvolwassenen van rond de 30 jaar. De resultaten benadrukken verder een gebrek aan 
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experimenteel onderzoek, een beperkte focus van onderzoek bij oudere volwassenen 
met CP, en een grote verscheidenheid in meetinstrumenten die worden gebruikt in de 
klinische praktijk en onderzoek. De meest gebruikte meetinstrumenten werden gelinkt 
aan de ICF om de tot nu toe meest onderzochte (‘core’) uitkomsten in het onderzoek 
naar volwassen met CP in kaart te brengen. Pijn, gewrichtsmobiliteit (lichaamsfuncties), 
mobiliteit, zelfverzorging, werk en recreatie (activiteiten en participatie) waren de meest 
bestudeerde uitkomsten.
Het onderzoeksprotocol in Hoofdstuk 6 beschrijft de aanleiding en opzet voor de 
ontwikkeling van een core set van meetinstrumenten om het risico op multimorbiditeit 
bij adolescenten en volwassenen met CP te meten in de praktijk en onderzoek. De eerste 
stap betreft het definiëren van de doelpopulatie en de te meten uitkomsten. Aan de hand 
van een literatuurstudie en een Delphi studie met internationale en deskundige clinici en 
onderzoekers wordt bepaald welke meetinstrumenten deze uitkomsten het beste kunnen 
meten bij deze doelpopulatie. Deze meetinstrumenten worden vervolgens toegepast in een 
haalbaarheidsstudie met adolescenten en volwassenen met CP in een internationaal klinisch 
onderzoeksnetwerk. Hoofdstuk 7 beschrijft de voorlopige resultaten van dit project, dat 
uiteindelijk gericht is op het verbeteren van de klinische praktijk en onderzoek om het 
risico op multimorbiditeit, met de nadruk op cardiometabole aandoeningen, systematisch 
te monitoren in deze populatie.
Hoofdstuk 7 presenteert de eerste stappen om te komen tot deze core set. Het consortium 
definieerde de doelpopulatie als adolescenten (14-18 jaar) en volwassenen (> 18 jaar) met CP, 
en selecteerde de volgende acht uitkomsten die het risico op cardiometabole aandoeningen 
in kaart brengen: cardiorespiratoir uithoudingsvermogen, lichaamssamenstelling, 
beweeggedrag, slaap, voeding, bloeddruk en bloed lipiden- en glucosewaarden. In de 
literatuur vonden we in totaal 90 bestaande meetinstrumenten voor deze uitkomsten. 
De kwaliteit van deze meetinstrumenten werd beoordeeld volgens bestaande normen. 
De resultaten werden vervolgens voorgelegd aan een panel van deskundigen die werden 
gevraagd om ieder instrument te scoren op aspecten van de haalbaarheid in drie iteratieve 
rondes. We constateerden dat veel van de gevonden meetinstrumenten een gebrek 
aan bewijs van goede kwaliteit in onze doelpopulatie hadden. Verder bleken er weinig 
instrumenten beschikbaar om slaap en voeding te meten. De haalbaarheidsscores gaven 
duidelijke indicaties voor de (fictieve) toepassing van ieder instrument in de klinische 
praktijk. De deskundigen zijn anoniem tot consensus gekomen over een voorlopige core set 
van 9 meetinstrumenten om de risicofactoren voor cardiometabole aandoeningen te meten.
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 177
177
Samenvatting
Hoofdstuk 8 van dit proefschrift bevat de algemene discussie. Hier worden de belangrijkste 
bevindingen geïnterpreteerd en bediscussieerd binnen de context van huidige literatuur 
over volwassenen met CP. Het belang van een levensloop perspectief in het onderzoek en 
de behandeling van mensen met CP wordt benadrukt. Daarnaast krijgen het standaardiseren 
van uitkomsten en meetinstrumenten, en het systematisch opvolgen van mensen met CP 
die ouder worden voldoende aandacht. Tot slot worden de toegepaste methodologieën 
en de klinische implicaties van de resultaten besproken, alsook onze aanbevelingen voor 
toekomstig onderzoek op dit gebied.
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waren zeer waardevol, jouw verrassende kijk op de toekomstige zorg en wetenschap zeer 
inspirerend. 
Dr. Roebroeck, beste Marij, co-promotor en dagelijks begeleider. Veel dank voor je 
vertrouwen en de energie die je erin hebt gestoken om mij tot dit punt te begeleiden. Jouw 
vele jaren onderzoekservaring waren voor mij bij aanvang zeer leerzaam, en gaandeweg 
heb ik jou ook nieuwe inzichten mogen geven. Bedankt ook voor je raad tijdens drukke 
of stroeve periodes, je interesse in mijn leven buiten het werk, en natuurlijk voor de 
gezelligheid tijdens onze (buitenlandse) tripjes. Veel succes met de uitdagende taken die 
in het verschiet liggen bij het kinderhersencentrum!
Mijn andere co-promotor dr. Hilberink, beste Sander, veel dank voor je begeleiding. Jouw 
ervaringen, zowel in het onderzoek en persoonlijk, zijn voor mij een mooi voorbeeld 
geweest. Ook toen we wat meer ‘op afstand’ van elkaar werkten toonde je altijd interesse 
en spraken we regelmatig af voor een bakkie om even bij te kletsen. Ik heb veel bewondering 
voor jou als persoon en als professional, en wens je het allerbeste in je nieuwe rol als lector 
bij de Hogeschool Rotterdam! 
Leden van de leescommissie, dr. Catsman-Berrevoets, prof.dr. de Groot en dr. Terwee, u 
wil ik hartelijk danken voor uw tijd en de snelle besluitvorming rondom de goedkeuring 
537270-L-sub01-bw-Benner
Processed on: 11-11-2019 PDF page: 181
181
Dankwoord
van dit proefschrift. Ook dank ik graag alle leden van de grote commissie voor hun tijd om 
tijdens de verdediging met mij in gesprek te gaan over de resultaten. 
Dr. van der Slot, beste Wilma, veel dank voor de altijd fijne samenwerking en je klinische 
blik. In alle fasen van alle studies kon ik een beroep op je doen, met gezamenlijke publicaties 
als resultaat. Dr. van den Berg-Emons, beste Rita, dank voor de samenwerking, goede 
begeleiding en waardevolle feedback op mijn stukken. Erg blij was ik met de kans om mee 
te werken aan de implementatie van de leefstijlinterventie voor mensen met hersenletsel 
in Rijndam. Dr. Selles, beste Ruud, ook jij bedankt voor de kans om samen te werken en je 
begeleiding binnen de Re-Arm studie.
I also want to thank my North American coauthors. Prof.dr. Gorter, beste Jan Willem, 
bedankt voor de mogelijkheid voor een werkbezoek aan de McMaster University, Hamilton, 
Canada. Ik heb de gastvrijheid bij CanChild en onze samenwerkingen zeer gewaardeerd. 
Dr. McPhee, dear Patrick, thanks for the fruitful collaboration, your hospitality during 
my visit to Hamilton, and the pleasant company during the European and American 
conferences. Thanks to Dr. Hurvitz and Dr. Peterson for their involvement and offering 
a different perspective than that of the Dutch. Dr. Verschuren en dr. Balemans, beste 
Olaf en Astrid, dank ook voor jullie bijdrage aan de manuscripten, de nieuwe inzichten en 
prettige samenwerking. 
Dank aan de studenten die ik heb mogen begeleiden tijdens hun stage, zowel in Rotterdam als 
op de Hogeschool van Amsterdam. Dank ook aan mijn mentoren van de docentenopleiding, 
Inge, Roos, Pauline en Frank, mede dankzij jullie heb ik mijn didactische aantekening 
bemachtigd in deze periode. Mijn huidige collega’s bij Noordwest Ziekenhuisgroep en de 
faculteit Gedrag- en Bewegingswetenschappen: bedankt voor jullie interesse bij de laatste 
fase van mijn promotietraject en de ruimte die ik krijg om mezelf verder te ontwikkelen 
als onderzoeker.
Veel dank aan mijn (oud-)collega’s in het Erasmus MC en Rijndam. De refereerbijeenkomsten 
op donderdag waren een vast leermoment tijdens mijn promotie, allen die daarbij aanwezig 
waren dank ik voor de vele lessen en input op mijn werk. Hetty Mulder, dank dat ik altijd 
bij je terecht kon, zéker in de laatste fase. Dank ook aan alle therapeuten in Rijndam met 
wie ik op verschillende momenten heb mogen samenwerken. Het moge duidelijk zijn dat 
ik jarenlang met ontzettend veel plezier op de 16e heb gewerkt, waar iedereen altijd 
wilde meedenken en er ruimte was voor een lach en een traan. Ik heb genoten van de 
verscheidene borrels, etentjes, competitieve uitdagingen (bijv. de trappenloop of beer-pong) 
en de Tour de Rotterdam. De grote kamer was altijd gevuld met gezelligheid, goede koffie, 
D
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vele traktaties, work-outs, gesprekken over Ajax… ik mis het nu al! In random volgorde: 
Nienke, Karin, Malou, Marlou, Iris, Hanneke, Lianne, Lianne, Rutger, Ruben, Wouter, Kerstin, 
Joris, Chonnanid, Everett, Hanneke, Levinia, Bram, Bram, Fabienne, Anna, Herwin, Emiel, 
Suzie en Marloes; bedankt! 
Lieve paranimfen, Suzie en Marloes, super bedankt dat jullie naast mij staan tijdens 
de verdediging. Suzie, meerdere jaren zaten we aan hetzelfde bureau, dachten en 
discussieerden we over onze studies, analyseerde en schreven we samen, en moedigden 
we elkaar aan. Dat laatste ga je tijdens mijn verdediging ook weer doen, dank daarvoor! 
Marloes, onbewust hebben we een bijna identieke weg bewandeld de afgelopen jaren. 
Fysiotherapeuten die het in de wetenschap gingen proberen, het op hetzelfde moment 
in het hoger onderwijs aandurfde, en nu beiden gaan promoveren. We hebben een hoop 
(van elkaar) geleerd en met elkaar kunnen delen, waarvoor dank! 
Lieve vrienden en familie, bedankt voor jullie interesse in mijn onderzoek maar vooral ook 
voor de fijne momenten buiten het werk. Een hoop van jullie weten misschien niet eens wat 
ik nou precies deed, maar juist daarom kon ik het werk loslaten en lekker ontspannen. Ik 
hoop dat we dit nog heel lang met elkaar mogen doen! Lieve pap en mam, dank voor jullie 
enthousiasme, support en liefde al 31 jaar lang. Jullie hebben me altijd gestimuleerd om het 
beste uit mezelf te halen, om te groeien en vooruit te kijken, maar ook om te waarderen 
wat je reeds hebt. Ik weet dat jullie trots op me zijn, bedankt!
Tot slot dank aan mijn alles. Lieve Tjerk, ontzettend bedankt voor je optimisme, vertrouwen 
en onvoorwaardelijke steun bij alles wat ik aangrijp. Hoeveel wij nog iedere dag van elkaar 
leren is ongekend, en waren we ook heen gaan, samen kunnen we de wereld aan. Dank 
voor ons leven samen waar ik altijd van geniet!
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PhD period: 2015-2019
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1. PhD training
Year Workload
(ECTS)
General academic skills
- Grant Application, BCF Career, Amsterdam
- Research Integrity, Erasmus MC, Rotterdam
Research skills
- Regression analysis, NIHES Erasmus MC, Rotterdam
- Longitudinal data-analysis, EpidM VUMC, Amsterdam
In-depth courses
- Systematic literature search, Medical library Erasmus MC, Rotterdam
- EndNote, Medical library Erasmus MC, Rotterdam
2019
2018
0.9
0.3
2015
2015
1.9
3.0
2016
2016
0.6
0.2
Presentations
 - Poster presentation: Outcomes measured in adults with cerebral palsy: 
a systematic review using the International Classification of Functioning, 
Disability and Health (ICF). EACD 31st annual conference, Paris
2019 0.3
 - Oral presentation: Understanding and preventing multimorbidity in adolescents 
and adults with cerebral palsy: an emphasis on health-promoting behaviors. 
Regional meeting for rehabilitation physicians, Rotterdam
2018 0.5
 - Oral presentation: Developing an ICF Core Set for adults with cerebral palsy: 
results of a systematic literature review. PhD-day VvBN, Amsterdam
2018 0.5
 - Seminar: Understanding and preventing multi-morbidity in adolescents and 
adults with cerebral palsy: an emphasis on health-promoting behaviours. 
AACPDM 72nd annual meeting, Cincinnati
2018 0.5
 - Poster presentation: Multi-morbidity risk assessment and prevention in clinical 
practice: establishing and testing a core outcome set for adolescents and adults 
with cerebral palsy. AACPDM 72nd annual meeting, Cincinnati
2018 0.3
 - Oral presentation: Aging with cerebral palsy comes with deterioration of health 
and functioning. ISPRM 12th world congress, Paris
2018 0.5
 - Oral presentation: Multimorbidity risk assessment in adolescents and adults 
with cerebral palsy: establishing a core outcome set for clinical research and 
practice. Research meeting department of Rehabilitation Medicine
2018 0.5
 - Oral presentation: Cerebrale parese in de maatschappij: maatschappelijk 
functioneren. Symposium ‘Impact van CP op volwassen leeftijd’, Rotterdam
2018 0.5
 - Oral presentation: Course of employment in adults with cerebral palsy over a 
14-year period. AACPDM 71st annual meeting, Montréal
2017 0.5
 - Oral presentation: Long-term deterioration of perceived health and functioning 
in adults with cerebral palsy. EACD 29th annual conference, Amsterdam
2017 0.5
 - Poster presentation: Course of employment in adults with cerebral palsy over 
a 14-year period. EACD 29th annual conference, Amsterdam
2017 0.3
 - Oral presentation: Impact van langdurige beperkingen op het dagelijks leven 
van volwassenen met cerebrale parese. Research meeting department of 
Rehabilitation Medicine
2016 0.5
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Presentations
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 - Oral presentation: Stability of employment in adults with cerebral palsy in the 
long-term. DCRM 2016, Maastricht
2016 0.5
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mobiliteit en arbeidsparticipatie van volwassenen met cerebrale parese: studie 
protocol. Research meeting department of Rehabilitation Medicine
2015 0.5
International conferences and symposia
 - EACD 31st annual conference, Paris
 - COMET 7th meeting, Amsterdam
 - AACPDM 72nd annual meeting, Cincinnati
 - ISPRM 12th world congress, Paris
 - AACPDM 71st annual meeting, Montréal
 - EACD 29th annual conference, Amsterdam
 - DCRM 2016, Maastricht
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0.3
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0.9
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2018
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0.3
0.1
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0.3
0.3
0.2
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 - Training ‘HBO-docent medisch-biologische vakken’; Vrije Universiteit, 
Amsterdam
2017-2018 22.5
Other
 - Participating in research meetings, department of Rehabilitation Medicine
 - Project member ‘Implementatie behandelmodule Gezonde Leefstijl bij 
hersenletsel’, Rijndam Revalidatie, Rotterdam
 - Organizing member symposium ‘Impact van CP op volwassen leeftijd’, Rotterdam
 - Work visit CanChild McMaster University, Hamilton
 - Organizing member PhD-day VvBN, Rotterdam
 - Interview ‘Het is niet mijn lichaam, maar mijn hoofd dat de grenzen bepaalt’, 
BOSK Magazine
 - Organizing research meetings, department of Rehabilitation Medicine
 - Contribution to ‘Zorgen om de revalidatiezorg aan volwassenen met cerebrale 
parese’, BOSK & Rijndam Revalidatie
2015-2019
2017-2018
2016-2018
2017
2017
2017
2016-2017
2016
6.0
2.0
2.0
4.0
0.5
0.2
2.0
1.0
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2. Teaching activities
Year Workload
(ECTS)
Lecturing
 - Courses of Bachelor program Physical Therapy, AUAS, Amsterdam 2017-2018 6.0
Supervision of students
 - Co-supervising scientific internship student Movement Technology
 - Supervising review assignment of medical students
 - Supervising bachelor theses of students Physical Therapy
 - Supervising review assignment of medical students
2019
2019
2018
2017
0.5
0.4
2.5
0.4
Other
 - Contribution to scientific course Clinical Technology 2017 0.2
Total 72
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International Society of Physical and Rehabilitation Medicine; VvBN, Vereniging voor Bewegingswetenschappen 
Nederland.
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